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Mature oocytes are held in a developmentally-quiescent, arrested state.  For 
development to occur, these oocytes must transition to a new cellular state that can 
support the processes of embryogenesis.  This transition is achieved by the events of 
egg activation.   
 My studies focused on protein phosphorylation changes that take place during 
egg activation in Drosophila.  Because there is little or no transcription at this time, 
egg activation is directed by maternal mRNAs and proteins regulated through post-
transcriptional and post-translational mechanisms.  Phosphorylation is an abundant 
post-translational modification with a wide array of regulatory effects.  In addition, 
phosphorylation regulators such as CaMKII and calcineurin are required for egg 
activation in a variety of organisms.  We hypothesize that simultaneously changing the 
phosphorylation states of a large number of proteins is a key contributor to the cellular 
changes that encompass the oocyte-to-embryo transition.    
I applied two different proteomic methods, IMAC and 2D-gel electrophoresis, 
to identify the proteins that change in phosphorylation state between mature oocytes 
and unfertilized, activated eggs.  This led to the identification of 311 proteins that are 
phospho-modulated during egg activation.  I used RNAi to knock down the genes that 
encode some of these proteins, testing a total of 71 genes for effects on female 
 fertility.  I identified multiple candidates for future study including, mrityu, which is 
required for progression through the early rounds of embryonic mitosis.   
I also used the phosphorylation changes of two proteins identified from the 
proteomics experiments, Spindly and Vap-33-1, as “molecular markers” to examine 
how the egg activation genes sarah, cortex, and prage relate to the phosphorylation 
changes that take place at egg activation.  I showed that all three genes are upstream of 
Spindly dephosphorylation, but only sarah and cortex are upstream of Vap-33-1 
phosphorylation.  These data, along with previous findings in the lab, suggest that 
sarah and cortex act in a common pathway.   
Overall, my studies have contributed to our understanding of the roles of 
protein phosphorylation during egg activation.  My results show that phosphorylation 
is an important area of study if we are to discover the proteins and pathways that 
regulate the oocyte-to-embryo transition. 
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CHAPTER ONE 
 
INTRODUCTION1 
 
Egg activation is the final transition that an oocyte goes through to become a 
developmentally competent egg.  This transition is usually triggered by a calcium-
based signal that is often, but not always, initiated by fertilization.  Activation 
encompasses a number of changes within the egg.  These include changes to the egg’s 
membranes and outer coverings to prevent polyspermy and support the developing 
embryo, as well as resumption and completion of the meiotic cell cycle, mRNA poly-
adenylation, translation of new proteins, and the degradation of specific maternal 
mRNAs and proteins.  The transition from an arrested, highly differentiated cell, the 
oocyte, to a developmentally active, totipotent cell, the activated egg or embryo, 
represents a complete change in cellular state.  This is accomplished by altering ion 
concentrations and widespread changes in both the proteome and the suite of mRNAs 
present in the cell.  Here, we review the role of calcium and zinc in the events of egg 
activation, and the importance of macromolecular changes during this transition.  The 
latter include the degradation and translation of proteins, protein post-translational 
regulation through phosphorylation, and the degradation of maternal mRNAs. 
Introduction  
At the end of oogenesis, mature oocytes are held in a developmentally-
quiescent, arrested state until an appropriate trigger initiates development.  In these 
                                                 
1 This chapter is submitted to Current Topics in Developmental Biology as Krauchunas, A.R. and 
Wolfner, M.F., “Molecular changes during egg activation.” 
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specialized cells, the cell cycle is paused and maternally provided mRNAs and 
proteins are stored until their time to function.  If development is to be successful, the 
oocyte must undergo one final transition from this steady state to a new cellular state 
that can support embryogenesis.  This transition is referred to as “egg activation”.  
Without this step of oocyte development, fertilization cannot lead to the creation of an 
embryo. 
The events of egg activation include cortical granule exocytosis (in many taxa) 
and the block to polyspermy, translation of new proteins, decreases in Mitogen 
Activated Protein Kinase (MAPK) activity, and resumption of the cell cycle through 
inactivation of Maturation Promoting Factor (MPF; composed of Cdc2 kinase and 
cyclin B) and activation of the Anaphase Promoting Complex (APC/c).  Without these 
changes the egg cannot limit fertilization to a single sperm, nor direct events of 
development such as mitosis and embryonic patterning.  Egg activation as a whole 
process, as well as specific events such as meiotic cell cycle regulation, have been 
well reviewed elsewhere (Tsaadon et al., 2006; Horner and Wolfner; 2008b; Li et al., 
2010; Marcello and Singson, 2010; Gadella and Evans, 2011; Liu, 2011).  Here we 
present egg activation as it relates to a complete cellular/molecular transition, through 
the regulation of ion concentrations, the suite of mRNAs present within the cell, and 
the composition of the proteome.  
Understanding how an oocyte becomes developmentally competent through 
egg activation is an important aspect of diagnosis and treatment of female infertility, 
especially as the field continues to work towards improved assisted reproductive 
technologies.  In addition, egg activation provides a unique model system to study the 
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transition from a differentiated cell to a totipotent cell.  In some ways, egg activation 
can be viewed as the converse of the change that the daughter cell of a stem cell 
undergoes when it differentiates, and is similar in concept to the cellular change 
required to form induced pluripotent cells. Upon fertilization, the highly differentiated 
oocyte suddenly becomes a one-cell embryo, which will give rise to all the varied 
cells, tissues, and organs of a complete multicellular organism.  This transition 
represents a large and rapid change in cellular state and requires a number of 
molecular changes that must be both highly regulated and properly coordinated.   
Ion Levels 
Calcium  
While the specific trigger of egg activation varies among organisms – from 
fertilization in vertebrates, to mechanical stimulation in some insects, to changes in pH 
or ionic environment for some marine invertebrates (reviewed in Horner and Wolfner, 
2008b) – a rise in intracellular calcium appears to be the nearly universal signal that 
sets off the events of egg activation.  As the regulation and role of this calcium signal 
has been extensively reviewed (Parrington et al., 2007; Horner and Wolfner, 2008b; 
Wakai et al., 2011; Nomikos et al., 2012), we will describe it only briefly here.   
In vertebrates, fertilization leads to a rise in cytosolic Ca2+ in the egg which is 
responsible for initiating all of the events of egg activation (Horner and Wolfner, 
2008b; Wakai et al., 2011).  In mammals, this Ca2+ rise is mediated by a sperm-
specific phospholipase C (PLCζ) (Saunders et al., 2002; reviewed in Wakai et al., 
2011 and Nomikos et al., 2012).  When a sperm enters the egg, PLCζ hydrolyzes 
phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-triphosphate (IP3) and 
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diacyl glycerol (DAG).  IP3 then binds its receptor (IP3R1), which results in the release 
of Ca2+ from internal stores in the endoplasmic reticulum and an overall rise in 
cytosolic Ca2+ in the egg (Wakai et al., 2011).  A recent report also showed that Ca2+-
influx from the external environment is necessary for complete egg activation in the 
mouse, suggesting greater complexity to the regulation of the Ca2+ signal than 
previously presumed (Miao et al., 2012).   
In some organisms, Ca2+ levels in the egg continue to rise and fall in an 
oscillatory pattern following fertilization.  In mammals, these oscillations last for 
several hours (Stricker, 1999).  The importance of the oscillatory nature of the Ca2+ 
signal is still a matter of discussion, though a couple of theories have been proposed 
(reviewed in Wakai et al., 2011).  Ducibella et al. (2002) showed that, in mouse, 
different egg activation events are sensitive to different numbers of calcium 
oscillations.  For instance, a single Ca2+ pulse is enough to initiate cortical granule 
exocytosis, while resumption of the cell cycle requires at least 4 Ca2+ pulses 
(Ducibella et al., 2002).  In addition, the number of Ca2+ pulses required for 
completion of egg activation events is greater than the number required to initiate 
those events; 8 Ca2+ pulses is not enough for polar body formation even though exit 
from metaphase arrest had been initiated (Ducibella et al., 2002).  However, other 
evidence suggests that the Ca2+ oscillations are not strictly required for proper egg 
activation.  A single large Ca2+ rise induced by ethanol can generate an equal number 
of embryos with a polar body as Ca2+ oscillations induced by Sr2+ (when observed six 
hours after exposure) and produces an equivalent percentage of embryos that develop 
full term (Rogers et al., 2006; Suzuki et al., 2010b).  This has led to the proposal that 
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it is the overall magnitude of the Ca2+ increase produced by the oscillations, rather 
than the actual oscillatory nature of the Ca2+ rise, that is necessary for the events of 
egg activation to occur (Ducibella et al., 2006; Ozil et al., 2006).   
The mechanisms of Ca2+ regulation at egg activation are less characterized in 
non-mammalian systems, though Ca2+ signaling itself appears to be a relatively 
conserved feature of the oocyte-to-embryo transition.  A sperm PLC has not yet been 
identified outside of mammals, though a different PLC (PLCγ), along with Src-family 
kinases, has been implicated in the activation of the phosphoinositide pathway during 
fertilization in Xenopus (reviewed in Sato et al., 2006).  In C. elegans, a single Ca2+ 
increase has been observed at the time of fertilization, but how this Ca2+ signal relates 
to the events of egg activation, or if it is dependent on a sperm-derived factor, is not 
yet known (Samuel et al., 2001).  Supporting the idea that the Ca2+ rise seen in C. 
elegans plays a role analogous to that seen in other species, knocking out a C. elegans 
IP3 receptor, itr-1, results in sterility, suggesting that the Ca2+ rise is necessary for 
development (Dal Santo P et al., 1999; Samuel et al., 2001).  A single Ca2+ rise also 
occurs in zebrafish during egg activation (Lee et al., 1999). Here, the Ca2+ rise is 
dependent on the RNA-binding protein brom bones, which acts upstream of IP3-
mediated Ca2+ release (Mei et al., 2009).  In Drosophila, in vitro experiments show 
that removal of Ca2+ from the buffer, through the use of the calcium chelators BAPTA 
or EGTA, prevents egg activation from occurring (Horner and Wolfner, 2008a).  
Gadolinium, which inhibits calcium influx into the cell, also prevents egg activation in 
this system (Horner and Wolfner, 2008a).  Thus, like other species, Drosophila 
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requires Ca2+ for egg activation and some, or all, of the Ca2+ must come from the 
external environment.   
A number of questions still remain regarding how well the mechanisms of Ca2+ 
regulation are conserved between invertebrates and mammals, and between species 
with sperm-dependent versus sperm-independent triggers of egg activation.  What is 
clear is that for a complete cellular transition, where coordination of all the changes is 
key, all of the events are initiated by a single signal.  An increase of cytosolic Ca2+ is 
typically the signal that triggers egg activation, after which individual events then 
appear to be carried out by various Ca2+-binding/Ca2+-dependent proteins (Figure 1.1).   
Zinc 
 While a role for Ca2+ has long been established in egg activation, the 
regulation of Zn2+ levels during mammalian fertilization has gained attention in recent 
years.  In contrast to Ca2+, where increasing levels are required to activate egg 
activation pathways, Zn2+ levels decrease at egg activation.  Upon fertilization or 
parthenogenetic activation in mouse, zinc is rapidly released from the egg in 1-5 
exocytosis events termed “zinc sparks” (Kim et al., 2011).  Zinc sparks are also 
observed in the two non-human primate species that have been tested (Kim et al., 
2011).  Each zinc spark is immediately preceded by a Ca2+ rise and none occur when 
Ca2+ rises are blocked by the calcium chelator BAPTA (Kim et al., 2011).  This 
suggests that the release of Zn2+ may be dependent on the Ca2+ signal.  If Zn2+ is 
artificially reduced in the mature oocyte by the zinc chelator TPEN, MAPK kinase 
activity decreases, cyclin B is degraded, and meiotic arrest is released (Suzuki et al., 
2010b; Kim et al., 2011).  These events occur in the absence of a Ca2+ increase in the  
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Figure 1.1  Diagram of known egg activation pathways in Drosophila, Xenopus, 
and mouse based on experimental results.  See text for references. *Knott et al. 
(2006) and Backs et al. (2010) show that the protein patterns observed by 2D- and 1D-
gel electrophoresis in activated mouse eggs are regulated by CaMKII and attribute 
these changes to maternal mRNA recruitment and protein synthesis.  However, it can 
not be ruled out that some of the observed changes are due to post-translational 
modifications.  As such, we have placed “proteome changes” in the pathway to 
encompass both of these possibilities.  
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oocyte and are unaffected by the addition of BAPTA, once again suggesting that the 
decrease of Zn2+ levels is downstream of the Ca2+ signal (Suzuki et al., 2010b).  Zn2+ 
sequestration by TPEN appears to be sufficient to induce all the events of egg 
activation, as eggs fertilized with heat-inactivated sperm heads (that cannot produce a 
Ca2+ signal), and then activated with TPEN, are able to fully develop into viable mice 
(Suzuki et al., 2010b).  Additionally, when zinc levels are increased with the zinc 
ionophore, ZnPT, mouse oocytes can no longer be parthenogenetically activated with 
SrCl2 (Bernhardt et al., 2012).  Thus, release of zinc is not only sufficient, but also 
necessary for the events of egg activation.  
Precisely how Zn2+ release triggers exit from meiotic arrest has not yet been 
worked out.  TPEN-induced resumption of the cell cycle is dependent on the APC/c 
activator Cdc20, suggesting that it requires APC/c activity (Suzuki et al., 2010b).  
However, TPEN does not induce degradation of the APC/c inhibitor Emi2 (Suzuki et 
al., 2010b).  The Emi2 protein is required to maintain the metaphase II arrest in 
mature mouse oocytes by inhibiting the APC/c; Emi2 is typically degraded at egg 
activation to allow cell cycle progression (discussed below; Schmidt et al., 2005; Shoji 
et al., 2006).  The fact that chelation of Zn2+ can induce resumption of the cell cycle 
without degradation of Emi2, along with the fact that Emi2 contains a putative zinc-
binding region, has led to the model that zinc binding may directly modulate the 
activity of Emi2 (Bernhardt et al., 2012).  This model is supported by the finding that 
a single mutation in the zinc-binding region of Emi2 completely inhibits its function 
(Schmidt et al., 2005).  In addition, Zn2+ has been shown to affect the activity of the 
phosphatase Cdc25 and thus its ability to dephosphorylate Cdc2 (also known as Cdk1) 
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(Sun et al., 2007).  Therefore, it is possible that decreases in Zn2+ levels also 
contribute to progression of the cell cycle by reducing the efficiency of Cdc25 and 
allowing Cdc2 to become phosphorylated and inhibited.  Further work is required to 
determine if these models are correct and to identify whether additional proteins are 
modulated by Zn2+ levels in the oocyte.   
Changes in Proteome Composition 
Large-scale changes in the egg’s proteome take place at egg activation that 
drastically alter the cellular properties from those of the mature oocyte.  Because there 
is little or no transcription associated with the oocyte-to-embryo transition, changes in 
protein composition within the cell rely on post-transcriptional and post-translational 
methods of regulation.  Studies have been undertaken to characterize the proteome of 
oocytes and/or embryos in multiple organisms including mouse, frog, sea urchin, and 
Drosophila and provide an overview of the dynamic changes that occur during egg 
activation.  In the mouse, over 3500 proteins have been identified in metaphase II 
oocytes and approximately 2000 have been found in zygotes  (Pfeiffer et al., 2011; 
Wang et al., 2010; reviewed in Yurttas et al., 2010).  This discrepancy in the number 
of proteins identified between oocytes and zygotes is suggestive of significant 
degradation of maternal proteins (Wang et al., 2010).  A functional role for this 
degradation is seen in sea urchins, where inhibition of the proteasome blocks proper 
entry into the first mitosis following fertilization (Kawahara et al., 2000).  In 
agreement with this result, 2-dimensional gel analysis of unfertilized and fertilized sea 
urchin eggs shows a 23% decrease in the number of detectable spots 2 minutes post-
fertilization (Roux et al., 2006).  This is likely due to a combination of protein 
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degradation as well as post-translational modifications, as the same study showed that 
approximately 30% of the proteins in unfertilized eggs are phosphorylated (Roux et 
al., 2006).  It is the overall combination of degradation and post-translation 
modification of existing maternal proteins, and new protein translation from maternal 
mRNAs, that transitions an oocyte into an embryo. 
Protein degradation  
 As mentioned above, substantial protein degradation is observed upon egg 
activation.  One important role for this degradation is the regulation of the meiotic cell 
cycle by the APC/c, an E3 ubiquitin-ligase that targets proteins for degradation by the 
26S proteosome (reviewed in McLean et al., 2011).  Targets of the APC/c include 
securin and cyclins, which hold the mature oocyte in metaphase arrest until egg 
activation.  As there are several recent reviews on the function and regulation of the 
APC/c (Pensin and Orr-Weaver, 2008; Verlhac et al., 2010; McLean et al., 2011), we 
will only mention the key points here.   
The APC/c is regulated by the adaptor protein Cdc20, which acts as an 
activator of the APC/c and confers substrate specificity.  While the role of Cdc20 in 
mitosis is well studied, its role in meiosis remains more elusive (reviewed in Pesin and 
Orr-Weaver, 2008).  However, in Drosophila, a meiosis-specific Cdc20, Cortex, has 
been identified that is required for cyclin degradation and completion of meiosis 
during egg activation (Page and Orr-Weaver, 1996; Chu et al., 2006; Pesin and Orr-
Weaver, 2007; Swan and Schupbach, 2007).  Cortex is also responsible for regulating 
its own degradation by the APC/c following egg activation, presumably to allow the 
canonical Cdc20 (Fizzy) to regulate the subsequent embryonic mitoses (Pesin and Orr-
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Weaver, 2007).  Continuing studies in Drosophila will provide a unique model system 
for understanding how Cdc20 is regulated to activate the metaphase-to-anaphase 
transition during egg activation.   
In Xenopus and mice, a novel mechanism for regulating the APC/c during egg 
activation was found through the identification of Emi2/XErp1 as a necessary protein 
for maintaining metaphase arrest (Schmidt et al., 2005; Shoji et al., 2006).  Emi2 
inhibits the APC/c in metaphase-arrested oocytes/egg extracts, evidenced by the fact 
that removal of Emi2 results in precocious metaphase exit, while overexpression of 
Emi2 prevents APC/c activation upon addition of SrCl2 or Ca2+ (Schmidt et al., 2005; 
Shoji et al., 2006).  Upon egg activation in Xenopus, Emi2 protein is degraded by the 
Skp1-Cullin F-box (SCF) ubiquitin ligase complex, showing that at least one other 
degradation pathway besides the APC/c is active during egg activation (Schmidt et al., 
2005).  This degradation is believed to be dependent on phosphorylation by Polo-like 
kinase 1 (Plx1).  Two Plx1 phosphorylation sites are present within the DSGX3S motif 
required for Emi2 degradation, and mutation of either of these sites reduces Emi2 
degradation in vivo and Plx1 phosphorylation of Emi2 in vitro (Schmidt et al., 2005).  
While Emi2 is also degraded upon egg activation in the mouse, a similar mechanism 
of phosphorylation by Plx1, and degradation by the SCF, has not been demonstrated 
(Shoji et al., 2006).  In addition, though Emi2 clearly inhibits the APC/c, the exact 
mechanism of this inhibition is not yet known.  Emi2 has been proposed to interact 
with, and inhibit, both Cdc20 and the core APC/c (Shoji et al., 2006; Wu et al., 2007).  
Finally, it is possible that once activated, the APC/c can contribute to the inactivation 
of Emi2.  Studies in Xenopus show that overexpression of the APC/c-cooperating E2 
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enzyme leads to the ubiquitylation of Emi2 and its disassociation from the APC/c 
(Hormanseder et al., 2011). 
Although the APC/c clearly plays a critical role in protein degradation during 
egg activation, it is not known to what extent other pathways contribute to the global 
degradation that is observed.  In Xenopus, action of the SCF is implicated by its role 
in Emi2 degradation, but whether it has any additional targets at this time remains to 
be investigated.  Additionally, autophagy [a bulk degradation system of the cell 
(reviewed in Mizushima, 2007)] is highly induced in early mouse embryos and is 
required for preimplantation development (Tsukamoto et al., 2008a; Tsukamoto et al., 
2008b).  A full understanding of the role of protein degradation, and the ways in which 
individual pathways regulate unique or overlapping sets of targets, will require a more 
complete characterization of the proteome after egg activation and how inhibition of 
each pathway affects global changes in protein composition in the egg.  
Protein phosphorylation  
Multiple types of post-translational modification are likely to act on the 
proteome during egg activation.  For instance, maternal sumoylation is important for 
eggshell patterning and mitosis during Drosophila embryogenesis (Nie et al., 2009).  
However, the main focus thus far has been on the role of phosphorylation, and that is 
where we will also focus in this review.  In sea urchins, fertilization causes the number 
of phosphorylated proteins to double within 2 minutes, before returning to pre-
fertilization levels 30 minutes later (Roux et al., 2006).  In Xenopus, 
phosphoproteomic analysis has identified a combined total of 654 phosphoproteins in 
oocytes, unfertilized eggs, and embryos (McGivern et al., 2009).  And in Drosophila, 
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we have identified 311 proteins that change in phosphorylation state between mature 
oocytes and unfertilized, activated eggs (Krauchunas et al., submitted).   
Phosphorylation can be a major contributor to a change in cellular state since it 
has the ability to rapidly modulate a large number of proteins and has a wide array of 
regulatory affects [ie. altering protein activity (Cargnello and Roux, 2011) or 
localization (Jans and Hubner, 1996)].  The importance of phosphorylation during egg 
activation is evidenced by the dynamic phosphorylation changes that take place during 
the oocyte-to-embryo transition, and the finding that phosphorylation modulators such 
as CaMKII and calcineurin (discussed below) are critical for successful egg activation.   
CaMKII 
Ca2+/calmodulin-dependent protein kinase II (CaMKII) is a serine/threonine 
protein kinase that is regulated by calcium and the calcium receptor molecule 
calmodulin (reviewed in Hudmon and Schulman, 2002).  Because of the relationship 
between Ca2+ and CaMKII, and the importance of Ca2+ to initiate egg activation, 
CaMKII has been proposed to be one of the main effectors of the Ca2+ signal at egg 
activation.  Numerous studies support this hypothesis, pointing primarily to a key role 
for CaMKII in the resumption of the cell cycle.   
An increase in CaMKII activity occurs at the time of fertilization/egg 
activation that correlates with the observed increase in Ca2+ levels in both Xenopus 
and mouse.  In Xenopus, where one Ca2+ spike occurs, CaMKII activity transiently 
spikes in the first 5 minutes after calcium addition (Liu and Maller, 2005; Nishiyama 
et al., 2007).  In mice, the activity of CaMKII is oscillatory, once again correlating 
with the pattern of Ca2+ rises in the egg  (Johnson et al., 1998; Tatone et al., 2002; 
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Markoulaki et al., 2003; Markoulaki et al., 2004).  When Ca2+ oscillations are 
produced by fertilization, or artificially induced, CaMKII activity is seen to peak at the 
time of Ca2+ peaks followed by a return to baseline activity levels; these increases in 
kinase activity can be observed for up to one hour post-insemination (Markoulaki et 
al., 2003; Markoulaki et al., 2004).  In contrast, if mouse oocytes are activated by 
ethanol, which produces only a single Ca2+ rise, CaMKII activity increases only once, 
showing that the oscillations of CaMKII activity are dependent on the oscillations of 
Ca2+ levels in the egg (Tatone et al., 2002).  When CaMKII is inhibited in Xenopus or 
mouse oocytes, cyclin B fails to be degraded, Cdc2 remains active, and the cell cycle 
remains arrested in metaphase (Lorca et al., 1993; Morin et al., 1994; Johnson et al., 
1998; Tatone et al., 1999; Markoulaki et al., 2003; Madgwick et al., 2005).  If a 
constitutively active form of CaMKII is added to the oocyte, cyclin B degradation is 
induced, Cdc2 and MAPK levels decrease, and meiosis resumes (Lorca et al., 1993; 
Morin et al., 1994; Madgwick et al., 2005; Knott et al., 2006).   
CaMKII exists in four different isoforms - α, β, δ, γ.  Ιn mouse oocytes, two 
splice forms of CaMKIIγ are predominantly expressed, while the other isoforms are 
present at low or undetectable levels (Backs et al., 2010; Chang et al., 2009; Suzuki et 
al., 2010a).  In CaMKIIγ conditional knockout mice, or when CaMKIIγ is knocked 
down by an antisense morpholino, eggs remain arrested in metaphase and MAPK and 
Cdc2 kinase levels remain high (Backs et al., 2010; Chang et al., 2009).  Injection of 
CaMKII cDNA rescues this phenotype.  Rescue is not isoform-specific, suggesting 
that it is the general activity of CaMKII that is required for meiotic resumption rather 
than any CaMKIIγ-specific targets (Backs et al., 2010).  In addition, characteristic 
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proteome changes that occur at egg activation, observed by either 2D- or 1D-gel 
electrophoresis, are not seen in the CaMKIIγ mutants (Backs et al., 2010), though they 
can be triggered by addition of constitutively active CaMKII (Knott et al., 2006).  
However, these proteome changes can also be induced by a Ca2+ signal and direct 
inactivation of Cdc2 kinase, even when CaMKII is not present (Backs et al., 2010).  
Thus, these observed changes in proteome composition appear to rely on resumption 
of the cell cycle but are only indirectly regulated by CaMKII.   
Two mechanisms for how CaMKII initiates the metaphase to anaphase 
transition have been elucidated in Xenopus.  The first comes from the finding that 
CaMKII is both necessary and sufficient for Emi2 degradation in Xenopus egg 
extracts (Rauh et al., 2005; Hansen et al., 2006).  As mentioned earlier, in Xenopus, 
Polo-like kinase 1 (Plx1) phosphorylates Emi2 to target it for degradation (Schmidt et 
al., 2005).  Removing Plx1 prevents release from the metaphase arrest, even when 
constitutively active CaMKII is added (Liu and Maller, 2005).  CaMKII is equally 
required for Plx1 to induce resumption of the cell cycle (Liu and Maller, 2005).  
Additionally, while expression of either CaMKII or Plx1 alone cannot overcome the 
arrest caused by Emi2 overexpression, a combination of both kinases can (Liu and 
Maller, 2005).  This suggests that the kinases work together to regulate Emi2 
degradation and the subsequent exit from meiotic arrest.  In vitro experiments show 
that Emi2 is a good substrate for CaMKII and that Emi2 interacts with, and is 
phosphorylated by, Plx1 in a CaMKII-dependent manner (Liu and Maller, 2005; Rauh 
et al., 2005; Hansen et al., 2006).  Thus, the current model is that when CaMKII is 
activated by the Ca2+ rise at egg activation it phosphorylates Emi2, which primes 
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Emi2 for subsequent phosphorylation by Plx1, eventually leading to its degradation 
(Liu and Maller, 2005; Rauh et al., 2005; Hansen et al., 2006).  CaMKII also promotes 
microtubule destabilization at the onset of anaphase (Reber et al., 2008).  This 
function is independent of APC/c activation, suggesting that CaMKII works at 
multiple levels to regulate progression of the cell cycle at egg activation.   
Whether a similar mechanism for the role of CaMKII in Emi2 degradation or 
microtubule destabilization exists in mammals has not yet been established.  However, 
in mouse, the kinase Wee1B has been shown to be a CaMKII target at egg activation.  
Knockdown of Wee1B in oocytes results in a failure to completely activate the APC/c 
and high levels of MAPK in parthenogenetically activated eggs, preventing exit from 
metaphase (Oh et al., 2010).  In addition, Wee1B knockdown reduces the ability of 
constitutively active CaMKII to induce polar body formation (Oh et al., 2010).  In 
vitro experiments show that Wee1B can be phosphorylated by CaMKII, and that this 
phosphorylation increases Wee1B activity (Oh et al., 2010).  Thus, in mouse, it has 
been shown that CaMKII regulates resumption of the cell cycle through 
phosphorylation of Wee1B, which in turn phosphorylates and inhibits Cdc2, leading to 
the inhibition of MPF activity and the transition from metaphase to anaphase.    
Calcineurin 
Calcineurin is a Ca2+/calmodulin-dependent serine/threonine phosphatase 
composed of a catalytic A subunit (CnA) and regulatory B subunit (Rusnak and Mertz, 
2000).  A role for calcineurin at egg activation was first suggested by studies in 
Drosophila which showed that the calcineurin regulator, Sarah (Sra), is necessary for 
multiple aspects of egg activation (Horner et al., 2006; Takeo et al., 2006).  Eggs laid 
 17 
 
by sra mutant females have defects in the polyadenylation and translation of maternal 
mRNAs and defects in protein degradation (Horner et al., 2006).  In addition, while 
meiosis briefly resumes in eggs laid by sra mutants, it re-arrests at anaphase I, perhaps 
due to the high levels of cyclin B in these eggs (Horner et al., 2006; Takeo et al., 
2006).   
The absence of these egg activation events in eggs laid by sra mutants is 
presumed to be due to misregulation of calcineurin when Sra is not present.  This 
hypothesis is supported by both genetic and biochemical assays.  Three calcineurin 
subunits are present in Drosophila oocytes and early embryos: two A subunits (Pp2B-
14D and CanA-14F) and one B subunit (CanB2) (Takeo et al., 2006).  Sra has been 
shown to interact with all three of these subunits, both in cell culture and in vivo by 
mass spectrometry experiments (Takeo et al., 2006; Takeo et al., 2012).  In addition, 
genetic interaction studies showed that the phenotype caused by expression of a 
dominant negative CnA is rescued by Sra overexpression and enhanced in sra 
heterozygotes (Takeo et al., 2010).  Thus, it is proposed that Sra is a positive regulator 
of calcineurin function during egg activation. 
A direct role for calcineurin in Drosophila egg activation has been shown 
through germline clonal analysis of both CanB2 mutants and CnA double mutants.  In 
both cases elimination of calcineurin function from the oocyte/embryo led to an 
anaphase I arrest identical to that seen in sra mutants (Takeo et al., 2010; Takeo et al., 
2012).  As the CnA double mutants can be rescued by expression of wild-type Pp2B-
14D, but not by a phosphatase-dead version of the protein, the phosphatase activity of 
calcineurin is required for its role at egg activation in Drosophila (Takeo et al., 2012).  
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What remains to be determined is whether the defect in polyadenylation and 
translation seen in sra mutants also occurs in calcineurin mutants, or if sra has 
additional functions beyond the regulation of calcineurin.  If calcineurin is indeed 
necessary for these events, it provides a link between the Ca2+ signal and maternal 
mRNA translation.  However, the possible calcineurin target(s) regulating this event 
remain unidentified. 
A role for calcineurin in egg activation has also been observed in Xenopus 
(Mochida and Hunt, 2007; Nishiyama et al., 2007).  Addition of Ca2+ to Xenopus egg 
extracts causes a transient increase in calcineurin activity (Mochida and Hunt, 2007; 
Nishiyama et al., 2007).  This transient activity occurs along the same time frame as 
the spike in CamKII activity that is seen upon addition of calcium, and precedes the 
degradation of cyclin B (Nishiyama et al., 2007).  When calcineurin is inhibited, Cdc2 
activity remains high and eggs/extracts are not able to exit metaphase II (Nishiyama et 
al., 2007).  Immunodepletion of calcineurin confirms these results, showing a failure 
to degrade both cyclin B and securin (Nishiyama et al., 2007).  Similar to the results in 
Drosophila, adding back constitutively active calcineurin reverses this phenotype but a 
phosphatase-dead version of the protein does not (Nishiyama et al., 2007).  
Surprisingly, constitutively active calcineurin reduces the size of sperm asters formed 
around demembranated sperm added to Ca2+-activated Xenopus egg extracts.  This is 
in contrast to Drosophila, where sperm asters fail to form in eggs laid by sra mutants 
(Horner et al., 2006).  Thus, at least in Xenopus, it appears that it is important that 
calcineurin is activated only transiently.   
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The necessity of calcineurin for cyclin B degradation and metaphase II exit 
leads to the hypothesis that calcineurin is involved in the regulation of the APC/c.  In 
Xenopus, it appears that calcineurin does directly regulate components of the APC/c 
(Mochida and Hunt, 2007).  Two APC/c subunits, Apc3 (a core subunit) and Fizzy 
(Cdc20), are phospho-regulated during the cell cycle (Peters et al., 1996; Chung and 
Chen, 2003) and both proteins undergo dephosphorylation when calcium is added to 
egg extracts (Mochida and Hunt, 2007).  However, the calcineurin inhibitor 
Cyclosporin A prevents this dephosphorylation from occurring (Mochida and Hunt, 
2007).  The ability of calcineurin to dephosphorylate immunopurified Apc3 and Fizzy 
suggests that these proteins are direct targets of the phosphatase (Mochida and Hunt, 
2007).  Whether calcineurin also contributes to the regulation of the APC/c through 
Emi2 is less clear.  While Nishiyama et al. (2007) report that inhibiting calcineurin 
reduces the degradation of Emi2, Mochida and Hunt (2007) find that Emi2 
dephosphorylation and degradation is unaffected in the presence of Cyclosporin A.  
Almost all the Ca2+ induced dephosphorylations that can be observed with an anti-
(phospho-Ser-Pro) antibody are prevented by Cyclosporin A, suggesting that there are 
many more calcineurin targets that remain to be identified (Mochida and Hunt, 2007).  
However, how many of these dephosphorylations are direct targets, and how many are 
indirect effects due to misregulation of the APC/c, is unknown.   
As with CamKII, calcineurin appears to be a key regulator activated by the 
Ca2+ signal that triggers egg activation.  The activation of calcineurin is independent 
of CamKII activity, and vice versa (Nishiyama et al., 2007).  However the transient 
activity of both proteins is required for metaphase II exit in Xenopus (Nishiyama et 
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al., 2007).  This appears to contrast with the findings that addition of constitutively 
active CaMKII alone can induce resumption of the cell cycle.  However, in those 
experiments the activity of CaMKII is not transient, the way it is under fertilization or 
Ca2+-induced activation.  When constitutively active CaMKII is inactivated 25 
minutes after its addition to Xenopus egg extracts, the inactivation of Cdc2 is no 
longer observed unless active calcineurin is also added (Nishiyama et al., 2007).  In 
addition, the results from Xenopus show that calcineurin activity and the appropriately 
timed inhibition of calcineurin are both required for successful egg activation and the 
initiation of embryogenesis.  In Drosophila, the regulation of calcineurin itself is more 
complex than simply direct activation by Ca2+, as Sra is also required for calcineurin 
activity.  Additionally, Sra itself is regulated through phosphorylation by glycogen 
synthase kinase 3β (GSK-3β) (Takeo et al., 2012).  Whether similar regulators of 
calcineurin are also present in Xenopus oocytes, or if GSK-3β plays a role in egg 
activation of other organisms remains to be tested. 
At present, there is no evidence to show that calcineurin plays an analogous 
role in mammalian egg activation.  Suzuki et al. (2010a) failed to detect the CnA 
subunit in mouse oocytes, and although ICSI-induced metaphase II exit was slowed by 
the addition of calcineurin inhibitors, it was not prevented.  More experimentation is 
required to conclusively rule out any contributions that calcineurin may make to egg 
activation in mammals, including testing Cyclosporin A and other inhibitors when 
eggs are activated by Ca2+ (rather than ICSI), a thorough investigation into what, if 
any, calcineurin subunits are present in mammalian oocytes, and subsequent knockout 
analysis of those proteins.   
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Other phosphorylation regulators 
 While CaMKII and calcineurin have been identified as two of the most 
upstream regulators that transduce the Ca2+ signal and initiate multiple aspects of egg 
activation, other phosphorylation regulators have also been implicated in egg 
activation events and early embryogenesis.  Polo-like kinase, GSK-3, Cdc25, and 
Wee1B have all been mentioned above.  Pan Gu (PNG), is a serine/threonine kinase in 
Drosophila that complexes with two other proteins, Giant Nuclei (GNU) and 
Plutonium (PLU), to function in the oocyte-to-embryo transition (Lee et al., 2003).  
Both GNU and PLU can be phosphorylated by the PNG kinase complex in vitro and 
GNU is dephosphorylated upon egg activation, suggesting that function of the 
complex is itself phospho-regulated (Lee et al., 2003; Renault et al., 2003).  However, 
other phosphorylation targets of PNG and the importance of GNU dephosphorylation 
remain to be determined.   
 In C. elegans, one critical phosphorylation regulator is the kinase MBK-2, 
which regulates maternal protein degradation during the oocyte-to-embryo transition 
(Pellettieri et al., 2003).  MBK-2 is regulated by the pseudo-phosphatases EGG-3, 
EGG-4, and EGG-5 (Maruyama et al., 2007; Cheng et al., 2009; Parry et al., 2009; 
reviewed in Parry and Singson, 2011).  Some of the targets of MBK-2 have been 
identified, and include major regulators of the oocyte-to-embryo transition (reviewed 
in Marcello and Singson, 2010).  At least one role of MBK-2 phosphorylation appears 
to be providing a priming phosphorylation for subsequent modification by an 
additional kinase, as MBK-2 targets have been shown to be further phosphorylated by 
GSK-3 and polo kinases (Nishi and Lin, 2005; Nishi et al., 2008). 
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Other kinases that have been implicated in the oocyte-to-embryo transition of 
various species include protein kinase C (PKC), myosin light chain kinase (MLCK), 
and MAPKs.  However, in many cases the roles of these kinases at egg activation are 
less clear than the findings on CaMKII and calcineurin.  The evidence for potential 
functions of these kinases as they relate to the events of egg activation are reviewed 
elsewhere (Ducibella and Fissore, 2008).   
New Protein Translation 
 Some of the proteins necessary for the oocyte-to-embryo transition and early 
embryogenesis are not present in the mature oocyte.  Instead these proteins are 
translated from maternal mRNAs loaded into the oocyte and held in a repressed state 
until egg activation.  Analysis of the protein classes that are required in the early 
embryo, as well as the function of specific proteins encoded by the maternally 
deposited mRNAs, will inform us of the cellular events that are critical at this time and 
help identify potential regulators of those processes.   
One way to determine the full set of proteins that are translated in the activated 
egg is by analyzing the transcripts that are associated with the polysome.  This 
analysis has been carried out in mouse oocytes and in one-cell embryos to determine 
which maternal mRNAs are recruited to the polysome after egg activation (Potireddy 
et al., 2006).  Nearly 2000 individual mRNAs were found to have greater signals in 
the one-cell polysomal RNA population when compared to the oocyte polysomal RNA 
population (Potireddy et al., 2006).  These RNAs were enriched for functional classes 
related to metabolism, transcription, and cell cycle regulation, consistent with the idea 
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that the proteins translated from maternal mRNAs are important for early embryonic 
mitosis and activation of the zygotic genome (Potireddy et al., 2006).   
Proteomic studies comparing mouse oocytes and zygotes also provide 
information on protein translation at egg activation.  While the overall number of 
proteins identified in zygotes was lower than the number of proteins in oocytes (Wang 
et al., 2010), a comparison of the identities of the proteins in each sample should 
reveal proteins that are present only in the zygote, indicating that they are not 
translated until egg activation.  It will also be of interest to compare the polysomal 
mRNA and proteomic data sets to determine how well polysomal recruitment 
correlates with identification of proteins in the embryo and/or the level of saturation 
reached by either of these screens. 
In addition to determining the identities of these proteins, another important 
aspect of protein translation at egg activation is understanding how maternal 
transcripts are regulated to ensure they are translated at the appropriate time.  One 
mechanism by which the translation of these transcripts is regulated is through 
polyadenylation of the 3’ untranslated regions (UTR).  During oocyte maturation in 
Xenopus, this process is regulated by opposing polymerase and deadenylase activities 
(Kim and Richter, 2006). The polymerase and deadenylase are both bound to the 
transcript through the cytoplasmic polyadenylation element binding protein (CPEB) 
and the cleavage and specificity factor (CPSF), which recognize cis-elements in the 3’ 
UTR (Kim and Richter, 2006).  When maturation is signaled, CPEB is phosphorylated 
and the deadenylase subsequently disassociates from the transcript.  As only the poly-
A polymerase remains, the result is a lengthening of the poly-A tail.  It is possible that 
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a similar mechanism works during egg activation to regulate the polyadenylation and 
translation that occurs at this time.   
 In Drosophila, the maternal protein Wispy is a cytoplasmic poly-A polymerase 
that is responsible for the polyadenylation of numerous targets during both oocyte 
maturation and egg activation (Cui et al., 2008; Benoit et al., 2008).  Targets of Wispy 
include Bicoid and Torso, which are important for patterning the early embryo and 
have been previously shown to be translated upon egg activation (Driever and 
Nusslein-Volhard, 1988; Casanova and Struhl, 1989).  In wispy mutants, the bicoid 
and torso transcripts fail to be polyadenylated in activated eggs; for bicoid this has 
been shown to result in a failure to translate the Bicoid protein (Cui et al., 2008; 
Benoit et al., 2008).  However, lengthening of the poly-A tail alone is not sufficient 
for translation, as elongation of the bicoid poly-A tail by overexpression of a poly-A 
polymerase in the oocyte does not result in Bicoid protein expression in oocytes (Juge 
et al., 2002).  Thus, it appears that protein translation at egg activation not only 
requires the lengthening of maternal mRNA poly-A tails, but either an additional 
activational pathway or the repression of an inhibitory pathway that is present in the 
mature oocyte.   
Wispy is not necessary for all protein translation during egg activation as 
translation of another protein, Smaug, is unaffected in wispy mutants (Cui et al., 2008; 
Benoit et al., 2008).  Smaug is important for degradation of maternal transcripts after 
egg activation (discussed below) (Tadros et al., 2007).  To ensure maternal transcripts 
are protected from Smaug-mediated degradation prior to egg activation, Smaug 
protein is not present in the mature oocyte (Dahanukar et al., 1999; Smibert et al., 
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1999).  Instead, maternal smaug mRNA is actively translated at egg activation; a 
process dependent on both pan gu and sra (Tadros et al., 2007; Cui et al., 2008).  
When pan gu is mutated smaug mRNA polyadenylation is also reduced (Tadros et al., 
2007).  Overexpression of a poly-A polymerase can rescue the poly-A tail phenotype 
of the pan gu mutant, however Smaug protein is still not translated, suggesting that 
Pan Gu works at multiple levels to control the translation of Smaug (Tadros et al., 
2007).  Pan Gu is also required for the translation of cyclin B in the early Drosophila 
embryo (Vardy and Orr-Weaver, 2007).  In the case of cyclin B, loss of Pumilio (a 
translational repressor) can restore cyclin B translation in a pan gu mutant 
background, suggesting that at least one additional function of Pan Gu is to inhibit 
Pumilio (Vardy and Orr-Weaver, 2007).  However, Smaug translation is not restored 
in pumilio; pan gu double mutants, indicating that additional mechanisms of Pan Gu 
translational regulation still remain to be discovered (Tadros et al., 2007). 
mRNA Degradation 
 The mature oocyte is stocked full of maternal mRNAs that were transcribed 
and loaded into the oocyte during oogenesis.  In Drosophila, it is estimated that up to 
55% of the genes in the genome are represented in maternal transcripts in the oocyte 
(Tadros et al., 2007).  For the transition to a totipotent cell (the embryo), the 
transcriptional profile of the differentiated cell (the oocyte) must be removed.  Thus, 
while some of the maternal mRNAs are translated in the early embryo, another key 
facet of egg activation is the targeted degradation of other maternal mRNAs.   
 Maternal transcript degradation in the early embryo has been observed in a 
number of species including mouse, zebrafish, and Drosophila (Hamatani et al., 2004; 
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Mathavan et al., 2005; Tadros et al., 2007; Thomsen et al., 2010).  In Drosophila, egg 
activation is both necessary and sufficient for this maternal mRNA degradation, at 
least for the specific transcripts examined so far (Bashirullah et al., 1999; Tadros et 
al., 2003).  While the mechanistic connection between the Ca2+ signal and maternal 
mRNA degradation remains elusive, studies in Drosophila provide some insight into 
the regulation of this process.  Here, the maternal protein Smaug is required for two-
thirds of the transcript degradation that is observed upon egg activation (Tadros et al., 
2007).  Studies of two known Smaug targets, nanos and Hsp83, show that Smaug acts 
by binding to cis-elements, known as Smaug Recognition Elements (SREs), in 
maternal transcripts and recruiting the CCR4/POP2/NOT-deadenylase complex 
(Smibert et al., 1996; Semotok et al., 2005; Semotok et al., 2008).  This leads to the 
deadenylation of these transcripts and their subsequent degradation.  In addition, it has 
been proposed that Smaug interacts with the piRNA pathway to promote the 
deadenylation and degradation of a subset of maternal transcripts (Rouget et al., 
2010).   
Once the zygotic genome is activated, a second wave of maternal transcript 
degradation is activated which relies on zygotic, as well as maternal, products 
(Bashirullah et al., 1999).  We will not discuss this second round of degradation and 
instead refer you to two comprehensive reviews on the maternal and zygotic 
regulation of mRNA degradation during egg activation and the maternal-to-zygotic 
transition by Tadros and Lipshitz (2005; 2009) and the role of microRNAs in maternal 
transcript degradation by Giraldez (2010).  These authors also discuss the possible 
biological consequences of maternal transcript degradation, presenting potential roles 
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in producing localized expression of RNA and proteins or acting as a permissive 
phenomenon to avoid interfering with zygotic transcripts.     
Summary 
 Egg activation represents a cellular transition from a highly differentiated 
oocyte into a totipotent embryo. There is a single initiating signal at the start of this 
transition, which ensures that all of the downstream signals and events are properly 
coordinated within the cell  This is especially important considering each event is 
regulated at multiple levels.  During egg activation, a rise in cytosolic Ca2+ 
independently activates the effector proteins CaMKII and calcineurin, and at least one 
other pathway, to initiate this cellular transition.  [At least one other pathway must be 
involved as cortical granule exocytosis occurs in the absence of both calcineurin and 
CaMKII, and CaMKII only partially contributes to the membrane block to polyspermy 
(Mochida and Hunt, 2007; Nishiyama et al., 2007; Chang et al., 2009; Backs et al., 
2010; Gardner et al., 2007).]  These effectors then have the potential to amplify the 
initial signal through phosphorylation of multiple target proteins, activating multiple 
pathways within the cell (Figure 1.1). 
 Because the oocyte-to-embryo transition represents a complete change in 
cellular state, it requires global changes in the composition of both RNAs and proteins 
within the cell.  Indeed, large-scale degradation of maternal mRNAs and proteins, 
translation of new proteins not present in the oocyte, and protein phosphorylation 
changes occur during egg activation.  To fully understand how the embryo differs 
from the oocyte will require a complete identification of the molecules that are 
removed (degraded) and the molecules that take their place.  In addition, a consistent 
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trend in the literature is the proposal that finding the targets of the phosphorylation 
regulators CamKII and calcineurin will be critical to improving our understanding of 
how these molecules effect the cellular changes that encompass egg activation.  
Identifying the proteins that are phosphorylated/dephosphorylated during egg 
activation will provide new proteins and pathways to explore in connecting Ca2+ to all 
of the egg activation events. Xenopus is the only species in which CaMKII and 
calcineurin are both known to be critical for egg activation.  At present there is no 
evidence of a role for calcineurin in mouse egg activation, or for CaMKII in 
Drosophila egg activation.  However, the possibility that roles for both pathways are 
conserved has not been definitively excluded and remains an important area for future 
studies.  
 Our current knowledge of egg activation shows that overlapping regulatory 
mechanisms ensure these cellular changes are tightly controlled.  For example, Emi2 
has been shown to be regulated by phosphorylation and subsequent degradation, 
ubiquitination, and Zn2+ levels.  Following that, Emi2 is only one regulator of the 
APC/c, which is also regulated by the activator protein Cdc20 and phosphorylation of 
other core subunits.  All of this works together so that the APC/c can activate the 
metaphase-to-anaphase transition, while at the same time activation of Wee1B kinase 
phosphorylates and inhibits Cdc2 (which is necessary for the metaphase arrest).  
Presumably, in an activated egg, all of these regulatory mechanisms are coordinated 
by proteins downstream of the Ca2+ signal to ensure the efficient transition from 
meiotic arrest to embryonic mitosis.  Understanding how these regulatory mechanisms 
inter-relate, or if they simply represent redundancy within the system, will be critical 
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to our success in understanding this type of cellular transition, as well manipulating it 
therapeutically.   
Dissertation Outline 
 My studies encompassed two aspects of the protein phosphorylation changes 
that take place during egg activation in Drosophila: the identification of proteins that 
change in phosphorylation state, and how these phosphorylation changes are 
regulated.  I used proteomic, molecular, and genetic techniques to examine the 
phosphoproteome, observe specific phosphorylation changes, and test new candidates 
for roles in egg activation. 
 In Chapter Two, I present the results from two proteomic methods aimed at 
identifying the proteins that are phospho-modulated during egg activation.  Proteins 
from mature oocytes and unfertilized activated eggs were separated by 2-dimensional 
gel electrophoresis and stained to visualize phosphorylated proteins.  Spots that 
changed in changed in intensity for the phosphorylation stain, but not total protein 
abundance, were selected for identification by mass spectrometry.  I also used a 
peptide-based approach in which proteins were first trypsin-digested and then samples 
were enriched for phospho-peptides by Immobilized Metal Affinity Chromatography 
(IMAC).  Peptide sequences were analyzed by mass spectrometry and the 
corresponding proteins were determined.  Combining results from the two methods 
produced 311 protein identifications.  Chapter Two also contains the results of 
knocking down the genes encoding 18 of these proteins to test their roles in female 
fertility, including the identification of mrityu as a maternal effect gene required for 
the first few embryonic mitosis. 
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 In Chapter Three, I tested the relationship between three egg activation genes 
sarah, cortex, and prage and the phosphorylation changes of Spindly and Vap-33-1 
that occur at egg activation.  I show that all three genes are required for Spindly 
dephosphorylation, but only sarah and cortex are required for Vap-33-1 
phosphorylation.  I also show that sarah is required for the degradation of Cort at egg 
activation, but prage is not.  Combined with data from a previous graduate student, 
Kate Sackton, these results suggest that sarah and cortex act in the same pathway.  
Prage regulates only a subset of the proteins that are regulated by sarah and cortex.  
Therefore I hypothesize that prage acts either downstream, or in parallel to the 
sarah/cortex pathway.   
 Chapter Four contains the summaries of two different screens that sought to 
identify new genes that are required for egg activation or early embryogenesis.  The 
first is a continuation of the RNAi experiments presented in Chapter Two, testing the 
phospho-proteomic candidates for roles in female fertility.  The second is a suppressor 
screen designed to identify genes that interact with calcineurin in the female germline.  
In Chapter Four, I also present preliminary observations of Vap-33-1 localization in 
the developing oocyte and early embryos.  I show that mrityu is not required for the 
phosphorylation changes of YA, GNU, Spindly, or Vap-33-1, consistent with a role 
for mrityu immediately after egg activation.  Finally I discuss my progress in creating 
a null allele of mrityu through imprecise P-element excision mutagenesis.   
Appendix A contains the results from my rotation project investigating the role 
of nplp3 in the female post-mating response. 
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CHAPTER TWO 
 
PROTEIN PHOSPHORYLATION CHANGES REVEAL NEW CANDIDATES IN 
THE REGULATION OF EGG ACTIVATION AND EARLY EMBRYOGENESIS 
IN D. MELANOGASTER2 
 
2.1 Introduction 
For development to initiate, a number of events must take place to convert a 
mature oocyte to an egg capable of supporting embryogenesis.  These include 
resumption and completion of the meiotic cell cycle, changes to the egg’s outer 
coverings, degradation of certain maternal mRNAs, and the poly-adenylation and 
translation of others.  These events are collectively termed “egg activation” [reviewed 
in (Ducibella and Fissore, 2008; Horner and Wolfner, 2008)].  In many organisms, egg 
activation is triggered by fertilization and a subsequent rise in intracellular Ca2+ (Eisen 
et al., 1984; Gilkey et al., 1978; Swann and Yu, 2008).  However, in Drosophila and 
other insects examined, egg activation occurs independent of fertilization (Doane, 
1960).  In these organisms, egg activation is triggered instead by passage of the oocyte 
through the reproductive tract (Heifetz et al., 2001; Went and Krause, 1974), though 
the importance of calcium remains conserved (Horner and Wolfner, 2008a).  Thus, 
Drosophila, with its ease of genetic manipulation, is a valuable model for studying the 
                                                 
2 This chapter has been been accepted to Developmental Biology as Krauchunas, A.R., Horner, V.L., 
and Wolfner, M.F., “Protein phosphorylation changes reveal new candidates in the regulation of egg 
activation and early embryogenesis in D. melanogaster”.  The first set of 2D gels were performed by 
Vanessa Horner.  Figure 2.1 and Table 2.1 are from Vanessa Horner’s dissertation (2008) and are 
acknowledged in the legends. 
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conserved features of egg activation without interference from otherwise concurrent 
post-fertilization events. 
However, traditional screening methods for recessive maternal-effect 
mutations have identified only a small number of factors necessary for egg activation 
in model systems such as Drosophila and C. elegans [reviewed in (Horner and 
Wolfner, 2008; Singson et al., 2008)].  One explanation for this modest success to date 
is that factors important for the oocyte-to-embryo transition may play additional 
essential roles at later stages of development, causing lethality and preventing their 
detection in a maternal-effect screen.  Additionally, large-scale genetic screens to 
identify mutations affecting egg activation are difficult to carry out and sterile mutants 
can be difficult to maintain in stock.  We take a different approach by identifying 
proteins that are post-translationally regulated during egg activation.  We hypothesize 
that these regulated proteins will include new factors important for egg activation and 
early embryogenesis. 
As little to no transcription occurs during egg activation, maternally provided 
mRNAs and proteins must be sufficient to regulate all of the events that take place 
during and immediately after this transition.  Indeed, considerable evidence suggests 
that maternal proteins direct the earliest events in egg activation (McKnight and 
Miller, 1976; Newport and Kirschner, 1982; Zalokar, 1976).  In Drosophila, meiosis 
can complete without the synthesis of any new proteins (Page and Orr-Weaver, 1997).  
In addition, proteomic studies of sea urchin eggs showed that in the first 2 minutes 
after fertilization the number of protein spots detectable by 2D gel electrophoresis 
decreases by 23%, suggesting that translation of new proteins is a relatively “late” 
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event of egg activation (Horner and Wolfner, 2008; Roux et al., 2006).  
Characterization of the C. elegans oocyte proteome and transcriptome shows that the 
oocyte proteome appears to be biased towards factors likely to act immediately upon 
fertilization while the oocyte transcriptome is biased towards factors that are likely to 
act later in embryogenesis (Chik et al., 2011).  These findings point to maternal 
proteins playing key roles in the initial events of egg activation.  As these proteins are 
present in the oocyte prior to egg activation, they must also be highly regulated so that 
the correct subsets of proteins are active before, during, and after egg activation is 
triggered.   
  One possible mechanism for rapid regulation of many proteins is modulation 
of their phosphorylation state.  Protein phosphorylation/dephosphorylation occurs 
quickly, consistent with the time frame of early activation events.  Phosphorylation 
can also cause a large array of regulatory effects, such as altering a protein’s activity, 
localization, and/or association with other proteins [for examples see (Cargnello and 
Roux, 2011; Poon and Jans, 2005)].  Additionally, a single kinase or phosphatase can 
act on many substrates [for example, MAPK (Cargnello and Roux, 2011)], allowing 
the rapid transmission of an upstream signal to multiple downstream targets.  Thus, 
regulation through phosphorylation can coordinate multiple events that are responsive 
to a single trigger.  At the same time, the substrate specificity of these enzymes also 
allows for individual pathways to be regulated independently.   
The importance of protein phosphorylation changes during egg activation is 
underlined by the findings that one critical regulator of this process is a kinase 
(CaMKII), while another is a phosphatase (calcineurin).  Ca2+/calmodulin-protein 
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kinase II (CaMKII) is required for meiotic cell cycle progression at egg activation in 
both mammals and amphibians (Backs et al., 2010; Chang et al., 2009; Hansen et al., 
2006; Liu and Maller, 2005; Markoulaki et al., 2004; Rauh et al., 2005; Tatone et al., 
1999).  In Xenopus, the phosphatase calcineurin must be both activated and 
subsequently inactivated for exit from metaphase II and proper migration of male and 
female pronuclei (Mochida and Hunt, 2007; Nishiyama et al., 2007).  In Drosophila, 
calcineurin and its regulator sarah are required for multiple aspects of activation, 
including completion of meiosis and translation of new proteins (Horner et al., 2006; 
Takeo et al., 2010; Takeo et al., 2006).     
While these protein phosphorylation regulators are clearly important, few of 
the proteins being phospho-modified during egg activation have been identified.  In 
Drosophila, two proteins necessary for early embryogenesis are known to be 
dephosphorylated during egg activation – Giant Nuclei [GNU; (Lee et al., 2003; 
Renault et al., 2003; Tadros et al., 2007)] and Young Arrest [YA; (Lin and Wolfner, 
1991; Sackton et al., 2009; Yu et al., 2002; Yu et al., 1999)].  In vertebrates, 
phosphorylation of the Emi2 protein at egg activation triggers its degradation, which is 
necessary for the resumption of meiosis (Liu and Maller, 2005; Rauh et al., 2005).  It 
is also known that MAPKs are dephosphorylated upon egg activation in vertebrates, as 
well as in Drosophila, leading to a decrease in MAPK activity in the egg (Fan and 
Sun, 2004; Sackton et al., 2007).  We hypothesize that, in addition to these examples, 
many more maternal proteins change in phosphorylation state at this time to rapidly 
permit the large change in cellular state that occurs at egg activation.  Consistent with 
this hypothesis, proteomic methods have detected dynamic changes in 
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phosphorylation at the time of fertilization/egg activation in sea urchins (Roux et al., 
2006; Roux et al., 2008).   
Here, we report the identification of proteins whose phosphorylation state 
changes upon egg activation in the genetic model system Drosophila melanogaster.  
Using multiple proteomic methods we identify 311 proteins that are phospho-
regulated at the time of egg activation.  These proteins fall into a number of functional 
classes that are biologically relevant to this developmental time, including calcium 
binding and regulation, proteolysis, and protein translation.  Through a pilot RNAi 
screen we show that one of these proteins, Mrityu, is important for early 
embryogenesis.  We also find that the majority of these phospho-regulated proteins are 
conserved from Drosophila to vertebrates.  These methods should be broadly 
applicable to other systems as an efficient way to identify important molecules that act 
in egg activation and early embryogenesis.  As these proteins are not only present, but 
also regulated, during this critical transition, they provide a targeted set of candidates 
to test in future studies for roles in the regulatory cascades and downstream events of 
egg activation.   
 
2.2  Materials and Methods 
Fly culture:  Drosophila melanogaster stocks were raised on yeast-glucose-agar 
medium at 23 ± 2oC in a 12-h L:12-h D photoperiod.  All experiments were carried out 
with females from the P2 strain of Oregon R (ORP2) (Allis et al., 1977). 
Collection of mature oocytes and laid eggs:  Stage 14 mature oocytes were obtained 
from 3-5 day old wild-type virgin females that had been reared on heavily-yeasted 
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food.  Dissection was performed in Isolation Buffer, a hypertonic solution that does 
not activate eggs (Page and Orr-Weaver, 1997).  Oocytes were dissected in one hour 
blocks of time, then flash-frozen in liquid nitrogen and stored at –80oC until use. 
Newly eclosed virgin females were aged on yeasted vials for 3-5 days and then 
mated to spermless males (Boswell and Mahowald, 1985) (produced by crossing  tud1 
bw sp ♀ x Canton-S ♂) to obtain unfertilized, but activated eggs.  For all experiments 
with activated laid eggs, mated females were allowed to deposit eggs on petri plates 
containing grape juice-agar for 0-30 minute periods.  Eggs were washed off the plates 
in Egg Wash  (Karr and Alberts, 1986), frozen in liquid nitrogen and stored at –80oC 
until use.  Eggs collected for Western blotting were dechorionated in a 50% bleach 
solution for 2 minutes before being flash frozen. 
Immunoblotting:  Samples of 50-100 mature oocytes or activated eggs were 
homogenized in Extraction Buffer (10 mM Tris pH 7.5; 20 mM NaF, 2 mM EGTA, 10 
mM DTT, 400 nM okadaic acid, and 2% SDS), followed by the addition of an equal 
amount of SDS sample buffer.  Extracts were electrophoresed on polyacrylamide SDS 
gels containing 0-25 µM Phos-tag (Wako Pure Chemical Industries, Ltd., Richmond, 
VA) and subjected to Western blotting analysis as previously described (Kinoshita et 
al., 2009; Kinoshita et al., 2006; Sackton et al., 2007).  Primary antibodies, kind gifts 
of H. Bellen, R. Vale, J. Raff, F.R. Jackson, and T. Hays were used at the following 
dilutions in 1% milk: guinea pig anti-Vap-33-1, 1:10,000 (Pennetta et al., 2002); rabbit 
anti-Spindly, 1:1000 (Griffis et al., 2007); rabbit anti-Spd-2, 1:500 (Dix and Raff, 
2007); rabbit anti-lark, 1:5000 (Newby and Jackson, 1996); mouse anti-DLIC, 1:3000 
(Mische et al., 2008).  HRP-conjugated secondary antibodies were used at a 1:2000 
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dilution and visualized with the ECL Plus Western Blotting Detection system (GE 
Healthcare, Piscataway, NJ). 
Immunostaining and microscopy:  Embryos and ovaries were fixed in 
methanol/heptane and stained with DAPI, or as described in (Horner et al., 2006).  For 
DAPI staining, fixed embryos were incubated in PBS containing 1 μg/ml DAPI for 5 
minutes, followed by five 15 minute washes in PBST.  Rat anti-sperm tail antibody 
(kind gift of T. Karr) was used at a dilution of 1:800 (Karr, 1991; T. Karr, ASU, 
personal communication).  Mouse anti-tubulin antibody was used at 1:400 (Sigma, St. 
Louis, MO, catalog#T5168) and Alexa secondary antibodies were used at 1:200 
(Invitrogen, Grand Island, NY).  RNaseA (Roche, Indianapolis, IN) was added at a 
final concentration of 5 μg/ml and propidium iodide (Molecular Probes, Eugene, OR) 
was used at a final concentration of 10 μg/ml.  Images were collected using a Zeiss 
Axioskop compound microscope or a Leica TCS SP2 confocal microscope as 
described in (Horner et al., 2006). 
mrityu RNAi flies: A fly line with an RNAi construct to the gene CG1216 (mrityu) was 
obtained from the Transgenic RNAi Resource Project at Harvard Medical School (line 
GL00033).  Females from this line were crossed to nanos-GAL4 males (Bloomington 
stock 4937) to specifically knockdown mrityu in the female germline (referred to as 
RNAi females).  Control females were nanos-GAL4/TM3 siblings. 
2D-gel electrophoresis:  Oocytes and embryos, stored at –80oC until use, were 
consolidated into batches of approximately 1500 mature oocytes or unfertilized laid 
eggs and homogenized in 50 µl protease inhibiting buffer (Monsma and Wolfner, 
1988) containing 1 mM Na-orthovanadate, 10 mM β-glycerophosphate, and 20 mM 
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NaF as phosphatase inhibitors (PPIHB).  Buffer exchange was performed three times 
for extracted proteins against 500 µl lysis buffer (7 M urea/2 M thio urea, 4% CHAPS) 
using a 10 kDa cut-off membrane filter (Millipore, Billerica, MA).  Protein 
concentrations were determined by the Bradford assay using BSA as a standard, and 
approximately 100 µg of oocyte or egg protein was used for each of the 2-D gel 
analyses.  The first-dimensional separation was performed by immobilized pH 
gradient isoelectric focusing (13cm IPG, nonlinear pH 3-10 strips; GE Healthcare).  
Isoelectric focusing was conducted using Multiphor II (GE Healthcare) according to 
the manufacturer’s instructions after 12 h in-gel rehydration.  For electrophoresis in 
the second dimension, the strips were then transferred and apposed to 12.5% SDS-
polyacryalmide vertical gels that were cast in-house at 14 x 16 cm using a Hoefer 
SE600 gel cast apparatus and run using a Hoefer vertical gel running system (Hoefer, 
Inc., Holliston, MA).  Peppermint Stick molecular weight markers (Molecular Probes) 
were applied to each gel at a concentration of 0.25 µg/protein.  Gels were first run to 
observe the extent of phosphorylation changes occurring during egg activation.  A 
second set of gels was run for protein identification from specific spots that changed in 
phosphorylation.  Both oocyte and egg samples were run either in triplicate (first set) 
or duplicate (second set).   
 Two-dimensional electrophoresis was performed by the Cornell Proteomics 
Facility in the Life Sciences Core Laboratories Center. 
Gel staining and imaging:  Gels were fixed in 40% methanol/10% acetic acid and 
stored overnight in 10% methanol/7% acetic acid.  Each gel was then incubated in 
Pro-Q Diamond Phosphorylation Stain (Molecular Probes) for the detection of 
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phosphoproteins.  Following de-staining, the gels were scanned using a Typhoon 9400 
laser scanner (GE Healthcare) with 532 nm excitation and 560 nm long pass emission 
filters.  The gels were further post-stained with SYPRO-Ruby (Molecular Probes) or 
Colloidal Coomassie Blue (Invitrogen) for detection of all protein spots and once 
again scanned with the Typhoon 9400 with 488 nm excitation and 610 nm band pass 
30 emission filters.   
 Gel staining and imaging were performed by the Cornell Proteomics Facility in 
the Life Sciences Core Laboratories Center. 
Gel image analysis:  Images from Pro-Q Diamond and Colloidal Coomassie Blue 
(CCB) or SYPRO-Ruby stains were analyzed using the Image Master 2D Platinum 
software (GE Healthcare).   
For the first set of gels, the replicate Pro-Q Diamond and CCB images for each 
sample type (mature oocyte or activated egg) were combined into a single Pro-Q or 
CCB synthetic gel image, containing the average volume of each spot.  Once values 
were obtained for each spot, Pro-Q spot volumes were normalized by dividing each 
spot by its corresponding CCB spot volume.  Two known phosphorylated proteins, 
ovalbumin and beta-casein, present in the PeppermintStick protein marker were used 
to set a Pro-Q/CCB ratio minimum which we used to determine which spots were 
phosphorylated.  The lowest Pro-Q/CCB ratio obtained for these control proteins was 
0.9.  Therefore, a protein spot was considered phosphorylated if the Pro-Q/CCB ratio 
was greater than or equal to 0.9.  Due to this normalization process, only the Pro-Q 
spots with a matching CCB spot could be analyzed for potential phosphorylation.  The 
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final normalized values were used in comparison between samples, with a 2-fold or 
higher difference in volume considered significant. 
For the second set of gels, stringent criteria were applied to select spots for 
quantification and expression profiling.  Only spots that were present in both 
biological duplicate gels of this second set were analyzed by Image Master software.  
The intensity of matching spots on the gels was compared between the Pro-Q 
Diamond and SYPRO-Ruby stained gels to detect potential phosphoprotein 
candidates.  If the intensity of the Sypro Ruby stained spot was greater than 50% of 
the corresponding ProQ Diamond stained spot intensity, the spot was selected as a 
phosphoprotein.  ProQ Diamond nonspecific staining of the nonphosphorylated 
proteins in the Peppermint Stick MW Standard was nearly undetectable.  For spots 
corresponding to potential phosphoproteins, we compared Pro-Q Diamond intensities 
between oocytes and eggs in order to determine changes in phosphorylation levels.  A 
similar comparison was made in the SYPRO-Ruby gels to determine quantitative 
changes in protein abundance between oocytes and eggs.  The average normalized 
volumes for each spot (% of total spot volume) from each sample group were 
compared, and spots with at least a 1.5-fold differential expression between two 
samples were considered to be up or down-regulated.  With a single exception, spots 
with changes only in Pro-Q Diamond staining, and not Sypro Ruby staining, were 
chosen for subsequent protein identification analysis.  (The one exception was spot 
number 1068, which showed a decrease in Sypro Ruby staining from oocyte to egg in 
addition to staining with Pro-Q Diamond only on the oocyte gels.)   
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 Computer analysis of the gels was performed by the Cornell Proteomics 
Facility in the Life Sciences Core Laboratories Center. 
 Relative abundance of proteins within a single spot was estimated by the 
exponentially modified protein abundance index (emPAI) as described by Yang et al. 
(2007). 
Immobilized Metal Affinity Chromatography (IMAC):  500-600 mature oocytes or 
unfertilized, activated laid eggs were combined and homogenized in PPIHB 
(containing 0.1% SDS) as described above.  After homogenization, additional PPIHB 
was added to a final volume of 250 µl.  Samples were centrifuged at 20,000 x g for 30 
minutes at 4oC and the supernatant was collected.  10 mM DTT (60oC for 30-60 min) 
was used as a reducing agent and 60 mM iodoacetamide was used for alkylation of 
cysteine residues.  Trypsin was added at a ratio of 1:15 trypsin:total protein and 
samples were incubated overnight at 37oC.  Reactions were stopped with 5% formic 
acid and samples were acidified to pH 2.5-3.0 with 1 M HCl.  Samples were added to 
equilibrated PHOS-Select Iron Affinity Gel (Sigma) and incubated for a minimum of 
one hour before the gel was washed to remove unphosphorylated peptide fractions.  
Phosphopeptides were eluted by adding 200-400 µL Elution Solution (400 mM 
ammonium hydroxide) for subsequent mass spectrometry analysis.   
 IMAC enrichment was performed by the Cornell Proteomics Facility in the 
Life Sciences Core Laboratories Center. 
Protein identification:  Spots of interest from the 2D gels were picked robotically from 
a master gel containing both mature oocyte and activated egg samples (Investigator 
ProPic; Genomic Solutions, Ann Arbor, MI) for in-gel digestion with trypsin and 
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extraction by robotic ProPrep (Genomic Solutions) using standard protocols 
(Shevchenko et al., 1996).  Spots of interest and IMAC enriched peptides were 
subjected to nanoLC-ESI-MS/MS analysis on a hybrid triple quadrupole linear ion 
trap mass spectrometer, the 4000 Q Trap (ABI/MDS Sciex, Framingham, MA).  A 
second mass spectrometry analysis of the IMAC peptides was also performed on a 
LTQ Orbitrap Velos mass spectrometer (Thermo Scientific, Waltham, MA).  The 
MS/MS data generated from the nanoLC-MS/MS IDA analysis on 2D gel spots and 
IMAC samples were submitted to Mascot 2.2 for database searching using an in-house 
licensed Mascot local server.  The search was performed to query the NCBInr 
database (Taxonomy: Drosophila) downloaded from NCBI (July 2008), allowing one 
missed cleavage site by trypsin.  Carbamidomethyl modification of cysteine, 
methionine oxidation and phosphorylation of serine/threonine/tyrosine were set as 
variable modifications.  All matches that occurred above a 95% confidence interval 
(CI), with significant scores for the peptides defined by Mascot probability analysis 
greater than “identity” were considered for the protein identifications.  Resulting 
spectra were inspected manually to verify phosphorylation site identifications.  Only 
peptides with an identified phosphorylation site were included in further analyses.  
Peptide sequences from the Orbitrap results were manually run through a BLAST 
analysis (http://blast.ncbi.nlm.nih.gov) to determine the proteins from which they were 
derived.   
 Mass spectrometry was performed by the Cornell Proteomics Facility in the 
Life Sciences Core Laboratories Center. 
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Characterization of candidate proteins: Function was chosen from the GO terms listed 
by AmiGO (amigo.geneontology.org).  Tissue expression was mined from FlyAtlas 
(www.flyatlas.org).  Unless otherwise indicated, independent evidence for 
phosphorylation was found at the Uniprot database (www.uniprot.org).  In cases 
where the only evidence for phosphorylation was from Zhai et al. (2008), the protein 
was considered a known Drosophila phosphoprotein only if the same phosphopeptide 
was found in our IMAC experiment.  If there was no evidence of phosphorylation in 
Drosophila, homologs were searched in the Uniprot database for reports of 
phosphorylation, beginning with human and followed by mouse, rat, and Xenopus.  
Both Uniprot and Pubmed were searched for previously known evidence of 
phosphorylation.  InParanoid  (http://inparanoid.sbc.su.se/cgi-bin/index.cgi) gene 
search was used to identify orthologs in any vertebrate species. 
Phosphatase treatment:  For Spindly, samples of 75 mature oocytes or 75 eggs were 
homogenized in 50 μl of modified protease inhibiting buffer containing 1X CIAP 
Dephosphorylation Buffer (Roche) instead of HEPES, and no Triton X-100.  Samples 
were then split in half.  The phosphatase inhibitor Okadaic Acid was added to one half 
at a concentration of 0.4 μM and calf intestine alkaline phosphatase (CIAP, Roche) 
was added to the other half.  Samples were then incubated at 37oC for 15 min.  
Following the incubation an equal volume of DTT loading buffer was added and 
samples were boiled and run as described earlier.   
For Vap-33-1, lark, and DLIC, 300 mature oocytes or egg were homogenized in 200 
μl Extraction Buffer and boiled for 5 minutes.  Protein was precipitated by 
methanol/chloroform and protein pellets were dried overnight.  Proteins were 
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resuspended in 1X Dephosphorylation Buffer (Roche) with 1% SDS and 5% Triton X-
100.  Samples were split in half and 1/10 the sample volume of CIAP was added to 
one half.  Both CIAP and control samples were incubated at 37 oC for 1 hour.  Protein 
was once again precipitated with methanol/chloroform.  The protein pellet was then 
resuspended in 1X SDS sample buffer and run as described earlier. 
RT-PCR: RNA was extracted from approximately 150 stage 14 mature oocytes 
collected from mri RNAi and control females.  1 μg of RNA was treated with 1 μl 
RQ1 DNase (Promega) for 37oC for 30 min.  The reaction was stopped with 1 μl RQ1 
DNase Stop Solution and a 10 min incubation at 65oC.  cDNA was synthesized using 
SMARTScribe Reverse Transcriptase (Clontech) and according to manufacturer’s 
protocol.  cDNA from mri RNAi and control oocytes was used as the template in a 
PCR with primers to mri or the control gene RpL32 (which is expect to be present in 
equal abundance in both samples).  Primer sequences for mri were 5’ – CGA CGG 
CAT TTC GCA CTT AGT GTT – 3’ and 5’ – AGG ACA TGT GGA TGA AAG 
GTC GCT – 3’.  RpL32 primer sequences were 5’ – CCG CTT CAA GGG ACA CTA 
TC – 3’ and 5’ – GAC AAT CTC CTT GCG CTT CT – 3’.  The mri primers span an 
intron, allowing genomic DNA and cDNA to be differentiated by size, to ensure that 
the observed PCR products did not result from any genomic DNA contamination 
within the cDNA prep.  The reaction was run for 30 cycles.  Products were run along 
with a 1 Kb Plus DNA ladder (Invitrogen) on a 1% agarose gel containing 0.5 μg/ml 
ethidium bromide. 
Fertility of RNAi females:  Fly lines with an RNAi construct to the genes of interest 
were obtained from the Transgenic RNAi Resource Project at Harvard Medical School 
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(see Table S5 for line numbers).  Females from the lines were crossed to nanos-GAL4 
males (Bloomington stock 4937) to specifically knockdown the genes in the female 
germline (referred to as RNAi females).  Control females were nanos-GAL4/TM3 
siblings from lines that were balanced.  Virgin RNAi and control females, aged 3-5 
days, were individually mated with wild-type (ORP2) males.  Following copulation, 
males were removed and females were allowed to lay eggs for 24 hours.  Every 24 
hours, females were transferred to a fresh vial and the number of eggs laid in the 
previous vial was counted.  In this way, the total number of eggs laid by each female 
over 3 days was determined.  After 15 days, the total number of adult progeny in each 
vial was also counted to determine the fertility of each female.  Viability was 
determined by dividing the total number of adult progeny by the total number of eggs 
laid and is presented as the average (± standard deviation) for 5 females of each 
genotype.  Exceptions are females knocked down for eif-4A for which n = 4, and the 
control for which n = 13 (summed over 2 experiments). 
 
2.3  Results 
2D gel electrophoresis detects dynamic phosphorylation changes:   
 To visualize proteomic changes that occur upon egg activation in Drosophila, 
we performed two-dimensional (2D) gel analysis of samples containing protein from 
mature, stage 14 oocytes or 0-30 minute activated, unfertilized laid eggs.  We detected 
830 protein spots in samples from mature oocytes and 822 protein spots in samples 
from activated eggs.  A subset of the spots detected in mature oocytes were not 
detected in activated eggs (231/830), suggesting that these proteins are degraded or 
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undergo post-translational modifications upon egg activation.  We also detected 
protein spots unique to activated eggs (223/822), indicative of translation or post-
translational modifications upon activation.   
In samples from both stages, approximately 30 percent of the total detected 
proteins were phosphorylated.  This result is similar to the percentage of 
phosphorylated proteins found in sea urchin unfertilized eggs, and to the percentage of 
the proteome that has been observed to be phosphorylated in mammalian cells (Ahn 
and Resing, 2001; Roux et al., 2006; Roux et al., 2008).  Of the phosphoproteins we 
analyzed, 40% were more highly phosphorylated (≥ 2 fold) in mature oocytes and 
38% were more highly phosphorylated in the activated egg, indicating that there is a 
high level of phospho-modulation during egg activation in Drosophila (Figure 2.1 and 
Table 2.1).   
IMAC enrichment of phosphopeptides identifies numerous proteins that change in 
phosphorylation state during egg activation: 
After observing the extent of the phosphorylation changes that take place 
during egg activation by 2D gel, we set out  to determine the identities of the proteins 
that undergo these changes.  We applied a peptide-based approach with enrichment of 
phosphopeptides by immobilized metal affinity chromatography (IMAC).  IMAC 
allowed us to identify a large number of phosphorylated proteins in both mature 
oocytes and activated eggs; including proteins that may not have been detectable, or 
appeared differently, on the 2D gels.  IMAC also provides the additional advantage 
that each protein is associated with an identified phosphorylation site.   
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Figure 2.1  ProQ Diamond Phosphorylation stained images of mature oocytes 
(left) and 0-30 minute activated eggs (right) show global phosphorylation changes 
take place upon egg activation.  The gels were stained with ProQ Diamond 
Phosphorylation Stain to detect phosphoproteins.  Spots are colored to indicate a 
difference in spot volume between the two samples; a spot with a 2-fold or higher 
volume in one sample is green, a 2-fold or lower volume in one sample is red, and 
spots that are approximately the same volume in both samples are blue.  
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 Unique spots/ 
Total spots 
 
Phosphorylated 
at ≥ 0.9 
2-fold or higher 
Phosphorylation 
 
Mature 
oocytes 
 
231/830  
(27.8%) 
 
163/555 
(29.4%) 
 
46/114 
(40.4%) 
 
Activated 
eggs 
 
223/822 
(27.1%) 
 
112/405 
(27.6%) 
 
43/112 
(38.4%) 
 
 
Table 2.1  Changes to the proteome and phosphoproteome upon egg activation in 
Drosophila observed by 2D gel analysis.  Colloidal Coomassie Blue (CCB) and 
ProQ stained images of mature oocytes and activated eggs were analyzed for total 
number of proteins, phosphoproteins, and phosphoprotein changes.  The left column 
shows the number of unique spots out of the total number of spots stained with CCB 
in the indicated samples.  The middle column shows the number of spots in the 
indicated sample that were considered phosphorylated out of the total number of spots 
that could be analyzed (see Materials and Methods).  The far right column shows that 
number of spots that were more highly phosphorylated in the indicated sample, out of 
the total number of spots that could be analyzed.  Analysis and table are from the 
dissertation of V.L. Horner. 
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Comparisons were made between the phosphopeptides that we found in either 
mature oocyte or activated egg samples, resulting in a total of 273 phosphopeptides 
that were identified in only one sample or the other; 205 in the mature oocyte and 68 
in the activated egg.  In most cases the phosphorylation(s) of a given protein was 
found within a single peptide sequence, although we also identified a few proteins 
phosphorylated within multiple phosphopeptide sequences.  Thus, these 273 unique 
phosphopeptides define 238 proteins: 174 with mature oocyte specific 
phosphorylations, 58 with activated egg specific phosphorylations, and 6 proteins that 
were phosphorylated in both samples, but at different sites.  We consider these 
candidates for proteins that change in phosphorylation state during egg activation.  
Our finding of more phosphorylated peptides in mature oocytes than in activated eggs 
also suggests that egg activation is accompanied by more dephosphorylation events 
than phosphorylation events.   
Since the IMAC experiment does not control for changes in protein abundance, 
some of the changes observed could be due to protein translation or degradation 
instead of a change in phosphorylation state.  However, we believe that majority of the 
changes we identified represent true changes in phosphorylation state.  Among the 
phosphoproteins identified only in the mature oocyte samples are GNU and ERK 
(encoded by the rolled gene), two proteins previously known to be dephosphorylated 
during egg activation (Renault et al., 2003; Sackton et al., 2007), demonstrating our 
ability to detect relevant phosphorylation changes by this method.  In addition, data 
from  previous mass spectrometry experiments informed us that for approximately 
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25% of the proteins identified by IMAC the protein is present in both oocytes and 
activated eggs (unpublished results).   
Additional proteins that change in phosphorylation state are identified from 2D 
gels: 
Recognizing that any single proteomic method is not saturating for the 
proteome, we ran a second set of 2D gels in an effort to identify additional proteins 
undergoing phosphorylation changes.  While we were unable to control for abundance 
changes in the IMAC experiment, we chose to control for it here.  We applied strict 
criteria for selecting spots for identification and selected spots that only showed 
differences between oocytes and activated eggs in phosphorylation (ProQ Diamond) 
but not protein abundance (SYPRO-Ruby).  Even though these criteria reduced the 
number of proteins that we identified from the 2D gels, they ensured that the spot 
changes we focused on were specifically due to phosphorylation differences between 
the samples.  Thirty spots met these criteria; eighteen of these represented proteins that 
were more highly phosphorylated in the mature oocyte, while 12 were more highly 
phosphorylated in activated eggs (Figure 2).  Mass spectrometry of the selected spots 
resulted in a total of 83 protein IDs, as most spots contained more than one protein 
(Table 2.2).  We hypothesize that the phosphorylation change of a given spot is most 
likely due to the most highly abundant protein present within the spot and/or the 
proteins for which we identified a phosphorylated peptide.  However, it is possible that 
multiple co-migrating proteins contributed to the observed ProQ Diamond staining.  
We therefore considered all proteins identified as candidate proteins that may be 
changing in phosphorylation state during egg activation.  
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Figure 2.2  2D gels stained with ProQ Diamond phosphorylation stain and spots 
chosen for identification. Gels are shown for A) mature oocyte proteome and B) 
unfertilized activated egg proteome.  Spots chosen for identification by mass 
spectrometry are indicated with their corresponding spot ID#.  Images of each 
individual spot chosen for identification are shown below for C) spots that were 
upregulated or unmatched in the mature oocyte and D) spots that were upregulated or 
unmatched in the activated egg. 
A B 
315 385 465 516 569 575 
C 
716 973 1045 1068 1226 1606 
1615 1626 1628 1634 1635 1643 
146 172 274 447 588 817 
841 957 962  1649 1674 
D 
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Table 2.2  Proteins identified from 2D gels as changing in phosphorylation state 
during Drosophila egg activation.  Proteins for which a phosphopeptide was found 
are marked with a Y in the phosphopeptide column and the relative abundance of a 
protein within a single spot is given.  Spots in red (starting at Spot ID 146) were more 
highly phosphorylated in the activated egg. 
      Phospho- Relative 
Spot ID CG Protein(s) peptide  Abundance (%) 
315 CG17246 Succinate dehydrogenase A N 100 
385 CG8439 T-complex Chaperonin 5 Y 98 
  CG8351 Tcp-1eta N 1 
  CG5384   N 1 
465 CG14309   N 50 
  CG3590   N 28 
  CG13425 bancal N 15 
  CG31293 recombination-defective Y 7 
516 CG8209   Y 49 
  CG11154 ATP synthase beta subunit N 25 
  CG6546 Brahma associated protein 55kD N 9 
  CG9556 alien N 7 
  CG7997   N 5 
  CG4535 FK506-binding protein FKBP59 N 3 
    actin N 2 
569 CG9075 eukaryotic translation initiation factor 4A N 73 
  CG2985 yolk protein 1 N 14 
  CG13349   N 6 
  CG2915   N 4 
  CG5330 Nucleosome assembly protein 1 N 3 
575 CG9075 eukaryotic translation initiation factor 4A N 68 
  CG2979 yolk protein 2 N 20 
  CG16916 Rpt3 N 6 
  CG2985 yolk protein 1 N 6 
716 CG4930 Endonuclease G inhibitor N 86 
  CG4299 Set N 14 
973 CG3183 geminin N 57 
  CG8582 Sh3beta N 43 
1045 CG4183 Heat shock protein 26 N 50 
  CG13922 mitochondrial ribosomal protein L46 N 37 
  CG1721 Phosphoglyceromutase N 13 
1068 CG1274 thioredoxin peroxidase 2 N 84 
  CG4466 Heat shock protein 27 N 9 
  CG7490 Ribosomal protein LP0 N 7 
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1226 CG3612 bellwether N 100 
1606 CG9946 eukaryotic translation initiation factor 2alpha N 91 
  CG10230 Rpn9 N 7 
  CG1906 alphabet N 2 
1615 CG11154 ATP synthase beta subunit N 56 
1615  CG11844 vig2 Y 18 
  CG3612 bellwether N 15 
  CG8209   Y 11 
1626 no ID       
1628 CG7070 pyruvate kinase N 30 
  CG8308 alpha-Tubulin at 67C N 18 
  CG1799 raspberry N 11 
  CG2263   N 11 
  CG7085 lethal (2) s5379 N 9 
  CG5330 Nucleosome assembly protein 1 N 7 
  CG1938 Dynein light intermediate chain N 5 
  CG5525   N 5 
  CG5320 Glutamate dehydrogenase N 4 
1634 CG10682 vihar N 64 
  CG9705   N 36 
1635 CG9705   N 100 
1643 CG13388 A kinase anchor protein 200 N 96 
  CG1242 Heat shock protein 83 N 4 
          
146 CG6603 Hsc70Cb Y 72 
  CG5520 Glycoprotein 93 N 15 
  CG4206 Minichromosome maintenance 3 N 13 
172 CG2331 TER94 Y 91.5 
  CG7528 Smt3 activating enzyme 2 Y 5.5 
  CG6603 Hsc70Cb N 2 
  CG1242 Heat shock protein 83 N 1 
274 CG4264 Heat shock protein cognate 4 N 48 
  CG8223   Y 38 
  CG9050 palisade N 8 
  CG6751   N 6 
447 CG5330 Nucleosome assembly protein 1 N 98 
  CG8439 T-complex Chaperonin 5 N 1.5 
  CG8351 Tcp-1eta N 0.5 
588 CG2985 yolk protein 1 N 39 
  CG2979 yolk protein 2 N 38 
  CG11129 yolk protein 3 N 17 
    actin N 4 
  CG3127 Phosphoglycerate kinase N 1 
  CG5880   N 1 
817 CG2207 Decondensation factor 31 Y 98 
  CG8893 Glyceraldehyde 3 phosphate dehydrogenase 2 N 1.5 
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  CG18174 Rpn11 N 0.5 
841 CG7490 Ribosomal protein LP0 N 100 
957 CG18190   N 100 
962 CG4912 eEF1delta Y 51 
  CG12131 Adam N 31 
  CG31196 14-3-3epsilon N 16 
962  CG7490 Ribosomal protein LP0 N 1 
  CG16725 survival motor neuron N 1 
987 CG4912 eEF1delta N 54 
  CG17870 14-3-3zeta N 29.5 
 CG9273 Replication protein A2 N 7 
  CG8947 26-29kD-proteinase N 6 
  CG9154   N 2 
  CG5921   N 0.5 
1649 CG7967   N 32 
  CG6692 Cysteine proteinase-1 N 29 
  CG5094 small glutamine-rich tetratricopeptide containing protein N 15 
  CG13630   N 13 
  CG8309 Transport and Golgi organization 7 N 11 
1674 CG17291 Protein phosphatase 2A at 29B N 74 
  CG1242 Heat shock protein 83 N 7 
  CG32190 NUCB1 N 6.5 
  CG3223   N 6.5 
  CG2774   N 6 
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  Only ten proteins were identified by both the 2D gels and IMAC.  Thus, 
neither method was saturating for the proteome.  For six of these proteins (Vig2, 
DLIC, Hsp26, Smt3 activating enzyme 2, CG8209, and CG14309) the results were 
consistent between the two methods.  The other four proteins (Nucleosome assembly 
protein 1, Yolk protein 1, A kinase anchor protein 200, and CG18190) were either 
identified in multiple spots on the 2D gels or were identified from spots more highly 
phosphorylated in the opposite sample from which we identified a phosphopeptide by 
IMAC.  It is possible that these proteins have additional phosphorylation sites that we 
failed to identify by IMAC and the overall change in phosphorylation state is in the 
direction indicated by the 2D gels.  Additional studies will be required to fully define 
the phosphorylation state of these proteins in oocytes and activated eggs.    
Western blots confirm phosphorylation state change for select proteins: 
The phosphorylation of a protein can affect its electrophoretic mobility through 
a gel: A more highly phosphorylated protein will often have a slower mobility than a 
less phosphorylated form of the same protein.  This difference in mobility can be 
enhanced by the addition of Phos-tag, which binds the phosphate groups on 
phosphorylated proteins, slowing their movement through a polyacrylamide gel 
(Kinoshita et al., 2006).  Thus, if a protein is present in different phosphorylation 
states between samples, this may appear as a band shift on a Western blot.   
We tested a subset of seven of our IMAC candidates with available antibodies 
by Western blot to see if we could observe a shift for any of these proteins when 
comparing samples from mature oocytes and activated eggs.  We observed a shift for 
five candidates - lark, Dynein light intermediate chain (DLIC), Spindly, Spd-2, and 
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Vap-33-1 (Figure 2.3).  Treatment of the samples with a phosphatase (CIAP) confirms 
that the shifts seen on the Western blot are due to phosphorylation differences (Figure 
2.4).  Because phosphorylation does not guarantee a change in electrophoretic 
mobility, our failure to observe a shift for the other two candidates (Cup and Slender 
lobes) does not rule out that they are phosphoregulated.   
Spindly, DLIC, Spd-2, and lark show shifts indicative of dephosphorylation 
during egg activation and Vap-33-1 appears to exist in an intermediate 
phosphorylation state that is oocyte specific.  Spindly protein migrates more slowly in 
mature oocytes than in activated eggs, indicating that a more highly phosphorylated 
form of the protein is present in the oocyte (Figure 2.3A).  DLIC protein runs as a 
doublet, the upper band of which was shown by Mische et al. (2008) to represent a 
phosphorylated form of the protein.  We observe this doublet in mature oocytes, 
however only the lower band is detectable in unfertilized activated eggs (Figure 2.3B).  
Spd-2 protein appears as a smear in the oocyte lane when run on a Phos-tag gel (5% 
acrylamide, 3.5 μM Phos-tag), indicating that the protein is phosphorylated.  This 
smear is no longer present in the activated egg lane, consistent with dephosphorylation 
of Spd-2 during egg activation (Figure 2.3C).  Phos-tag gels (10.6% acrylamide, 25 
μM Phos-tag) also allow us to visualize slower mobility fractions of lark and Vap-33-1 
proteins which correspond to phosphorylated forms of the proteins.  For lark, the 
phosphorylated state is specific to the mature oocyte, again consistent with 
dephosphorylation of the protein during egg activation (Figure 2.3D).  Vap-33-1 
protein appears to exist in two distinct phosphorylation states, one of which is oocyte 
specific (Figure 2.3E).  These results are consistent with our identification of mature  
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Figure 2.3  Western blots confirm a change in phosphorylation state for A) 
Spindly B) DLIC C) Spd-2 D) lark and E) Vap-33-1 upon egg activation.  Oocyte 
specific phosphorylation states of lark and Vap-33-1 are indicated by arrow. 
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Figure 2.4  Phosphatase treatment confirms that band shifts are due to 
phosphorylation. 
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oocyte specific phosphopeptides for these five proteins, supporting the validity of the 
candidates we have identified.       
RNAi knockdown of candidates identifies a new gene important for the first 
embryonic mitosis: 
 We next used RNAi to test our hypothesis that our candidates include new 
genes that act during egg activation or embryogenesis.  We attempted to knock down 
18 of our candidates by female germline-specific RNAi and found that 6 are essential 
for female fertility and that knockdown of a seventh severely reduced fertility (only 
33% of laid eggs produced adult progeny)(Table 2.3).  The lack of a phenotype for the 
remaining 11 candidates indicates that maternal expression of these genes is either not 
essential for early development, perhaps due to redundant molecules, or that we failed 
to successfully knock down the genes by RNAi.  Of the 6 genes whose knockdown 
caused sterility, knockdown of 4 prevented the production of eggs, indicating roles for 
these genes in oogenesis.  Knockdown of the other 2 resulted in eggs that were 
defective in embryogenesis.  Knockdown of one of these genes, PyK, leads to embryos 
that are able to complete early embryonic mitosis (data not shown), possibly due to 
insufficient knockdown to reveal earlier functions of the protein.  In contrast, we find 
the early arrest caused by knockdown of the other gene, mrityu (mri), to be of 
particular interest.   
Mri, which our IMAC experiments detected as a protein that is phosphorylated 
during egg activation, is a BTB/POZ domain-containing protein with no previously 
known function (flybase.org).  mri RNAi females lay eggs, but those eggs fail to hatch 
(Supplementary Table 2.4).  RT-PCR confirms that mri is knocked down in mature  
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Table 2.3  Viability of laid eggs when candidate genes are knocked down by 
female germline specific RNAi.  Genes were knockdown using a nanos-GAL4 driver.  
Viability is presented as the percentage of eggs laid that resulted in adult progeny (± 
standard deviation).  N=5, except for eif-4A and control (see Supplementary Methods 
for details). 
 
 
Knockdown 
gene 
TRiP line # Viability (%) 
CG7597  HMS00155 no oocytes 
CG9609  HMS01000 no oocytes 
CG5602  HMS01036 no oocytes 
Rtf1  HMS00168 no oocytes 
PyK  GL00099 0 (± 0) 
mrityu  GL00033 0 (± 0) 
Pk92B GL00238 33 (± 18) 
D1  HMS00061 84 (± 9.0) 
Eps-15  HMS00947 98 (± 1.3) 
HIP-R HMS00988 96 (± 1.6) 
5-HT1A HMS00823 98 (± 1.9) 
rasputin HMS00269 98 (± 2.1) 
Sodh-1  HMS01028 98 (± 0.73) 
RPA2 HMS01061 86 (± 26) 
Apc HMS 00188 92 (± 11) 
RhoGAP92B HMS00268 99 (± 1.5) 
myopic HMS00836 94 (± 4.1) 
eif-4A HMS00927 99 (± 0.60) 
Control 
(no knockdown) 
  
97 (± 2.5) 
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Table 2.4  Females with mriytu knocked-down in the germline produce eggs, but 
no progeny.  Egg and progeny counts are the totals over three days, presented as the 
average of 5 females (± standard deviation). 
 # eggs # progeny 
 
Control  
n = 5 
 
107 (± 14.9) 
 
105 (± 15.2) 
 
mrityu RNAi  
n = 5 
 
141 (± 23) 
 
0 
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oocytes of RNAi females, indicating that mri expression in the germline is necessary 
for female fertility (Figure 2.5).  To determine if the embryos laid by mri RNAi 
mothers arrested early or late in embryogenesis we stained 1-3 hr old embryos with 
DAPI to observe the number of nuclei present.  We failed to observe more than 5 
nuclei in any mri arrested embryos (n = 30), indicating an early arrest point.  To 
confirm that embryos from mri RNAi females are fertilized prior to their 
developmental arrest, we stained 0-90 minute old embryos with an anti-sperm tail 
antibody.  A sperm tail was clearly visible within both control and RNAi embryos (7/8 
control; 11/12 RNAi), indicating that the sterility of mri RNAi females is not due to a 
lack of fertilization (Figure 2.6A).   
To determine the specific arrest point of the RNAi embryos, we then stained 
them with propidium iodide and anti-tubulin antibody, to visualize DNA and 
microtubules, respectively.  While 1-3 hour old control embryos have undergone 
multiple rounds of syncytial mitosis (Figure 2.6B), we never observe such divisions in 
mri RNAi embryos.  Instead, these embryos arrest during metaphase of the first 1-3 
mitotic divisions (Figure 2.6C and Figure 2.7).  In approximately half of the embryos 
observed (14/30) only one nucleus is present within the egg, while another 30% (9/30) 
contain only 2 nuclei.  Our ability to find a polar body in one-third of these embryos 
suggest that meiosis able to resume and complete (Figure 2.6D), leading to our 
hypothesis that the arrest is during the first or second embryonic mitosis.  However, 
we can not currently rule out the possibility that we are observing either the single 
male pronucleus, or the male and female pronuclei.  Additionally, we observed two 
embryos that appear to still be arrested in meiosis I.  We attribute the slight variability 
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Figure 2.5  RT-PCR confirms that mrityu is knocked-down in mature oocytes. 
PCR was run with primers for mri unless otherwise indicated.  Lanes:1) 100% control 
cDNA 2) 50% control cDNA 3) 10% control cDNA 4) 1% control cDNA 5) 100% 
mrityu RNAi cDNA 6) no template 7) genomic DNA 8) 100% control cDNA with 
RpL32 primers 9) 100% mrityu RNAi cDNA with RpL32 primers. 
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Figure 2.6  Embryos are fertilized but arrest early when mrityu is knocked-down 
in the mother.  A) Anti-sperm tail antibody (red) was used to visualize the sperm 
within 0-90 minute embryos laid by mri RNAi females.  B-D) One to three hour old 
embryos laid by mri RNAi or control females were stained with propidium iodide to 
visualize DNA (red) and anti-tubulin antibody to visualize microtubules (green). 
Control embryos undergo mitotic divisions (B) while RNAi embryos typically arrest 
with a single nucleus (C).  The visualization of  a polar body rosette (D) suggests that 
meiosis is able to complete in these embryos. Insets are zoomed in images of the 
boxed region.  
Scale bar = 50 µm 
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Figure 2.7  Additional arrest points observed for mrityu RNAi embryos.  A) 
meiosis I B) single nucleus and possible second nucleus with no associated tubulin C) 
two nuclei D) 4-5 nuclei E) polar body and one possible nucleus with no associated 
tubulin.  C-E each show one embryo at two different focal planes.   
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in the arrest point to the variable efficiency of RNAi and the fact that we are able to 
reduce, but not eliminate, the mri transcript in the oocyte.  Further studies of mrityu 
will benefit from the creation of a mutant line that eliminates all Mrityu protein.  This 
will allow us to pinpoint the arrest point and more fully characterize the mechanism by 
which mrityu contributes to the regulation of early embryonic development.  
By screening a small subset of the phosphoproteins we identified in this study, 
we have found a new gene, mrityu, that is required for early embryonic development.  
These findings indicate that the phosphoregulated proteins we identified can be a rich 
source of molecules needed for the oocyte-to-embryo transition and that further RNAi 
screening will reveal additional genes that act during this early developmental period.   
 
2.4  Discussion 
Egg activation is a rapid and highly regulated set of events that allow a 
relatively quiescent oocyte to transition to the cellular state necessary for embryo 
development.  Much work has been done to understand the initial calcium signal that 
triggers egg activation in most organisms, and a few of the immediate downstream 
molecules that transduce this calcium signal have been identified, primarily the kinase 
CaMKII and the phosphatase calcineurin (Backs et al., 2010; Chang et al., 2009; 
Takeo et al., 2010).  In addition, we know the ultimate cellular events that occur when 
egg activation is successful – modifications of the egg coverings, resumption and 
completion of meiosis, translation of new proteins, and degradation of specific 
maternal macromolecules [reviewed in (Horner and Wolfner, 2008)].  However, the 
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pathways and proteins that connect the early triggers of activation to the final 
downstream events remain largely unknown.   
We have identified a set of proteins that will help us to better understand the 
connections between the early triggers and final events of egg activation.  As this 
transition occurs before zygotic transcription and too early for major effects of any 
new protein synthesis, we explored the possibility that post-translational modifications 
might activate or inactivate critical molecules during egg activation.  Identifying the 
molecules that are regulated during this transition will provide new molecular insights 
into this important developmental period, as well as new candidates to test for roles in 
egg activation.  Here we report that large-scale phosphoproteome changes occur 
during Drosophila egg activation.  We identified a total of 311 proteins that change in 
phosphorylation state during this transition; these include proteins that we found to be 
phosphorylated in only mature oocytes or activated eggs, as well as proteins that 
changed in the specific phosphorylation site between samples.   
Our results show the importance of combining proteomic approaches and the 
complementary, rather than redundant, nature of these methods; consistent with 
studies that compared protein-based and peptide-based proteomic methods (Wu et al., 
2006).  The 2D gels provide a global view of the protein differences found between 
the two states and do not require the specific phosphorylated peptide of a protein to be 
detectable by mass spectrometry.  In contrast, IMAC does require the identification of 
the phosphorylated peptide, but does not depend on the protein being detectable, or 
appearing differently, on a gel.  Thus, by combining methods with different strengths 
we were able to expand the number, and type, of proteins within our data set.  Even so, 
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we do not expect that the 311 proteins we identified represent the full list of proteins 
that are phospho-regulated during egg activation.  However, they provide an important 
start in providing new candidates to test for roles in egg activation and improving our 
understanding of the importance of phosphorylation during this period of 
development.  Through a pilot genetic screen, which identified mrityu as a new gene 
with an essential role in early Drosophila development, we verified that the phospho-
modified proteins we detected will be a source of new regulators of this process.   
 
Large scale phosphorylation changes occur during egg activation 
We showed here that a relatively large fraction of the Drosophila oocyte 
proteome (~30%) is phospho-modified during egg activation.  Of the 311 phospho-
modulated proteins that we identified by proteomic comparison of mature oocytes 
(prior to egg activation) and activated eggs, we found 84 Drosophila proteins, and the 
Drosophila homologs of another 123 proteins from other organisms, that were known 
to be phospho-modified in at least one cell type.  The proteins that we identified 
include two (ERK and GNU) that had previously been shown to be phospho-modified 
during this time-window (Sackton et al.,2007; Renault et al., 2003) and five more 
(Spd2, Spindly, lark, DLIC, and Vap33) whose phosphorylation changes during egg 
activation we verified independently by Western blotting.  
The proteins identified in this study fall into a number of functional classes 
(based on known and/or predicted functions) (Table 2.5).  These include calcium 
binding/regulation, cell cycle, metabolism/glycolysis, proteolysis, and protein 
translation; all classes which are anticipated to act during egg activation.  Our finding  
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Table 2.5  All proteins identified from 2D gels and IMAC experiments.  Each protein is described by (A) function and 
presence of vertebrate homologs and (B) expression, previously shown evidence of phosphorylation, method (2D-gel or IMAC) 
by which it was identified in this study, and the sample (mature oocyte or activated egg) that it was found to be phosphorylated in.  
NA for expression indicates no conclusive data available on Flyatlas. YD indicates evidence of phosphorylation in Drosophila.  
 
 78 
 Table 2.5A     Conserved 
CG Protein Name Function in Vertebrates 
CG31196 14-3-3epsilon Ras protein signal transduction Y 
CG17870 14-3-3zeta Ras protein signal transduction Y 
CG8947 26-29kD-proteinase proteolysis Y 
CG13388 A kinase anchor protein 200 protein kinase A binding N 
  actin structural constituent of cytoskeleton Y 
CG5712 ACXD adenylate cyclase activity N 
CG12131 Adam translation initiation factor Y 
CG1070 alhambra regulation of transcription Y 
CG9556 alien negative regulation of transcription Y 
CG4260 alpha-Adaptin protein transporter activity Y 
CG1906 alphabet phosphatase activity Y 
CG8308 alpha-Tubulin at 67C pronuclear migration N 
CG2446 Amun protein binding Y 
CG6631 anastral spindle 1 mitotic spindle organization Y 
CG1451 APC-like microtubule binding Y 
CG11154 ATP synthase beta subunit proton transport Y 
CG6137 aubergine RNA binding N 
CG6877 Aut1 autophagy Y 
CG7926 axin beta-catenin binding Y 
CG6386 ballchen protein kinase activity Y 
CG13425 bancal RNA binding Y 
CG5529 BarH1  regulation of transcription Y 
CG3612 bellwether proton transport Y 
CG8276 bicoid-interacting protein 3 regulation of transcription Y 
CG6546 Brahma associated protein 55kD mitosis Y 
CG10542 Bre1  histone modification Y 
CG9097 bric a brac 1 regulation of transcription Y 
CG42344 bruchpilot calcium channel activity Y 
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Table 2.5A (continued) 
      Conserved 
CG Protein Name Function in Vertebrates 
CG31132 BRWD3  phagocytosis Y 
CG12892 Caf1-105 DNA binding Y 
CG11958 calnexin protein folding Y 
CG12019 Cdc37  protein tyrosine kinase activator activity Y 
CG7597 Cdk12 cyclin-dependent protein kinase activity Y 
CG7464 chitin synthase 2 chitin synthase activity Y 
CG4145 collagen type IV extracellular matrix structural constituent Y 
CG33957 cp309 microtubule nucleation Y 
CG34389 crossveinless c Rho GTPase activator activity Y 
CG11181 cup  regulation of translation N 
CG6081 Cyp28d2  electron carrier activity N 
CG6692 Cysteine proteinase-1 proteolysis Y 
CG9745 D1 chromosomal protein satellite DNA binding N 
CG2207 Decondensation factor 31 histone binding N 
CG2175 defective chorion 1 structural constituent of chorion N 
CG42799 dikar unknown Y 
CG1938 Dynein light intermediate chain mitotic spindle organization Y 
CG8598 eco mitotic spindle organization Y 
CG4912 eEF1delta translation elongation factor Y 
CG9841 EfSec translation elongation factor Y 
CG6542 Egg-derived tyrosine phosphatase  protein phosphatase activity Y 
CG10315 eIF2B-delta translation initiation factor Y 
CG32859 eIF4E-7 translation initiation factor Y 
CG10840 eIF5B translation initiation factor Y 
CG5345 Eip55E catalytic activity Y 
CG4930 Endonuclease G inhibitor ribonuclease inhibitor activity N 
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Table 2.5A (continued) 
      Conserved 
CG Protein Name Function in Vertebrates 
CG16932 Eps-15 calcium ion binding Y 
CG10837 eukaryotic initiation factor 4B translation initiation factor Y 
CG9946 eukaryotic translation initiation factor 2alpha translation initiation factor Y 
CG9075 eukaryotic translation initiation factor 4A translation initiation factor Y 
CG10192 eukaryotic translation initiation factor 4G2 translation initiation factor N 
CG15573 femcoat  structural constituent of chorion N 
CG4535 FK506-binding protein FKBP59 regulation of calcium ion transport Y 
CG9611 flyers-cup Ras protein signal transduction Y 
CG7004 four wheel drive 1-phosphatidylinositol 4-kinase activity Y 
CG11086 Gadd45  JNK cascade Y 
CG3183 geminin negative regulation of DNA replication Y 
CG5272 giant nuclei regulation of cell cycle N 
CG5320 Glutamate dehydrogenase glutamate dehydrogenase activity Y 
CG8893 Glyceraldehyde 3 phosphate dehydrogenase 2 glycolysis Y 
CG7254 glycogen phosphorylase glycogen phosphorylase activity Y 
CG5520 Glycoprotein 93 protein folding Y 
CG8384 groucho negative regulation of transcription Y 
CG4183 Heat shock protein 26 protein binding Y 
CG4466 Heat shock protein 27 protein refolding Y 
CG1242 Heat shock protein 83 protein folding Y 
CG4264 Heat shock protein cognate 4 protein folding Y 
CG4261 helicase 89B DNA binding Y 
CG7269 helicase at 25E mitotic spindle organization Y 
CG3373 hemomucin  RNA binding Y 
CG4451 Heparan sulfate 6-O-sulfotransferase sulfotransferase activity Y 
CG12749 heterogeneous nuclear ribonucleoprotein at 87F RNA splicing Y 
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Table 2.5A (continued) 
      Conserved 
CG Protein Name Function in Vertebrates 
CG10473 hook-like protein targeting to lysosome Y 
CG2947 Hsc/Hsp70-interacting protein related protein folding Y 
CG6603 Hsc70Cb protein folding Y 
CG3504 inaD calmodulin binding Y 
CG10101 Ionotropic receptor 84a glutamate binding N 
CG3654 Jarid2 DNA binding Y 
CG1804 kek6 unknown Y 
CG6217 knickkopf  chitin biosynthetic process N 
CG32464 l(3)82Fd unknown Y 
CG42551 la related protein  spindle assembly Y 
CG8597 lark RNA splicing Y 
CG8465 lethal (1) G0222 unknown Y 
CG7085 lethal (2) s5379 unknown Y 
CG5738 lola like regulation of transcription Y 
CG18543 matrimony  female meiosis N 
CG7162 mediator complex subunit 1 regulation of transcription Y 
CG3697 meiotic 9 female meiosis Y 
CG42572 microcephalin mitosis Y 
CG4206 Minichromosome maintenance 3 chromatin binding Y 
CG16973 misshapen JNK cascade Y 
CG13922 mitochondrial ribosomal protein L46 structural constituent of ribosome Y 
CG18124 mitochondrial transcription termination factor termination of mitochondrial transcription N 
CG32491 modifier of mdg4 chromatin binding Y 
CG2050 modulo  DNA binding, RNA binding N 
CG18740 moira  regulation of transcription Y 
CG1216 mrityu protein homooligomerization Y 
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Table 2.5A (continued) 
      Conserved 
CG Protein Name Function in Vertebrates 
CG11156 mutagen-sensitive 101 oogenesis Y 
CG9311 myopic protein phosphatase activity Y 
CG32156 myosin binding subunit  myosin phosphatase activity Y 
CG3845 NAT1 translation initiation factor Y 
CG17704 Nipped-B regulation of transcription Y 
CG17255 no circadian temperature entrainment circadian clock Y 
CG32190 NUCB1 calcium ion binding Y 
CG5330 Nucleosome assembly protein 1 regulation of transcription Y 
CR9700 Odorant receptor 85e odorant binding N 
CG5581 otefin negative regulation of transcription N 
CG6824 ovo regulation of transcription N 
CG9050 palisade eggshell formation N 
CG33103 papilin extracellular matrix structural constituent Y 
CG4845 phagocyte signaling impaired immune response Y 
CG3127 Phosphoglycerate kinase glycolysis Y 
CG1721 Phosphoglyceromutase glycolysis Y 
CG9183 plutonium  regulation of cell cycle Y 
CG8169 Pms2  protein binding Y 
CG4532 pod1 actin binding Y 
CG7913 PP2A-B' protein phosphatase regulator Y 
CG30342 pre-mRNA processing factor 38 RNA splicing Y 
CG4904 proteasome 35kD subunit proteolysis Y 
CG1519 proteasome alpha7 subunit  proteolysis Y 
CG10149 proteasome p44.5 subunit  proteolysis Y 
CG4720 protein kinase at 92B protein kinase activity Y 
CG2049 protein kinase related to protein kinase N protein kinase activity Y 
CG17291 Protein phosphatase 2A at 29B phosphatase activity Y 
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Table 2.5A (continued) 
      Conserved 
CG Protein Name Function in Vertebrates 
CG9181 protein tyrosine phosphatase 61F protein phosphatase activity Y 
CG7752 putzig  zinc ion binding Y 
CG7070 pyruvate kinase glycolysis Y 
CG5627 rab3-GEF activation of MAPK activity Y 
CG1799 raspberry IMP dehydrogenase activity Y 
CG9412 rasputin  Ras protein signal transduction Y 
CG31293 recombination-defective DNA replication Y 
CG9273 Replication protein A2 DNA replication Y 
CG40494 RhoGAP1A  regulation of Rho protein signal transduction Y 
CG6811 RhoGAP68F  signal transduction Y 
CG4755 RhoGAP92B  signal transduction Y 
CG9774 Rho-kinase protein kinase activity Y 
CG5371 ribonucleoside diphosphate reductase large subunit DNA replication Y 
CG7434 ribosomal protein L22 translation N 
CG1821 ribosomal protein L31 translation Y 
CG7490 Ribosomal protein LP0 structural constituent of ribosome Y 
CG4420 rings lost proteolysis Y 
CG12559 rolled protein kinase activity Y 
CG18174 Rpn11 proteolysis Y 
CG10230 Rpn9 proteolysis Y 
CG16916 Rpt3 proteolysis Y 
CG10955 Rtf1  transcription initiation Y 
CG11427 ruby  regulation of protein ubiquitination Y 
CG18572 rudimentary dihydroorotase activity Y 
CG5505 scrawny ubiquitin thiolesterase activity Y 
  
84 
Table 2.5A (continued) 
      Conserved 
CG Protein Name Function in Vertebrates 
CG5661 Semaphorin-5c  receptor activity Y 
CG16720 Serotonin receptor 1A serotonin receptor activity Y 
CG4299 Set cyclin binding Y 
CG6939 SET domain binding factor protein phosphatase activity Y 
CG43770 sex lethal RNA splicing Y 1 
CG6987 SF2 RNA splicing Y 
CG8582 Sh3beta unknown Y 
CG18397 short spindle 3 mitotic spindle elongation Y 
CG18076 short stop microtubule binding Y 
CG12819 slender lobes 2 nucleolus organization N 
CG5094 small glutamine-rich tetratricopeptide containing protein binding Y 
CG1391 small optic lobes proteolysis Y 
CG6369 Smg6  nonsense-mediated decay Y 
CG7528 Smt3 activating enzyme 2 protein sumoylation Y 
CG1982/CG4649 sorbitol dehydrogenase oxidoreductase activity Y 
CG13570 spaghetti  protein phosphatase activity Y 
CG11451 Spc105-related mitotic spindle organization N 3 
CG17286 spindle defective 2 mitotic spindle organization Y 
CG15415 spindly regulation of metaphase/anaphase transition Y 
CG4602 Srp54 RNA splicing Y 
CG5434 Srp72  7S RNA binding Y 
CG31641 stathmin microtubule binding Y 
CG17246 Succinate dehydrogenase A succinate dehydrogenase activity Y 
CG3283 succinate dehydrogenase B succinate dehydrogenase (ubiquinone) activity Y 
CG8409 Suppressor of variegation 205 regulation of transcription Y 
CG16725 survival motor neuron RNA binding Y 
CG33094 syndapin  synaptic vesicle endocytosis Y 
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Table 2.5A (continued) 
      Conserved 
CG Protein Name Function in Vertebrates 
CG8439 T-complex Chaperonin 5 mitotic spindle organization Y 
CG8351 Tcp-1eta mitotic spindle organization Y 
CG2331 TER94 proteolysis Y 
CG1274 thioredoxin peroxidase 2 antioxidant activity Y 
CG9765 transforming acidic coiled-coil protein microtubule binding Y 
CG8309 Transport and Golgi organization 7 golgi organization Y 
CG1782 ubiquitin activating enzyme 1  ubiquitin activating enzyme activity Y 
CG4347 UGP UTP:glucose-1-phosphate uridylyltransferase activity Y 
CG12359 Ulp1 proteolysis N 
CG2174 unconventional myosin class XV intracellular protein transport Y 
CG5014 vap-33-1  neuromuscular junction development Y 
CG11844 vig2 heterochromatin organization Y 
CG10682 vihar regulation of cell cycle Y 
CG31764 virus-induced RNA 1 defense response to virus N 
CG14542 vps2 protein transport Y 
CG8390 vulcan cell-cell signaling Y 
CG13176 washout oogenesis Y 
CG42396 wech unknown Y 
CG4148 weckle regulation of transcription Y 
CG5344 whacked Rab GTPase activator activity Y 
CG4548 XNP regulation of JNK cascade Y 
CG2985 yolk protein 1 vitellogenesis N 
CG2979 yolk protein 2 vitellogenesis N 
CG11129 yolk protein 3 vitellogenesis N 
CG1372 yolkless  vitellogenesis N 
CG3994 ZnT35C zinc ion transmembrane transporter activity Y 
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Table 2.5A (continued) 
      Conserved 
CG Protein Name Function in Vertebrates 
CG10011    unknown Y 
CG10083    actin binding Y 
CG10103    unknown Y 
CG10185    unknown Y 
CG10417   protein phosphatase activity Y 
CG10588    proteolysis Y 
CG11188    unknown Y 
CG11236    oxidation reduction Y 
CG11395    unknown Y 
CG11414    protein binding Y 
CG12945    unknown N 
CG13151    DNA binding N 
CG1317    zinc ion binding Y 
CG13349   proteasome assembly Y 
CG13350    DNA binding Y 
CG13373   unknown Y 
CG13630   proteolysis Y 
CG13907    transmembrane transport Y 
CG14184    unknown Y 
CG14309    unknown N 
CG14446    unknown Y 
CG14749    poly(A)+ mRNA export from nucleus Y 
CG15237   unknown N 
CG1597    oligosaccharide metabolic process Y 
CG1646    RNA splicing Y 
CG1647    zinc ion binding N 
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Table 2.5A (continued) 
      Conserved 
CG Protein Name Function in Vertebrates 
CG16903   cyclin-dependent protein kinase regulator activity Y 
CG16952   protein binding Y 
CG1703    transporter activity Y 
CG17261    unknown N 
CG18190    microtubule binding N 
CG18259    nucleotide binding Y 
CG18273   unknown N 
CG18659   unknown Y 
CG1910   unknown N 
CG2091    RNA catabolic process Y 
CG2263   tRNA binding Y 
CG2774   phosphatidylinositol binding Y 
CG2915   proteolysis Y 
CG30101    unknown Y 
CG30115   regulation of Rho protein signal transduction Y 
CG30122    RNA splicing Y 
CG31108    tubulin-tyrosine ligase activity Y 
CG31368   RNA splicing Y 
CG32088    unknown N 
CG32206    unknown N 
CG3223   unknown N 
CG32626   protein binding Y 
CG3368    unknown N 
CG34356    protein kinase activity N 
CG3511    protein folding Y 
CG3590   purine nucleotide metabolic process Y 
CG3632   protein phosphatase activity Y 
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Table 2.5A (continued) 
      Conserved 
CG Protein Name Function in Vertebrates 
CG3689    mRNA cleavage Y 
CG3759    oxidation reduction N 
CG3760   unknown Y 
CG42554   unknown N 
CG42669   unknown N 
CG42748   zinc ion binding N 
CG4434    oxidation reduction N 
CG4857    unknown N 
CG4968    protease Y 
CG5131    KU70 binding Y 
CG5195    protein binding Y 
CG5245    zinc ion binding Y 
CG5315   hormone binding Y 
CG5384   microtubule associated complex Y 
CG5525   mitotic spindle organization Y 
CG5527    proteolysis N 
CG5554    protein disulfide isomerase activity Y 
CG5602   DNA ligase activity Y 
CG5880   zinc ion binding Y 
CG5921   unknown Y 
CG6052    transporter activity Y 
CG6118   mitotic spindle organization N 
CG6129    regulation of transcription Y 
CG6254    zinc ion binding Y 
CG6509   antimicrobial humoral response Y 
CG6540    unknown Y 
CG6751   general RNA polymerase II transcription factor activity Y 
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Table 2.5A (continued) 
      Conserved 
CG Protein Name Function in Vertebrates 
CG6904   glycogen synthase activity Y 
CG7044    unknown Y 
CG7565   chitinase activity Y 
CG7927    unknown Y 
CG7967   unknown Y 
CG7997   carbohydrate metabolic process Y 
CG8060    protein binding Y 
CG8197    protein binding Y 
CG8209    zinc ion binding Y 
CG8223   unknown Y 
CG8909    calcium ion binding Y 
CG9154   methylation Y 
CG9360    oxidation reduction Y 
CG9468    zinc ion binding Y 
CG9512    choline dehydrogenase activity Y 
CG9601    unknown Y 
CG9609    zinc ion binding Y 
CG9667    RNA splicing Y 
CG9705   regulation of transcription Y 
CG9727    regulation of transcription Y 
 
 
_______________ 
1 InParanoid identifies a ortholog in gallus gallus: Ensembl ID ENSGALT00000012486 
2 some peptides also align to CG12592 which is a gene prediction at the junction of a tandemly duplicated region of which the 3' end is highly homolgous to 
the 3' end of flanking gene slender lobes. (FlyBase) 
3 Schittenhelm et al, 2009 identifies this gene as a homologue of the human protein Blinkin and other eukaryotic Spc105/Spc7/KNL-1/Blinkin protein family 
members 
  
90 
 Table 2.5B   Evidence Method of    
CG Expression of Phosphorylation Identification Phosphorylated in 
CG31196 up in multiple tissues, including ovary YD 2D gel activated egg 
CG17870 up in multiple tissues, not ovary Y 2D gel activated egg 
CG8947 up in ovary N 2D gel activated egg 
CG13388 up in multiple tissues, including ovary YD both oocyte (2D gel) / activated egg (IMAC) 
  expressed everywhere Y 2D gel both 
CG5712 up in multiple tissues, not ovary N* (not on tyrosine) IMAC oocyte 
CG12131 up in multiple tissues, including ovary Y 2D gel activated egg 
CG1070 up in ovary and larval CNS Y IMAC oocyte 
CG9556 up in multiple tissues, including ovary Y 2D gel oocyte 
CG4260 up in multiple tissues, not ovary YD IMAC oocyte 
CG1906 NA YD 2D gel oocyte 
CG8308 up in ovary N 2D gel oocyte 
CG2446 up in multiple tissues, including ovary YD IMAC oocyte 
CG6631 up in multiple tissues, including ovary N IMAC oocyte 
CG1451 up in multiple tissues, including ovary Y IMAC oocyte 
CG11154 up in multiple tissues, not ovary Y 2D gel oocyte 
CG6137 up in ovary N IMAC oocyte 
CG6877 up in multiple tissues, including ovary Y IMAC oocyte 
CG7926 up in multiple tissues, including ovary Y IMAC oocyte 
CG6386 up in ovary and larval CNS YD IMAC oocyte 
CG13425 up in multiple tissues, not ovary Y 2D gel oocyte 
CG5529 up in multiple tissues, not ovary N IMAC activated egg 
CG3612 up in multiple tissues, not ovary Y 2D gel oocyte 
CG8276 up in multiple tissues, including ovary Y IMAC oocyte 
CG6546 up in ovary and larval CNS N 2D gel oocyte 
CG10542 up in ovary, brain, and larval CNS Y IMAC activated egg 
CG9097 up in multiple tissues, not ovary Y IMAC activated egg 
CG42344 NA Y IMAC oocyte 
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Table 2.5B (continued) 
    Evidence Method of    
CG Expression of Phosphorylation Identification Phosphorylated in 
CG31132 up in ovary, brain, and larval CNS Y IMAC oocyte 
CG12892 up in ovary YD IMAC oocyte 
CG11958 expressed everywhere YD IMAC oocyte 
CG12019 up in multiple tissues, including ovary YD IMAC activated egg 
CG7597 up in multiple tissues, including ovary Y IMAC activated egg 
CG7464 up in multiple tissues, not ovary N IMAC oocyte 
CG4145 up in multiple tissues, not ovary N IMAC activated egg 
CG33957 up in multiple tissues, not ovary Y IMAC oocyte 
CG34389 up in multiple tissues, including ovary N IMAC activated egg 
CG11181 up in ovary and testis YD IMAC oocyte 
CG6081 up in multiple tissues, not ovary N IMAC oocyte 
CG6692 up in multiple tissues, not ovary N 2D gel activated egg 
CG9745 up in multiple tissues, including ovary YD IMAC oocyte 
CG2207 up in ovary, larval CNS, and larval trachea YD 2D gel activated egg 
CG2175 up in ovary N IMAC oocyte 
CG42799 NA N IMAC activated egg 
CG1938 up in multiple tissues, including ovary YD both oocyte 
CG8598 up in ovary and larval salivary gland Y IMAC oocyte 
CG4912 up in multiple tissues, including ovary YD 2D gel activated egg 
CG9841 up in multiple tissues, including ovary N IMAC oocyte 
CG6542 up in ovary, fat body, and spermatheca Y IMAC oocyte 
CG10315 up in multiple tissues, including ovary Y IMAC oocyte 
CG32859 up in testis Y IMAC activated egg 
CG10840 up in multiple tissues, including ovary YD IMAC oocyte 
CG5345 up in multiple tissues, including ovary Y IMAC oocyte 
CG4930 up in multiple tissues, including ovary N 2D gel oocyte 
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Table 2.5B (continued) 
    Evidence Method of    
CG Expression of Phosphorylation Identification Phosphorylated in 
CG16932 up in multiple tissues, including ovary Y IMAC activated egg 
CG10837 up in multiple tissues, including ovary YD IMAC oocyte 
CG9946 up in male accessory glands, larval salivary gland and trachea YD 2D gel oocyte 
CG9075 up in multiple tissues, not ovary N 2D gel oocyte 
CG10192 up in multiple tissues, including ovary N IMAC activated egg 
CG15573 up in ovary N IMAC oocyte 
CG4535 up in multiple tissues, including ovary Y 2D gel oocyte 
CG9611 up in multiple tissues, not ovary Y IMAC oocyte 
CG7004 up in multiple tissues, including ovary N IMAC activated egg 
CG11086 up in multiple tissues, not ovary N IMAC oocyte 
CG3183 up in ovary and larval CNS YD 2D gel oocyte 
CG5272 up in ovary YD IMAC oocyte 
CG5320 up in multiple tissues, not ovary Y 2D gel oocyte 
CG8893 up in multiple tissues, including ovary YD 2D gel activated egg 
CG7254 up in multiple tissues, not ovary N* (not on threonine) IMAC activated egg 
CG5520 up in multiple tissues, not ovary Y 2D gel activated egg 
CG8384 expressed everywhere YD IMAC oocyte 
CG4183 up in ovary and larval tubule YD both oocyte (2D gel) / both (IMAC) 
CG4466 up in multiple tissues, including ovary YD 2D gel oocyte 
CG1242 up in ovary and larval salivary gland YD 2D gel both 
CG4264 up in multiple tissues, not ovary Y 2D gel activated egg 
CG4261 up in multiple tissues, including ovary Y IMAC oocyte 
CG7269 up in ovary and larval CNS Y IMAC oocyte 
CG3373 expressed everywhere YD 4 IMAC oocyte 
CG4451 up in multiple tissues, including ovary N IMAC oocyte 
CG12749 up in multiple tissues, including ovary Y IMAC oocyte 
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Table 2.5B (continued) 
    Evidence Method of    
CG Expression of Phosphorylation Identification Phosphorylated in 
CG10473 up in multiple tissues, including ovary YD IMAC oocyte 
CG2947 up in multiple tissues, including ovary Y IMAC oocyte 
CG6603 up in multiple tissues, including ovary Y 2D gel activated egg 
CG3504 up in head and eye YD IMAC oocyte 
CG10101 up in testis N IMAC oocyte 
CG3654 up in multiple tissues, including ovary N IMAC activated egg 
CG1804 NA Y IMAC oocyte 
CG6217 up in multiple tissues, not ovary N IMAC activated egg 
CG32464 up in multiple tissues, including ovary YD IMAC oocyte 
CG42551 up in multiple tissues, including ovary YD IMAC oocyte 
CG8597 up in multiple tissues, including ovary YD IMAC oocyte 
CG8465 up in multiple tissues, including ovary YD IMAC oocyte 
CG7085 up in multiple tissues, not ovary Y 2D gel oocyte 
CG5738 up in multiple tissues, including ovary N IMAC oocyte 
CG18543 up in ovary N IMAC oocyte 
CG7162 up in multiple tissues, including ovary Y IMAC oocyte 
CG3697 up in ovary, larval CNS, and larval trachea Y IMAC oocyte 
CG42572 up in ovary and testis Y IMAC activated egg 
CG4206 up in ovary and larval CNS YD 2D gel activated egg 
CG16973 up in multiple tissues, including ovary YD IMAC oocyte 
CG13922 up in multiple tissues, including ovary N 2D gel oocyte 
CG18124 up in multiple tissues, including ovary N IMAC activated egg 
CG32491 up in multiple tissues, including ovary Y IMAC activated egg 
CG2050 up in ovary and male accessory glands YD 5 IMAC oocyte 
CG18740 up in multiple tissues, including ovary Y IMAC activated egg 
CG1216 up in multiple tissues, including ovary N* (not on serine) IMAC activated egg 
  
94 
Table 2.5B (continued) 
    Evidence Method of    
CG Expression of Phosphorylation Identification Phosphorylated in 
CG11156 up in ovary Y IMAC oocyte 
CG9311 up in multiple tissues, including ovary Y IMAC activated egg 
CG32156 up in multiple tissues, not ovary Y IMAC oocyte 
CG3845 up in multiple tissues, including ovary Y IMAC oocyte 
CG17704 NA Y IMAC activated egg 
CG17255 up in multiple tissues, including ovary YD IMAC oocyte 
CG32190 up in multiple tissues, not ovary Y 2D gel activated egg 
CG5330 up in multiple tissues, including ovary YD both both (2D gel) / oocyte (IMAC) 
CR9700 NA N IMAC oocyte 
CG5581 up in ovary and larval CNS YD 6 IMAC both 
CG6824 up in ovary N IMAC oocyte 
CG9050   N 2D gel activated egg 
CG33103 up in multiple tissues, not ovary N IMAC activated egg 
CG4845 up in multiple tissues, including ovary N* (not on tyrosine) IMAC activated egg 
CG3127 up in multiple tissues, not ovary Y 2D gel activated egg 
CG1721 up in multiple tissues, not ovary Y 2D gel oocyte 
CG9183 up in ovary YD IMAC oocyte 
CG8169 up in ovary, testis, and larval CNS Y IMAC activated egg 
CG4532 up in multiple tissues, including ovary Y IMAC oocyte 
CG7913 up in multiple tissues, including ovary YD IMAC activated egg 
CG30342 up in multiple tissues, including ovary Y IMAC oocyte 
CG4904 up in multiple tissues, including ovary Y IMAC oocyte 
CG1519 up in multiple tissues, including ovary YD IMAC oocyte 
CG10149 up in multiple tissues, not ovary Y IMAC oocyte 
CG4720 up in multiple tissues, including ovary Y IMAC oocyte 
CG2049 up in multiple tissues, including ovary Y IMAC oocyte 
CG17291 up in multiple tissues, not ovary N 2D gel activated egg 
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Table 2.5B (continued) 
    Evidence Method of    
CG Expression of Phosphorylation Identification Phosphorylated in 
CG9181 up in multiple tissues, including ovary YD IMAC oocyte 
CG7752 up in multiple tissues, not ovary N IMAC oocyte 
CG7070 up in multiple tissues, not ovary Y 2D gel oocyte 
CG5627 up in multiple tissues, not ovary Y IMAC activated egg 
CG1799 up in multiple tissues, including ovary YD 2D gel oocyte 
CG9412 up in multiple tissues, including ovary YD 7 IMAC oocyte 
CG31293 up in multiple tissues, including ovary N 2D gel oocyte 
CG9273 up in ovary and larval CNS Y 2D gel activated egg 
CG40494 up in multiple tissues, including ovary Y IMAC oocyte 
CG6811 up in multiple tissues, including ovary YD IMAC oocyte 
CG4755 up in multiple tissues, including ovary YD IMAC oocyte 
CG9774 up in multiple tissues, including ovary Y IMAC activated egg 
CG5371 up in ovary N IMAC activated egg 
CG7434 expressed everywhere YD 8 IMAC oocyte 
CG1821 expressed everywhere YD IMAC activated egg 
CG7490 up in multiple tissues, not ovary YD 2D gel both 
CG4420 up in multiple tissues, including ovary YD IMAC activated egg 
CG12559 up in ovary, male accessory glands, and larval tubule YD IMAC oocyte 
CG18174 up in multiple tissues, including ovary Y 2D gel activated egg 
CG10230 up in multiple tissues, including ovary Y 2D gel oocyte 
CG16916 up in multiple tissues, including ovary Y 2D gel oocyte 
CG10955 up in ovary and testis YD IMAC oocyte 
CG11427 up in multiple tissues, including ovary Y IMAC activated egg 
CG18572 up in ovary, larval CNS, and larval salivary gland Y IMAC activated egg 
CG5505 up in multiple tissues, including ovary YD IMAC oocyte 
  
96 
Table 2.5B (continued) 
    Evidence Method of    
CG Expression of Phosphorylation Identification Phosphorylated in 
CG5661 up in multiple tissues, including ovary Y IMAC oocyte 
CG16720 up in multiple tissues, not ovary Y 9 IMAC oocyte 
CG4299 up in ovary, larval CNS, and larval salivary gland YD 2D gel oocyte 
CG6939 up in multiple tissues, including ovary Y IMAC oocyte 
CG43770 NA Y IMAC oocyte 
CG6987 up in multiple tissues, including ovary Y IMAC oocyte 
CG8582 up in multiple tissues, including ovary YD 2D gel oocyte 
CG18397 up in multiple tissues, including ovary Y IMAC oocyte 
CG18076 up in multiple tissues, not ovary Y IMAC oocyte 
CG12819 up in ovary, testis, and larval CNS YD IMAC both 
CG5094 up in multiple tissues, including ovary Y 2D gel activated egg 
CG1391 up in multiple tissues, including ovary N* (not on tyrosine) IMAC oocyte 
CG6369 up in multiple tissues, including ovary Y IMAC oocyte 
CG7528 up in ovary, larval CNS, and larval salivary gland Y both activated egg 
CG1982/CG4649 up in multiple tissues, not ovary Y IMAC oocyte 
CG13570 up in ovary, testis, and larval CNS Y IMAC oocyte 
CG11451 up in ovary and larval CNS N IMAC oocyte 
CG17286 up in ovary N IMAC oocyte 
CG15415 up in ovary and larval CNS Y IMAC oocyte 
CG4602 up in multiple tissues, including ovary Y IMAC oocyte 
CG5434 up in multiple tissues, including ovary Y IMAC oocyte 
CG31641 up in ovary and larval CNS Y IMAC oocyte 
CG17246 up in multiple tissues, not ovary Y 2D gel oocyte 
CG3283 up in multiple tissues, not ovary N IMAC oocyte 
CG8409 up in ovary, larval CNS, and larval trachea YD IMAC activated egg 
CG16725 up in ovary, testis, and larval CNS Y 2D gel activated egg 
CG33094 up in multiple tissues, including ovary Y IMAC oocyte 
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Table 2.5B (continued) 
    Evidence Method of    
CG Expression of Phosphorylation Identification Phosphorylated in 
CG8439 up in ovary, larval salivary gland, and larval trachea N 2D gel both 
CG8351 up in ovary and larval CNS N 2D gel both 
CG2331 up in multiple tissues, including ovary YD 2D gel activated egg 
CG1274 up in multiple tissues, not ovary N 2D gel oocyte 
CG9765 up in multiple tissues, including ovary YD 10 IMAC both 
CG8309 up in multiple tissues, not ovary Y 2D gel activated egg 
CG1782 up in multiple tissues, including ovary Y IMAC oocyte 
CG4347 up in multiple tissues, not ovary N IMAC oocyte 
CG12359 up in ovary and larval CNS N IMAC oocyte 
CG2174 up in multiple tissues, not ovary N IMAC oocyte 
CG5014 up in multiple tissues, including ovary Y IMAC oocyte 
CG11844 up in ovary and male accessory glands Y both oocyte 
CG10682 up in ovary and testis N 2D gel oocyte 
CG31764 up in multiple tissues, not ovary N IMAC activated egg 
CG14542 up in multiple tissues, not ovary Y IMAC oocyte 
CG8390 up in ovary and testis Y IMAC oocyte 
CG13176 up in testis Y IMAC oocyte 
CG42396 NA YD IMAC activated egg 
CG4148 up in ovary Y IMAC oocyte 
CG5344 up in multiple tissues, including ovary N* (not on tyrosine) IMAC activated egg 
CG4548 up in multiple tissues, including ovary Y IMAC oocyte 
CG2985 up in eye, heart and adult carcass YD both both (2D gel) / oocyte (IMAC) 
CG2979 up in heart and adult carcass YD 2D gel both 
CG11129 up in multiple tissues, not ovary YD 2D gel activated egg 
CG1372 up in ovary YD IMAC oocyte 
CG3994 up in larval tubule, tubule, and testis N IMAC oocyte 
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Table 2.5B (continued) 
    Evidence Method of    
CG Expression of Phosphorylation Identification Phosphorylated in 
CG10011  up in multiple tissues, not ovary Y IMAC oocyte 
CG10083  up in multiple tissues, including ovary Y IMAC activated egg 
CG10103  up in multiple tissues, including ovary YD IMAC oocyte 
CG10185  up in head N IMAC oocyte 
CG10417 up in multiple tissues, including ovary YD IMAC activated egg 
CG10588  up in testis and male accesory gland Y IMAC oocyte 
CG11188  up in ovary Y IMAC oocyte 
CG11236  up in multiple tissues, not ovary N IMAC oocyte 
CG11395  up in multiple tissues, not ovary YD IMAC activated egg 
CG11414  up in multiple tissues, including ovary Y IMAC oocyte 
CG12945  up in ovary N IMAC oocyte 
CG13151  up in multiple tissues, including ovary N IMAC oocyte 
CG1317  expressed everywhere Y IMAC oocyte 
CG13349 up in multiple tissues, including ovary YD 2D gel oocyte 
CG13350  up in ovary YD IMAC oocyte 
CG13373 up in ovary N IMAC oocyte 
CG13630 up in multiple tissues, including ovary YD 2D gel activated egg 
CG13907  up in multiple tissues, including ovary N IMAC oocyte 
CG14184  up in multiple tissues, including ovary YD IMAC oocyte 
CG14309  NA YD both oocyte 
CG14446  up in multiple tissues, including ovary N IMAC activated egg 
CG14749  up in ovary Y IMAC oocyte 
CG15237 up in multiple tissues, including ovary N IMAC oocyte 
CG1597  up in multiple tissues, including ovary N IMAC activated egg 
CG1646  up in multiple tissues, including ovary N IMAC oocyte 
CG1647  up in multiple tissues, including ovary N IMAC oocyte 
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Table 2.5B (continued) 
    Evidence Method of    
CG Expression of Phosphorylation Identification Phosphorylated in 
CG16903 up in multiple tissues, including ovary YD IMAC oocyte 
CG16952 up in multiple tissues, including ovary Y IMAC oocyte 
CG1703  up in multiple tissues, including ovary YD IMAC oocyte 
CG17261  up in testis N IMAC activated egg 
CG18190  up in ovary N both activated egg (2D gel) / oocyte (IMAC) 
CG18259  up in ovary and testis N IMAC oocyte 
CG18273 up in multiple tissues, not ovary N IMAC both 
CG18659 up in multiple tissues, including ovary Y IMAC activated egg 
CG1910 up in multiple tissues, including ovary N IMAC oocyte 
CG2091  up in ovary and larval CNS YD IMAC oocyte 
CG2263 up in multiple tissues, including ovary Y 2D gel oocyte 
CG2774 expressed everywhere Y 2D gel activated egg 
CG2915 up in multiple tissues, not ovary N 2D gel oocyte 
CG30101  up in testis and eye N IMAC oocyte 
CG30115 up in multiple tissues, not ovary N IMAC oocyte 
CG30122  up in multiple tissues, including ovary YD IMAC oocyte 
CG31108  up in multiple tissues, including ovary Y IMAC oocyte 
CG31368 up in multiple tissues, including ovary N IMAC oocyte 
CG32088  up in testis and larval fat body N IMAC oocyte 
CG32206  up in multiple tissues, not ovary N IMAC oocyte 
CG3223 up in multiple tissues, including ovary N 2D gel activated egg 
CG32626 up in multiple tissues, not ovary Y IMAC activated egg 
CG3368  up in multiple tissues, including ovary N IMAC activated egg 
CG34356  up in multiple tissues, not ovary N IMAC oocyte 
CG3511  up in ovary, brain, and larval CNS N IMAC oocyte 
CG3590 up in multiple tissues, including ovary Y 2D gel oocyte 
CG3632 up in multiple tissues, including ovary YD IMAC oocyte 
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    Evidence Method of    
CG Expression of Phosphorylation Identification Phosphorylated in 
CG3689  up in multiple tissues, including ovary N IMAC oocyte 
CG3759  up in multiple tissues, not ovary N IMAC activated egg 
CG3760 up in multiple tissues, including ovary YD IMAC oocyte 
CG42554 up in multiple tissues, including ovary N IMAC oocyte 
CG42669 up in eye, midgut, and testis YD IMAC oocyte 
CG42748 up in multiple tissues, including ovary N IMAC oocyte 
CG4434  up in testis N IMAC oocyte 
CG4857  up in ovary N IMAC oocyte 
CG4968  up in ovary and testis N IMAC activated egg 
CG5131  up in ovary N IMAC activated egg 
CG5195  up in multiple tissues, not ovary N IMAC activated egg 
CG5245  up in ovary N IMAC oocyte 
CG5315 up in multiple tissues, not ovary N IMAC oocyte 
CG5384 up in multiple tissues, including ovary Y 2D gel oocyte 
CG5525 up in ovary and larval CNS N 2D gel oocyte 
CG5527  up in multiple tissues, not ovary N IMAC oocyte 
CG5554  up in multiple tissues, including ovary Y IMAC oocyte 
CG5602 up in ovary and larval CNS YD IMAC oocyte 
CG5880 up in ovary, brain, and thoracicoabdominal ganglion N 2D gel activated egg 
CG5921 up in multiple tissues, not ovary N 2D gel activated egg 
CG6052  up in testis Y IMAC oocyte 
CG6118 NA N IMAC activated egg 
CG6129  up in multiple tissues, not ovary Y IMAC oocyte 
CG6254  up in multiple tissues, including ovary Y IMAC oocyte 
CG6509 up in multiple tissues, including ovary Y IMAC oocyte 
CG6540  up in ovary and larval CNS YD IMAC oocyte 
CG6751 up in multiple tissues, including ovary Y 2D gel activated egg 
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Table 2.5B (continued) 
    Evidence Method of    
CG Expression of Phosphorylation Identification Phosphorylated in 
CG6904 up in multiple tissues, including ovary YD IMAC both 
CG7044  up in multiple tissues, including ovary N IMAC activated egg 
CG7565 up in multiple tissues, not ovary N IMAC oocyte 
CG7927  up in multiple tissues, not ovary N IMAC activated egg 
CG7967 expressed everywhere N 2D gel activated egg 
CG7997 up in multiple tissues, not ovary Y 2D gel oocyte 
CG8060  up in multiple tissues, including ovary Y IMAC oocyte 
CG8197  up in testis Y IMAC oocyte 
CG8209  up in multiple tissues, including ovary YD both oocyte 
CG8223 up in multiple tissues, including ovary YD 2D gel activated egg 
CG8909  up in multiple tissues, not ovary Y IMAC oocyte 
CG9154 up in multiple tissues, including ovary Y 2D gel activated egg 
CG9360  up in multiple tissues, not ovary N IMAC oocyte 
CG9468  up in midgut N IMAC oocyte 
CG9512  up in multiple tissues, not ovary N IMAC oocyte 
CG9601  up in ovary, larval CNS, and thoracicoabdominal ganglion Y IMAC activated egg 
CG9609  up in ovary and brain Y IMAC activated egg 
CG9667  up in multiple tissues, including ovary N IMAC activated egg 
CG9705 up in multiple tissues, including ovary YD 2D gel oocyte 
CG9727  up in multiple tissues, including ovary Y IMAC oocyte 
_____________ 
4 Theopold et al. (1996) J Biol Chem 271(22):12708-15. 
5 Perrin et al. (1999) J Biol Chem 274(10):6315-23. 
6 Ashery-Padan et al. (1997) Mol Cell Biol 17(7):4114-23. 
7 Zhai et al. (2008) J Proteome Res. 7(4):1675-82. 
8 Zhao et al. (2002) Biochem Biophys Res Commun. 298(1):60-6. 
9 Raymond (1991) J Biol Chem. 266(22):14747-53. 
10 Giet et al. (2002) J Cell Biol. 156(3):437-51.
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of phosphomodulated proteins in these classes also agrees with a previous report that 
found proteins phospho-modulated at the time of fertilization in sea urchins in the 
classes of calcium binding/regulation, metabolism, and protein translation (Roux et al., 
2008) and supports the hypothesis that phosphorylation is a key regulator of many of 
the events of egg activation.  Our results also identify proteins whose functions 
suggest new pathways to examine for roles in or immediately after egg activation.  For 
example, our finding of phospho-regulation of both the SUMO activating enzyme 
Uba2 and the SUMO-specific protease Ulp1 suggests that sumoylation may be 
important during this developmental transition.  Consistent with this idea, SUMO 
germline clones are reported to have defects in both patterning of the embryo and in 
the syncytial mitotic cell cycles (Nie et al., 2009).  Additionally, our identification of 
multiple zinc-binding proteins suggests that zinc-based processes may be important 
during this developmental transition in Drosophila, as was recently proposed for 
mammals (Kim et al., 2010; Suzuki et al., 2010). 
 
Phospho-regulated proteins include new regulators of egg activation and 
embryogenesis 
The proteins identified in this study represent a focused set of candidates that 
we can now test genetically for roles in egg activation and early embryogenesis.  This 
includes a number of proteins that would not have been identified through a traditional 
genetic screen for female steriles, as approximately one-third of these candidates are 
essential for viability (flybase.org).  We can now take advantage of recent advances in 
RNAi tools that allow successful knockdown of genes (and their protein products) in 
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the female germline (Ni et al., 2011) and test these candidates for functional roles 
during or immediately after egg activation.   
Verifying that our approach can uncover players in the oocyte-to-embryo 
transition, approximately 15% of the proteins we identified are known to be important 
for female fertility, playing roles in oogenesis and embryogenesis (flybase.org) and 
others are implicated in the meiotic cell cycle.  For example, our finding of phospho-
modulation of Spd-2 and Spindly suggested roles for these proteins during or 
immediately after egg activation.  Consistent with this, fertilized embryos from spd-2 
mutant mothers fail to enter the first mitosis due to problems in pronuclear migration 
and fusion (Dix and Raff, 2007).  Likewise, Spindly (a mitotic phosphoprotein in 
humans) is necessary for the metaphase-anaphase transition in both mitosis and 
meiosis (Barisic et al., 2010; Chan et al., 2009; Griffis et al., 2007; Zhang et al., 2010).  
As Drosophila oocytes are arrested in metaphase prior to egg activation, we 
hypothesize that the dephosphorylation of Spindly is involved in regulating its 
association with dynein and the transition to anaphase.     
To test our hypothesis that the proteins identified in this study include novel 
factors required for egg activation or early embryogenesis we performed a pilot study 
testing 18 of our candidates.  In addition to four proteins required for oogenesis, we 
found that activity of the protein encoded by the mrityu gene is required for initiation 
of embryo development.  We expect future extension of this RNAi screen to the 
remaining proteins we detected as phospho-modulated will reveal additional new 
essential players in the egg-to-embryo transition.  Once we understand the functional 
role of these proteins, we will then be able to progress to understanding the importance 
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of their phospho-regulation by creating transgenic lines that mutate the 
phosphorylation sites (to residues that can not be phosphorylated and/or phospho-
mimetic residues).  
Since 82.9% of our candidates have homologs in vertebrates, the pathways 
thus uncovered are likely to be conserved.  Indeed, the importance of calcium, and the 
early signaling through calcineurin in egg activation, are conserved between 
Drosophila, sea urchins, and vertebrates [reviewed in Ducibella and Fissore, 2008 and 
Horner and Wolfner, 2008; Takeo et al., 2010].  Our results suggest that in addition to 
these early events, many other pathways controlling egg activation may be conserved 
across species.  Consistent with this idea, two proteins that we find to be 
dephosphorylated during Drosophila egg activation (Cup and eIF-2alpha), are also 
dephosphorylated in mouse oocytes at the time of fertilization (Alves et al., 2009; 
Villaescusa et al., 2006).  Thus, in addition to identifying the phospho-regulated 
proteins during Drosophila egg activation, the results we reported here will likely help 
to uncover the molecular mechanisms that regulate the egg-to-embryo transition even 
in animals such as mammals where such screens would be prohibitive. 
 
2.5  Conclusions 
This study took an alternative proteomic approach to find new genes important 
for the oocyte-to-embryo transition.   By identifying proteins that are not only present, 
but phospho-modulated during this transition, we have produced an enriched source of 
new candidate genes important for egg activation and early embryogenesis.  
Comparison of the proteomes of Drosophila mature oocytes and unfertilized activated 
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eggs identified 311 proteins that change in phosphorylation state during this transition.  
Many of these proteins fall into functional categories such as calcium binding and 
regulation of translation, which are related to the known events of egg activation.  As 
the 82.9% of these genes are conserved from Drosophila to vertebrates, they also 
represent candidates that may be tested for roles in egg activation and embryogenesis 
in other species of interest.  Using the genetic tools available for Drosophila, including 
new RNAi lines that successfully knockdown genes in the female germline, we have 
begun testing these genes for their roles in egg activation and the initiation of 
development.  Within the set of genes we tested, we identified one new gene, mrityu, 
which is necessary for embryos to progress past the first mitosis.  We expect that 
continued testing of these candidates will reveal additional genes previously not 
known to act during egg activation or embryogenesis.  
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CHAPTER THREE 
 
PHOSPHO-REGULATION PATHWAYS DURING EGG ACTIVATION IN 
DROSOPHILA MELANOGASTER3  
 
3.1 Introduction 
 Phosphorylation is an important post-translational modification that can 
regulate protein activity by a number of different mechanisms.  For example, 
phosphorylation can be required for a protein’s enzymatic activity, as is the case for 
Mitogen-Activated Protein Kinases (MAPKs) (Cargnello and Roux, 2011), or 
influence protein-protein interactions [e.g. 14-3-3 proteins (Mackintosh, 2004)].  
Through these regulatory functions, phosphorylation is known to play a role in diverse 
biological processes such as the cell cycle, neuronal function, and signal transduction 
(Marks, 1996).  Another process that can be added to this list is egg activation – the 
cellular events that convert a mature oocyte into a developmentally competent egg. 
 Several lines of evidence suggest the importance of phosphorylation changes 
in egg activation.  First, two Drosophila phosphoproteins known to act at the egg-to-
embryo transition, Young Arrest (YA) and Giant Nuclei (GNU), are dephosphorylated 
upon egg activation (Renault et al., 2003; Yu et al., 1999).  Second, levels of phospho-
MAPKs decrease upon egg activation in Drosophila, Xenopus, mice, and some marine 
invertebrates (Ferrell et al., 1991; Kubiak et al., 1993; Sackton et al., 2007; Sanghera 
                                                 
3 A modified form of this chapter will be submitted as Krauchunas A.R.*, Sackton K.L.*, and Wolfner 
M.F., “Phospho-regulation pathways during egg activation in Drosophila melanogaster”.   K. Sackton 
performed the Westerns looking at YA and GNU in oocytes and embryos from sarah, cortex, and prage 
mutants. 
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et al., 1991; Shibuya et al., 1992).  This inactivates the MAPKs, and may affect 
phosphorylation levels of MAPK protein targets present in the egg.  Third, the 
phosphatase calcineurin and the kinase Ca2+/calmodulin-dependent kinase II (CamKII) 
are required for egg activation in multiple species (reviewed in Chapter One).  Fourth, 
proteomic screens in Drosophila and sea urchin have observed large-scale changes of 
the phosphoproteome during fertilization/egg activation (Krauchunas et al., submitted; 
Roux et al., 2006; Roux et al., 2008).  However, much work remains to fully 
understand how these phosphorylation changes relate to the events of egg activation.  
We are just beginning to identify the repertoire of proteins that are phospho-
modulated, and in most cases we do not yet know the functional significance of the 
different phosphorylation states of a given protein.  Additionally, we do not know 
what upstream proteins regulate these phosphorylation changes. 
 In Drosophila, a small number of genes have been identified whose action is 
required for the events of egg activation.  The sarah (sra) gene encodes the Drosophila 
calcipressin (or RCAN1), which regulates the phosphatase calcineurin (Horner et al., 
2006; Takeo et al., 2010; Takeo et al., 2006).   Embryos laid by sra mutant mothers 
arrest in anaphase of meiosis I, and have defects in maternal mRNA polyadenylation 
and translation (Horner et al., 2006; Takeo et al., 2006).  An identical meiotic arrest is 
also seen in calcineurin germline clones (Takeo et al., 2010; 2012).  The cortex (cort) 
gene encodes a meiosis-specific Cdc20, which is a regulatory component of the 
Anaphase Promoting Complex (APC/c) (Chu et al., 2001; Pesin and Orr-Weaver, 
2007).  The APC/c is an E3 ubiquitin ligase responsible for degrading a number of 
maternal proteins during the oocyte-to-embryo transition (Pesin and Orr-Weaver, 
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2008).  Embryos laid by cort mutant mothers arrest at metaphase of meiosis II (Page 
and Orr-Weaver, 1996).  Similar to sra mutants, these embryos have defects in 
maternal mRNA polyadenylation and translation, as well as defects in mRNA 
degradation (Lieberfarb et al., 1996; Tadros et al., 2003).  The prage (prg) gene is also 
required for mRNA translation and degradation at the time of egg activation (Tadros et 
al., 2003).  While the exact cell cycle arrest point of embryos laid by prg mutant 
mothers is not known, it appears to be during or around the time of meiosis.  Finally, 
the wispy gene encodes a cytoplasmic poly-A polymerase that is required for 
polyadenylation and translation of proteins in the oocyte and embryo (Benoit et al., 
2008; Cui et al., 2008).   
 Although the genes sra, cort, and prg affect multiple aspects of egg activation, 
one event that is independent of their function is the decrease in phospho-MAPKs 
(Sackton et al., 2007).  This observation led us to investigate whether other 
phosphorylation changes rely on these egg activation genes.  In this study we ask 
whether the activity of sra, cort, and prg is needed for the phosphorylation state 
changes of maternal proteins.  We used the changes in phosphorylation state of four 
proteins, GNU, YA, Spindly, and Vap-33-1, as markers of the phospho-regulation that 
takes place during egg activation.  (Since wispy has a significant role in oocyte 
maturation, in addition to its role during egg activation, we did not include it in this 
analysis).   
GNU, YA and Spindly are all dephosphorylated upon egg activation.  GNU is 
required for the assembly of the Pan Gu kinase complex, which is essential for 
chromosome condensation and the coupling of S phase and mitosis during early 
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embryo cell cycles (Lee et al., 2003).  The Pan Gu complex is also required for 
translation of Smaug, a protein that regulates maternal mRNA degradation during egg 
activation (Tadros et al., 2007).  YA is a nuclear protein that is necessary for 
progression through the first embryonic mitosis (Lin and Wolfner, 1991; Sackton et 
al., 2009).  For YA, dephosphorylation is hypothesized to allow it to disassociate from 
cytosolic binding partners, permitting it to enter the nucleus where it can then function 
(Yu et al., 2002).  Spindly is another cell cycle regulator previously shown to act 
during mitosis and meiosis (Barisic et al., 2010; Griffis et al., 2007; Zhang et al., 
2010).  In mitotic cells Spindly associates with the Rod-Zw10-Zwilch complex and is 
necessary for the metaphase-to-anaphase transition (Barisic et al., 2010; Chan et al., 
2009; Griffis et al., 2007).  We hypothesize that Spindly may play the same role 
during meiosis, and that dephosphorylation of Spindly is important for the release 
from the metaphase arrest of mature oocytes.  In contrast to the other three proteins, 
Vap-33-1 is phosphorylated during egg activation and its function in the oocyte is 
currently unknown (Krauchunas et al., submitted).   
We find that sra and cort contribute to the phospho-modulation of all four 
proteins tested.  We also find that degradation of Cort [a process dependent on the 
APC/c (Pesin and Orr-Weaver, 2007)] fails to occur in sra mutants.  In contrast, prg is 
only required for the dephosphorylation of YA and Spindly.  Thus, we propose that 
sra and cort work in a common pathway to regulate the phosphorylation state of many 
proteins during egg activation, while prg acts downstream or in a parallel pathway to 
regulate a smaller subset of proteins.   
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3.2 Materials and Methods 
Flies:  Drosophila melanogaster stocks were raised on standard yeast-glucose-agar 
medium at room temperature on a 12:12 light:dark cycle.  To make sarah hemizygotes 
(Horner et al., 2006), sra687/TM3 (Fbal0175443) were crossed to Df(3R)sbd45, mwh1 
e1/TM6 (FBst0003678) or sraA426/ TM3 (FBal0194825) were crossed to Df(3R)sbd45, 
mwh1 e1/TM3.  To make cortex hemizygotes (Chu et al., 2001), cortQW55 cn1bw1/CyO, 
l(2)DTS5131 (Fbst0004974) were crossed to Df(2L)BSC9, w+mC/SM6a (FBst0006454).  
Prage mutants (Tadros et al., 2003) were prg32/prg32 homozygotes obtained from the 
prg32/FM6 stock.  CanB2 germline clones (Takeo et al., 2010) were produced by 
crossing w; P{FRT}2R-G13CanB2EP(2)0774/CyO Cy females with P{hsFLP}12, y w/Y; 
P{FRT}2R-G13P{ovoD1}2R/CyO Cy males.  Larvae, at approximately the third instar 
stage, were heat shocked at 37oC for 2 hours.  The effects of constitutively active 
calcineurin (CnAact) in the germline were tested by expressing UASp-Pp2B-14Dact 
driven by nanos-GAL4 (Takeo et al., 2006).  In all cases, balancer siblings were used 
as controls. 
Oocytes, embryos, and protein extraction:  Ovaries or stage 14 mature oocytes were 
obtained from 3-5 day old wild-type virgin females that had been reared on heavily-
yeasted food.  Dissection was performed in Isolation Buffer, a hypertonic solution that 
does not activate eggs (Page and Orr-Weaver, 1997).  Oocytes were dissected in one 
hour blocks of time, then flash-frozen in liquid nitrogen. 
To obtain embryos, newly eclosed virgin females were aged on yeasted vials for 3-8 
days and then mated to wild-type males (OregonR P2; Allis et al., 1977).  Mated 
females were allowed to deposit eggs onto petri plates containing grape juice-agar for 
  116 
 
0-30 minute, 0-1 hour, or 0-2 hour periods.  [No differences were seen in Western blot 
results for 0-30 minute, 0-1 hour, or 0-2 hour samples.  All phosphorylation changes 
were examined at least once with 0-30 minute samples.  Due to the technical 
difficulties of collecting enough material during 0-30 minute collections, additional 
biological replicates were sometimes run with 0-1 hour or 0-2 hour samples.  
Degradation of Cort was examined in either 0-1 hour or 0-2 hour samples.]  Eggs were 
washed off the plates in Egg Wash (Karr and Alberts, 1986), dechorionated in a 50% 
sodium hypochlorite solution for 2 minutes, and flash frozen in liquid nitrogen.   
Samples of 40-100 mature oocytes or activated eggs were homogenized in protease 
inhibiting homogenization buffer (PIHB; Monsma et al., 1988) with the addition of 
two phosphatase inhibitors (20 mM NaF and 10 mM β-glycerophosphate) or in 
Extraction Buffer (10 mM Tris pH 7.5; 20 mM NaF, 2 mM EGTA, 10 mM DTT, 400 
nM okadaic acid, and 2% SDS), followed by the addition of an equal amount of SDS 
sample buffer.  Samples were boiled for 5 minutes and stored at –80oC until use. 
Immunoblotting:  Proteins were separated on polyacrylamide SDS gels and subjected 
to Western blotting analysis as previously described (Sackton et al., 2007).  
Acrylamide percentage varied based on the protein of interest: 7.5% for YA and 
Spindly, 12% for GNU, 10.6% for Vap-33-1 and Cortex, and 5% for Cdc27.  Gels for 
Vap-33-1 also contained 25 µM Phos-tag and gels for Cdc27 contained 3.5 µM Phos-
tag (Wako Pure Chemical Industries, Ltd., Richmond, VA) (Kinoshita et al., 2006).  
Primary antibodies were used at the following dilutions in 1% milk: rabbit anti-YA, 
1:1000 (Liu et al., 1995); guinea pig anti-GNU, 1:5000 (gift of T. Orr-Weaver; Lee et 
al., 2003); guinea pig anti-Vap-33-1, 1:10,000 (gift of H. Bellen; Pennetta et al., 
  117 
 
2002); rabbit anti-Spindly, 1:1000 (gift of R. Vale; Griffis et al., 2007); guinea pig 
anti-Cort, 1:2000 (gift of T. Orr-Weaver; Pesin and Orr-Weaver, 2007); rabbit anti-
Cdc27, 1:500 (gift of J. Raff; Huang and Raff, 1999).  HRP-conjugated secondary 
antibodies were used at a 1:2000 dilution and visualized with the ECL Plus Western 
Blotting Detection system (GE Healthcare, Piscataway, NJ). 
 
3.3 Results and Discussion 
sarah and calcineurin regulate the phosphorylation state of multiple proteins 
during egg activation 
 We took advantage of the fact that different phosphorylation states can have 
different electrophoretic mobilities in a gel; a more highly phosphorylated form of a 
protein will often have a slower mobility than a less phosphorylated form of the same 
protein.  When egg activation occurs properly, GNU, YA, Vap-33-1, and Spindly all 
have different electrophoretic mobilities in embryos (or unfertilized activated eggs) as 
compared to what is seen in mature (stage 14) oocytes.  These gel mobility differences 
are abolished when samples are treated with a phosphatase, showing that the slower 
migrating forms of these proteins are phosphorylated (Yu et al., 1999; Renault et al., 
2003; Krauchunas et al., submitted).  Thus, we compared the electrophoretic 
mobilities of these four proteins in mature oocytes and embryos from sra mutants to 
determine if they underwent the typical changes that are observed upon fertilization.  
We find that the phosphorylation states of all four proteins are regulated by sra.   
 GNU, YA, Vap-33-1, and Spindly all show normal mobility in oocytes of sra 
mutants (Figure 3.1A, compare lanes 1 and 3, 5 and 7, 9 and 11, 13 and 15), but in all 
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Figure 3.1 sarah and cortex function in the phospho-modulation of GNU, YA, 
Vap-33-1, and Spindly.  Western blots of GNU, YA, Vap-33-1 and Spindly in 
ovaries (ov) or mature oocytes (mo) and embryos (emb) from heterozygotes (controls) 
and hemizygous mutants.  For each protein examined, equal amounts of protein were 
loaded into each lane based on the number of oocytes and embryos, or micrograms of 
protein.  (A) GNU, YA, Spindly and Vap-33-1 have normal mobilities in oocytes of 
sra mutants as compared to controls.  In sra embryos, all four proteins fail to shift to 
the mobilities observed in control embryos.  The mobilities of GNU and Vap-33-1 are 
indistinguishable from oocytes, while YA and Spindly run at intermediate mobilities 
between control oocytes and embryos. (B) GNU, YA, Spindly and Vap-33-1 have 
normal mobilities in oocytes of cort mutants as compared to controls.  In cort 
embryos, all four proteins run at mobilities that are more similar to oocytes than 
control embryos.  A significant fraction of GNU protein remains phosphorylated in 
cort embryos and YA and Spindly run at intermediate mobilities between control 
oocytes and embryos.  The oocyte-specific band of Vap-33-1 can be seen in cort 
embryos, though there may also be a slight increase in the fully phosphorylated form 
of the protein.  Western blots shown are representative of 3 or more independent 
replicates. 
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cases lack of sra activity prevents the normal shift in gel mobility upon egg activation 
(Figure 3.1A, compare lanes 2 and 4, 6 and 8, 10 and 12, 14 and 16).  GNU mobility 
in embryos laid by sra mutant mothers (hereafter referred to as “sra embryos”) is 
comparable to that seen in mature oocytes, rather than the faster gel mobility observed 
in control embryos (Figure 3.1A, compare lanes 2 and 4).  Similarly, the gel mobility 
of Vap-33-1 in sra embryos (Figure 3.1A, lane 12) is indistinguishable from the 
mobility observed in mature oocytes (Figure 3.1A, lanes 9 and 11).  This is in contrast 
to the mobility of Vap-33-1 in heterozygous control embryos where majority of the 
protein is present in the slowest mobility band and the band with an intermediate 
mobility is no longer observed (Figure 3.1A, lane 10).  The gel mobilities of YA and 
Spindly proteins in sra embryos are intermediate between their mobilities in mature 
oocytes and their mobilities in control embryos (Figure 3.1A, compare lane 8 with 
lanes 6 and 7, lane 16 with lanes 14 and 15).  This intermediate mobility is consistent 
with these proteins being phosphorylated at multiple sites (Yu et al., 1999; Yu et al., 
2002; Griffis et al., 2007; Barisic et al., 2010), and suggests that dephosphorylation of 
some, but not all, of those sites require sra.  Thus, YA and Spindly are able to be 
partially, but not fully, dephosphorylated in the absence of Sra.   
It has been proposed that the primary role of sra is to positively regulate 
calcineurin (Horner et al., 2006; Takeo et al., 2010; Takeo et al., 2012).   If this is 
true, then loss of calcineurin function in the oocyte should lead to the same phenotypes 
as observed in sra mutants.  This has already been shown for the meiotic arrest caused 
by loss of Sra or calcineurin function in the oocyte (Takeo et al., 2010).  Our results 
show that GNU, Spindly, and Vap-33-1 have the same phosphorylation defects in 
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embryos lacking calcineurin (germline clones) as are seen in sra embryos (Figure 3.2).  
Preliminary results suggest that YA also has the same defect in embryos lacking 
calcineurin as is seen in sra embryos (results not shown.)  Without calcineurin 
activity, these proteins fail to change in phosphorylation state upon egg activation.   
Since calcineurin activity is required for the phosphorylation changes of GNU, 
YA, Spindly, and Vap-33-1, we tested whether expression of constitutively active 
calcineurin (CnAact) was sufficient to induce any of these phosphorylation changes in 
the mature oocyte.  When CnAact is expressed in the female germline, YA is either 
partially or fully dephosphorylated in mature oocytes (Figure 3.3, lanes 3 and 7).  This 
suggests that either the activity of calcineurin is sufficient to dephosphorylate YA, or 
mis-expression of calcineurin during oogenesis prevents YA from being properly 
phosphorylated.  
 In contrast, the phosphorylation states of GNU, Spindly, and Vap-33-1 were 
unaffected by the expression of CnAact in mature oocytes and embryos (Figure 3.3 and 
data not shown).  The mobilities of these proteins are the same in mature oocytes 
expressing CnAact and control oocytes (Figure 3.3, compare lanes 9 and 11, 13 and 
15).  The phosphorylation changes of GNU, Spindly, and Vap-33-1 that take place at 
egg activation were also unaffected by expression of CnAact (Figure 3.3, compare 
lanes 10 and 12, 14 and 16).  One explanation why active calcineurin does not induce 
phosphorylation changes for GNU, Spindly, and Vap-33-1 is that other factors, active 
in the embryo, are not yet active in the mature oocyte.  If calcineurin requires other 
proteins to bind or recruit its targets then these additional factors must also be 
activated for calcineurin to exert its function.  If these proteins are held in an inactive
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Figure 3.2  Lack of calcineurin activity in oocytes and embryos causes the same 
mobility phenotypes as seen in sarah mutants.  No differences can be seen in the 
mobilities of GNU, Vap-33-1, and Spindly in mature oocytes (mo) lacking calcineurin 
as compared to controls.  In embryos (emb) lacking calcineurin activity, GNU, Vap-
33-1, and Spindly have the same mobilities as are seen in oocytes, not control 
embryos.  Western blots shown are representative of two biological replicates.
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Figure 3.3  YA is not fully phosphorylated in oocytes (mo) expressing 
constitutively active calcineurin (CnAact) and appears to be degraded in embryos 
(emb) expressing CnAact.  The mobilities of Vap-33-1 and Spindly are normal in 
oocytes and embryos expressing CnAact.  TM3 are balancer sibling controls.  
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state in the mature oocyte, then we may fail to see an effect of constitutively active 
calcineurin in the oocyte.  Sra is phosphorylated upon egg activation, and this 
phosphorylation is required for its activity (Takeo et al., 2010; Takeo et al., 2012).  
Thus, if Sarah (or additional unidentified regulators) is required for calcineurin to 
recognize or bind its targets, and Sarah is not active in the mature oocyte, then even 
constitutively active calcineurin may not be able to dephosphorylate its targets until 
egg activation.   
 
cortex is required for the phosphorylation state changes of GNU, YA, Spindly 
and Vap-33-1 upon egg activation 
As cortex (cort) is another gene whose mutants show defects in multiple egg 
activation events (Pesin and Orr-Weaver, 2008; Tadros et al., 2003; Page and Orr-
Weaver, 1996; Lieberfarb et al., 1996), we examined whether cortex is also required 
for any of the phosphorylation changes that take place at egg activation.  We find that 
embryos laid by cort mutant mothers (“cort embryos”) have defects in the 
dephosphorylation of GNU, YA, and Spindly, as well as in the phosphorylation of 
Vap-33-1 (Figure 3.1B).  Similar to what is seen in sra embryos, YA and Spindly in 
cort embryos have mobilities in between the mobilities of either oocytes or control 
embryos, indicating that partial dephosphorylation takes place (Figure 3.1B, compare 
lane 8 with lanes 6 and 7, lane 16 with lanes 14 and 15).  Likewise, cort embryos 
retain a proportion of GNU in its phosphorylated form.  But unlike in sra embryos, a 
significant fraction of GNU protein is still dephosphorylated in the absence of Cort 
(Figure 3.1B, lane 4).  In addition, cort embryos retain the mature oocyte specific 
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phospho-state of Vap-33-1, but also show a small increase in the slowest mobility 
form of the protein (Figure 3.1B).  Thus, the phosphorylation defects in cort embryos 
are less severe than those seen in sra or calcineurin mutants.   
The finding that GNU, YA, Spindly, and Vap-33-1 all require both sra and 
cort for their phosphorylation changes upon egg activation suggests that sra and cort 
work in a common pathway to regulate the phosphorylation of these, and possibly 
other, proteins.  As the defects in cort embryos are not as complete as in sra embryos, 
we propose that cort acts downstream of sra.  However, it is important to note that the 
cort mutation is a single point mutation and though it has been proposed to be a 
functional null, it is possible that this allele retains some function (Chu et al., 2001; 
Pesin and Orr-Weaver, 2007).  In addition, the canonical Cdc20, fizzy, is also present 
in the Drosophila oocyte and embryo (Swan and Schupbach, 2007).  Both of these 
factor could contribute to our finding that the defects in phosphorylation changes are 
less severe in cort embryos than in sra embryos.   
If cort does act downstream of sra, one hypothesis is that the defects observed 
in sra embryos are then due to mis-regulation of cort and at least one other 
protein/pathway to result in the complete sra phenotype.  This scenario would also 
imply none of these four proteins (GNU, YA, Spindly, or Vap-33-1) are direct targets 
of calcineurin.  Alternatively, it is possible that calcineurin directly dephosphorylates 
GNU, YA, or Spindly and that cort (through the APC/c) is necessary to inhibit the 
kinase(s) that phosphorylate these proteins in the oocyte.  Both GNU and YA contain 
predicted MAPK sites (Renault et al., 2003; Zhang et al., 2004; Yu et al., 1999; Yu et 
al., 2002), while Spindly contains seven consensus Cdk1 sites (Griffis et al., 2007).  
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Since MAPK activity decreases normally in sra and cort embryos (Sackton et al., 
2007), there are either additional kinases that phosphorylate these proteins or 
activation of at least one phosphatase is required for the dephosphorylation of GNU 
and YA.   
 
sarah is required for Cort degradation after egg activation 
 Our hypothesis that sra acts upstream of cort is supported by the fact that in 
Xenopus, Cdc20 is dephosphorylated during egg activation and this dephosphorylation 
requires calcineurin (Mochida and Hunt, 2007).  In Drosophila, Cort (a meiosis-
specific Cdc20) is degraded by the APC/c upon egg activation (Pesin and Orr-Weaver, 
2007).  We looked at whether Cort is degraded in sra embryos.  We find that sra is 
required for Cort degradation after egg activation (Figure 3.4).  In control embryos, 
Cort is present at less than 50% of the levels observed in mature oocytes.  In contrast, 
in sra embryos the amount of Cort protein present is 80% of the amount observed in 
sra mature oocytes (Figure 3.4B).  These data support our model in which cort acts 
downstream of sra in a common pathway, leading to the overlapping requirements of 
sra and cort for the phospho-regulation of GNU, YA, Spindly and Vap-33-1.  Since 
the degradation of Cort is dependent on the function of the APC/c, this could mean 
that the APC/c is not fully functional in the absence of Sra.  Sra could regulate APC/c 
activity through Cort or other subunits of the complex.  Alternatively, Sra could 
regulate Cort stability by targeting it for degradation.   
 In Xenopus, another subunit of the APC/c, Apc3, is also dephosphorylated in a 
calcineurin-dependent manner upon egg activation (Mochida and Hunt, 2007).  To test  
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Figure 3.4  Cortex is not degraded in sarah embryos.  (A) Western blot showing 
Cort (arrow) in mature oocytes (mo) and embryos (emb) from sra heterozygotes 
(controls) and sra hemizygous mutants.  Equal amounts of protein were loaded into 
each lane.  Levels of Cort appear similar between control and sra oocytes, but remain 
high in sra embryos compared to controls.  Non-specific cross-reactive is marked     
by *.  (B) Levels of Cort were quantified by normalizing to the *cross-reactive.  
Numbers on x-axis correspond to the lane numbers in (A).
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whether the same regulation occurs in Drosophila, we first tested whether the 
Drosophila ortholog of Apc3, Cdc27, is similarly dephosphorylated during egg 
activation.  When run on a polyacrylamide gel containing Phos-tag, which slows the 
mobility of phosphorylated proteins, we see a slower mobility band of Cdc27 only in 
mature oocytes (Figure 3.5A).  This indicates that, as in Xenopus, egg activation 
triggers the dephosphorylation of Cdc27 in Drosophila embryos.  We then examined 
whether the dephosphorylation of Cdc27 occurs in sra embryos.  In contrast to the 
situation for Xenopus Apc3, we find that sra is not required for Cdc27 
dephosphorylation in embryos (Figure 3.5B).  Therefore, while regulation of Cdc20 by 
calcineurin appears to be conserved between Xenopus and Drosophila, other specific 
targets of calcineurin may not be. 
 
prage is only required for a subset of phosphorylation changes at egg activation 
 We next asked whether prg acts in the same pathway as sra and cort to 
regulate the phosphorylation states of GNU, YA, Spindly, and Vap-33-1 during egg 
activation.  We find that YA and Spindly have the same mobilities in embryos laid by 
prg mutant mothers (“prg embryos”), as is observed in prg mature oocytes (Figure 
3.6, compare lanes 7 and 8, 15 and 16), though for YA this is a slightly lower mobility 
than seen in control oocytes (Figure 3.6, compare lanes 15 and 16 with lane 13).  
Thus, like sra and cort, prg is required for dephosphorylation of YA and Spindly.  In 
addition, the failure to dephosphorylate both proteins is more complete than in either 
sra or cort embryos where intermediate mobilities were observed.  In contrast, prg 
does not regulate the phosphorylation states of GNU and Vap-33-1, as the mobilities   
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Figure 3.5  Cdc27 is dephosphorylated upon egg activation, but this is 
independent of sarah. (A) Cdc27 has a higher mobility band in ORP2 (wild-type) 
mature oocytes (lane 1, arrow) that is not present in ORP2 embryos (lane 2).  (B) No 
difference in Cdc27 mobility is observed between mature oocytes from sra mutants or 
controls (lanes 3 and 5) or between sra embryos and control embryos (lanes 4 and 6). 
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Figure 3.6  prage is required for YA and Spindly dephosphorylation, but not 
phospho-modulation of GNU or Vap-33-1.  For each protein examined equivalent 
amounts of protein were loaded into each lane.  No differences are seen in GNU or 
Vap-33-1 mobilities between prg mutant and control oocytes, or between prg embryos 
and control embryos.  The mobilities of YA and Spindly in prg embryos are the same 
as those seen in prg oocytes.  These proteins fail to shift to the mobilities seen in 
control embryos. 
ov     emb    ov     emb ov       emb       ov        emb
mo  emb   mo  emb mo     emb     mo     emb
prage/+       prage -/-
prage/+       prage -/-
prage/+          prage -/-
prage/+       prage -/-
1        2        3         4                 5            6    7            8     
9       10      11      12
13        14       15       16  
GNU
GNU P
Vap-33-1
Vap-33-1 P
YA
YA
P
Spindly
Spindly P
  131 
 
of GNU and Vap-33-1 in prg embryos are indistinguishable from those observed in 
control embryos (Figure 3.6, compare lanes 2 and 4, 10 and 12).  These results show 
that there are at least two subsets of phosphorylation changes that are regulated during 
egg activation, prg-dependent and prg-independent.  These findings also suggest that 
prg works downstream of, or in parallel to the sra/cort pathway to regulate the prg-
dependent subset of phosphorylated proteins.  If prg were upstream of sra and cortex, 
we would expect that prg would also be required for the phosphorylation changes of 
GNU and Vap-33-1 that take place at egg activation. Consistent with prg being 
downstream or parallel with sra and cort, we find that Cort is degraded in prg 
embryos (Figure 3.7).  In control embryos, Cort is present at approximately 30% the 
levels observed in mature oocytes and in prg embryos we observed only 22% of the 
levels observed in mature oocytes (Figure 3.7B). 
 
3.4  Conclusions 
 Large-scale phosphorylation changes have been observed at the time of egg 
activation/fertilization in Drosophila (Krauchunas et al., submitted) and sea urchins 
(Roux et al., 2006; 2008).  In Xenopus and mouse, phosphorylation regulators such as 
Ca2+/calmodulin-dependent kinase II (CaMKII) and calcineurin are critical effectors of 
egg activation events (reviewed in Chapter One).  However, we still have a limited 
understanding of which genes and enzymes regulate of the phosphorylation changes at 
egg activation.  How many proteins are direct targets of CaMKII or calcineurin and 
how many phosphorylation changes are indirect effects due to not yet identified 
phosphatases and kinases?  Do the known egg activation genes regulate unique 
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Figure 3.7  Cortex degradation is independent of prage.  (A) Western blot showing 
Cort (arrow) in mature oocytes and embryos from prg heterozygotes (controls) and 
prg hemizygous mutants.  Equal amounts of protein were loaded into each lane. 
Levels of Cort appear similar between control and prg oocytes, and between prg and 
control embryos.  Non-specific cross-reactive is marked by *.  (B) Levels of Cort were 
quantified by normalizing to the *cross-reactive.  Numbers on the x-axis correspond to 
the lane numbers in (A).
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downstream events or do they work in common pathways to regulate overlapping 
groups of proteins?  What are the functional consequences of these phosphorylation 
changes? 
We have begun to answer these types of questions using the Drosophila model 
system.  We examined the role of three egg activation genes, sra, cort, and prg, in 
regulating the phosphorylation state of four proteins: GNU, YA, Spindly, and Vap-33-
1.  We find that sra is required for all four of these proteins to change in 
phosphorylation state upon egg activation.  Since we observe an identical phenotype in 
calcineurin germline clones, the effects seen in sra embryos are most likely due to the 
misregulation of calcineurin.   
The fact that GNU fails to be dephosphorylated in sra mutants begins to link 
phosphorylation changes with functional consequences.  GNU acts within the PNG 
kinase complex which is necessary for the translation of Smaug upon egg activation.  
It has been shown previously that Smaug is not translated in sra embryos (Cui et al., 
2008), however no mechanism for how sra affects Smaug translation has been 
proposed.  If GNU dephosphorylation is required for its activity, our finding that GNU 
is not dephosphorylated in sra embryos provides one possible explanation for why 
Smaug translation requires sra. 
We find that cort also regulates the phosphorylation state of GNU, YA, 
Spindly, and Vap-33-1, though cort mutants show a less severe phenotype in this trait 
than do sra embryos.  In contrast, prg only regulates a subset of these phosphorylation 
changes; YA and Spindly fail to be dephosphorylated in prg embryos, but GNU and 
Vap-33-1 are unaffected by a lack of prg.  Finally, we show that the degradation of 
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Cort requires sra, but is independent of prg.  From these data we propose a model in 
which sra and calcineurin act upstream of cort (and the APC/c) to regulate the 
phosphorylation state of multiple proteins, while prg acts downstream or in parallel as 
an additional regulator of only a subset of the sra/cort targets (Figure 3.8).  Thus, we 
have shown a link between known egg activation genes and phospho-regulation during 
egg activation, and have begun to place these genes into a common pathway.  
Additional work will be necessary to clarify where prg acts in relation to this pathway.  
At present we are unable to observe the developmental arrest point of prg embryos 
and we have been unsuccessful at developing an antibody that recognizes Prage.  
These tools will be important to establish if and how Prage is affected by sra or cortex. 
Determining the targets of prg will begin to address the mechanisms by which prg can 
affect the phosphorylation state of YA and Spindly and may provide additional 
avenues to test the relationship between prg, and the sra/cortex pathway. 
Changes in the phosphorylation state of many proteins at once can rapidly alter 
molecular and cellular properties and evidence suggests that phosphorylation changes 
are a key aspect of egg activation.  Therefore, it is important that we figure out the 
pathways that lead to the global phosphorylation changes taking place at this time 
(Krauchunas et al., submitted).  We have shown that the conserved proteins, 
calcineurin and Cdc20, are upstream of multiple phosphorylation events during egg 
activation.  It is likely through these phosphorylation changes that these egg activation 
regulators are exerting their effects.   
By understanding how these proteins work together to alter the 
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Figure 3.8  Summary of phospho-modulation pathways at egg activation.  Sarah 
and calcineurin act in a single pathway with cortex to regulate the phosphorylation 
states of YA, Spindly, GNU and Vap-33-1 at egg activation.  Prage acts downstream, 
or in a parallel pathway to regulate only a subset of the proteins that are regulated by 
sarah, calcineurin, and cortex. 
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phosphoproteome of the oocyte, we will gain important insight into how the events of 
egg activation are coordinated to achieve the oocyte-to-embryo transition. 
  137 
 
3.5  References 
Allis, C. D., Waring, G. L., Mahowald, A. P., 1977. Mass isolation of pole cells from 
Drosophila melanogaster. Dev Biol. 56, 372-81. 
Barisic, M., Sohm, B., Mikolcevic, P., Wandke, C., Rauch, V., Ringer, T., Hess, M., 
Bonn, G., Geley, S., 2010. Spindly/CCDC99 is required for efficient 
chromosome congression and mitotic checkpoint regulation. Mol Biol Cell. 21, 
1968-81. 
Benoit, P., Papin, C., Kwak, J. E., Wickens, M., Simonelig, M., 2008. PAP- and GLD-
2-type poly(A) polymerases are required sequentially in cytoplasmic 
polyadenylation and oogenesis in Drosophila. Development. 135, 1969-79. 
Cargnello, M., Roux, P. P., 2011. Activation and function of the MAPKs and their 
substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev. 75, 
50-83. 
Chan, Y. W., Fava, L. L., Uldschmid, A., Schmitz, M. H., Gerlich, D. W., Nigg, E. A., 
Santamaria, A., 2009. Mitotic control of kinetochore-associated dynein and 
spindle orientation by human Spindly. J Cell Biol. 185, 859-74. 
Chu, T., Henrion, G., Haegeli, V., Strickland, S., 2001. Cortex, a Drosophila gene 
required to complete oocyte meiosis, is a member of the Cdc20/fizzy protein 
family. Genesis. 29, 141-52. 
Cui, J., Sackton, K. L., Horner, V. L., Kumar, K. E., Wolfner, M. F., 2008. Wispy, the 
Drosophila homolog of GLD-2, is required during oogenesis and egg 
activation. Genetics. 178, 2017-29. 
Ferrell, J. E., Jr., Wu, M., Gerhart, J. C., Martin, G. S., 1991. Cell cycle tyrosine 
phosphorylation of p34cdc2 and a microtubule-associated protein kinase 
homolog in Xenopus oocytes and eggs. Mol Cell Biol. 11, 1965-71. 
Griffis, E. R., Stuurman, N., Vale, R. D., 2007. Spindly, a novel protein essential for 
silencing the spindle assembly checkpoint, recruits dynein to the kinetochore. J 
Cell Biol. 177, 1005-15. 
Horner, V. L., Czank, A., Jang, J. K., Singh, N., Williams, B. C., Puro, J., Kubli, E., 
Hanes, S. D., McKim, K. S., Wolfner, M. F., Goldberg, M. L., 2006. The 
Drosophila calcipressin sarah is required for several aspects of egg activation. 
Curr Biol. 16, 1441-6. 
Huang, J., Raff, J. W., 1999. The disappearance of cyclin B at the end of mitosis is 
regulated spatially in Drosophila cells. EMBO J. 18, 2184-95. 
Karr, T. L., Alberts, B. M., 1986. Organization of the cytoskeleton in early Drosophila 
embryos. J Cell Biol. 102, 1494-509. 
Kinoshita, E., Kinoshita-Kikuta, E., Takiyama, K., Koike, T., 2006. Phosphate-
binding tag, a new tool to visualize phosphorylated proteins. Mol Cell 
Proteomics. 5, 749-57. 
Krauchunas, A. R., Horner, V. L., Wolfner, M. F., submitted. Identifying protein 
phosphorylation changes to reveal new candidates in the regulation of egg 
activation and early embryogenesis in D. melanogaster. 
Kubiak, J. Z., Weber, M., de Pennart, H., Winston, N. J., Maro, B., 1993. The 
metaphase II arrest in mouse oocytes is controlled through microtubule-
  138 
 
dependent destruction of cyclin B in the presence of CSF. EMBO J. 12, 3773-
8. 
Lee, L. A., Van Hoewyk, D., Orr-Weaver, T. L., 2003. The Drosophila cell cycle 
kinase PAN GU forms an active complex with PLUTONIUM and GNU to 
regulate embryonic divisions. Genes Dev. 17, 2979-91. 
Lieberfarb, M. E., Chu, T., Wreden, C., Theurkauf, W., Gergen, J. P., Strickland, S., 
1996. Mutations that perturb poly(A)-dependent maternal mRNA activation 
block the initiation of development. Development. 122, 579-88. 
Lin, H. F., Wolfner, M. F., 1991. The Drosophila maternal-effect gene fs(1)Ya 
encodes a cell cycle-dependent nuclear envelope component required for 
embryonic mitosis. Cell. 64, 49-62. 
Liu, J., Song, K., Wolfner, M. F., 1995. Mutational analyses of fs(1)Ya, an essential, 
developmentally regulated, nuclear envelope protein in Drosophila. Genetics. 
141, 1473-81. 
Mackintosh, C., 2004. Dynamic interactions between 14-3-3 proteins and 
phosphoproteins regulate diverse cellular processes. Biochem J. 381, 329-42. 
Marks, F., 1996. Protein phosphorylation. VCH, Weinheim; New York. 
Mochida, S., Hunt, T., 2007. Calcineurin is required to release Xenopus egg extracts 
from meiotic M phase. Nature. 449, 336-40. 
Monsma, S. A., Wolfner, M. F., 1988. Structure and expression of a Drosophila male 
accessory gland gene whose product resembles a peptide pheromone precursor. 
Genes Dev. 2, 1063-73. 
Page, A. W., Orr-Weaver, T. L., 1996. The Drosophila genes grauzone and cortex are 
necessary for proper female meiosis. J Cell Sci. 109 ( Pt 7), 1707-15. 
Page, A. W., Orr-Weaver, T. L., 1997. Activation of the meiotic divisions in 
Drosophila oocytes. Dev Biol. 183, 195-207. 
Pennetta, G., Hiesinger, P. R., Fabian-Fine, R., Meinertzhagen, I. A., Bellen, H. J., 
2002. Drosophila VAP-33A directs bouton formation at neuromuscular 
junctions in a dosage-dependent manner. Neuron. 35, 291-306. 
Pesin, J. A., Orr-Weaver, T. L., 2007. Developmental role and regulation of cortex, a 
meiosis-specific anaphase-promoting complex/cyclosome activator. PLoS 
Genet. 3, e202. 
Pesin, J. A., Orr-Weaver, T. L., 2008. Regulation of APC/C activators in mitosis and 
meiosis. Annu Rev Cell Dev Biol. 24, 475-99. 
Renault, A. D., Zhang, X. H., Alphey, L. S., Frenz, L. M., Glover, D. M., Saunders, R. 
D., Axton, J. M., 2003. giant nuclei is essential in the cell cycle transition from 
meiosis to mitosis. Development. 130, 2997-3005. 
Roux, M., Townley, I., Raisch, M., Reade, A., Bradham, C., Humphreys, G., 
Gunaratne, H., Killian, C., Moy, G., Su, Y., 2006. A functional genomic and 
proteomic perspective of sea urchin calcium signaling and egg activation. 
Developmental Biology. 300, 416-433. 
Roux, M. M., Radeke, M. J., Goel, M., Mushegian, A., Foltz, K. R., 2008. 2DE 
identification of proteins exhibiting turnover and phosphorylation dynamics 
during sea urchin egg activation. Developmental Biology. 313, 630-647. 
  139 
 
Sackton, K. L., Buehner, N. A., Wolfner, M. F., 2007. Modulation of MAPK activities 
during egg activation in Drosophila. Fly (Austin). 1, 222-7. 
Sackton, K. L., Lopez, J. M., Berman, C. L., Wolfner, M. F., 2009. YA is needed for 
proper nuclear organization to transition between meiosis and mitosis in 
Drosophila. BMC Dev Biol. 9, 43. 
Sanghera, J. S., Paddon, H. B., Pelech, S. L., 1991. Role of protein phosphorylation in 
the maturation-induced activation of a myelin basic protein kinase from sea 
star oocytes. J Biol Chem. 266, 6700-7. 
Shibuya, E. K., Boulton, T. G., Cobb, M. H., Ruderman, J. V., 1992. Activation of p42 
MAP kinase and the release of oocytes from cell cycle arrest. EMBO J. 11, 
3963-75. 
Swan, A., Schupbach, T., 2007. The Cdc20 (Fzy)/Cdh1-related protein, Cort, 
cooperates with Fzy in cyclin destruction and anaphase progression in meiosis 
I and II in Drosophila. Development. 134, 891-9. 
Tadros, W., Goldman, A. L., Babak, T., Menzies, F., Vardy, L., Orr-Weaver, T., 
Hughes, T. R., Westwood, J. T., Smibert, C. A., Lipshitz, H. D., 2007. 
SMAUG is a major regulator of maternal mRNA destabilization in Drosophila 
and its translation is activated by the PAN GU kinase. Dev Cell. 12, 143-55. 
Tadros, W., Houston, S. A., Bashirullah, A., Cooperstock, R. L., Semotok, J. L., Reed, 
B. H., Lipshitz, H. D., 2003. Regulation of maternal transcript destabilization 
during egg activation in Drosophila. Genetics. 164, 989-1001. 
Takeo, S., Hawley, R. S., Aigaki, T., 2010. Calcineurin and its regulation by 
Sra/RCAN is required for completion of meiosis in Drosophila. Dev Biol. 344, 
957-67. 
Takeo, S., Swanson, S. K., Nandanan, K., Nakai, Y., Aigaki, T., Washburn, M. P., 
Florens, L., Hawley, R. S., 2012. Shaggy/glycogen synthase kinase 3beta and 
phosphorylation of Sarah/regulator of calcineurin are essential for completion 
of Drosophila female meiosis. Proc Natl Acad Sci U S A. 109, 6382-9. 
Takeo, S., Tsuda, M., Akahori, S., Matsuo, T., Aigaki, T., 2006. The calcineurin 
regulator sra plays an essential role in female meiosis in Drosophila. Curr Biol. 
16, 1435-40. 
Yu, J., Garfinkel, A. B., Wolfner, M. F., 2002. Interaction of the essential Drosophila 
nuclear protein YA with P0/AP3 in the cytoplasm and in vitro: implications for 
developmental regulation of YA's subcellular location. Dev Biol. 244, 429-41. 
Yu, J., Liu, J., Song, K., Turner, S. G., Wolfner, M. F., 1999. Nuclear entry of the 
Drosophila melanogaster nuclear lamina protein YA correlates with 
developmentally regulated changes in its phosphorylation state. Dev Biol. 210, 
124-34. 
Zhang, Q. H., Wei, L., Tong, J. S., Qi, S. T., Li, S., Ou, X. H., Ouyang, Y. C., Hou, 
Y., An, L. G., Schatten, H., Sun, Q. Y., 2010. Localization and function of 
mSpindly during mouse oocyte meiotic maturation. Cell Cycle. 9. 
Zhang, X. H., Axton, J. M., Drinjakovic, J., Lorenz, L., White-Cooper, H., Renault, A. 
D., 2004. Spatial and temporal control of mitotic cyclins by the Gnu regulator 
of embryonic mitosis in Drosophila. J Cell Sci. 117, 3571-8. 
 
  140 
 
CHAPTER FOUR 
 
SCREENING FOR NEW EGG ACTIVATION GENES 
 
4.1 Introduction 
 Traditional screens for female sterile mutants have identified only a handful of 
genes that are required for egg activation (reviewed in Chapter One).  While female 
sterility may be a useful filter, defects in a number of other processes (such as 
oogenesis) can also cause females to be sterile.  In addition, genes that are important 
for egg activation may have pleiotropic effects that make them difficult to identify 
through traditional female sterile screens.  For example, mutations in essential genes 
would be lethal and could not be studied for roles in egg activation (or fertility) except 
by analysis with germline clones.  The egg activation genes that have been identified 
so far such as sra and calcineurin (Horner et al., 2006; Takeo et al., 2010; Takeo et al., 
2006) and other genes reviewed in Chapter One, have provided important insight into 
how egg activation is regulated.  However, without knowing the full suite of 
genes/proteins that act to allow or regulate egg activation, our understanding of this 
process will remain incomplete.  In this chapter I summarize the results from two 
alternative genetic screens that aimed to identify new egg activation genes. 
 In Chapter Two I described a proteomic approach to identify proteins that are 
phospho-regulated during egg activation.  Since these proteins are not only present, 
but also regulated, in the oocyte/activated egg, we hypothesize that they are an 
enriched candidate set to test for new players in the oocyte-to-embryo transition.  
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Chapter Two contains results of knocking down 18 of these candidates by RNAi.  
Those were the first genes tested and include a promising new egg activation/early 
development gene, mrityu.  The present chapter presents the results of testing 
additional candidates through germline-specific RNAi, P-element insertions, and 
tissue-specific gene expression.  Proteins that are phospho-regulated during egg 
activation may be important for maintaining the arrested state of the mature oocyte 
prior to activation, for regulating the events of egg activation, or for early 
embryogenesis immediately after egg activation.  By screening the proteomic 
candidates for female sterility when the genes encoding these proteins are knocked 
down in the female germline, we should identify genes/proteins that act at any of these 
three stages.  Further analysis will then allow us to dissect when and how theses genes 
and proteins function. 
 Another approach for identifying new factors important for egg activation is to 
search for genes that interact with known egg activation genes.  Therefore, we 
performed a screen to identify genes that genetically interact with calcineurin in the 
oocyte.  This screen was initiated by the lab of Dr. Toshiro Aigaki, who kindly 
provided us with flies and preliminary findings.  To study the role of calcineurin 
during female meiosis, the Aigaki lab created transgenic flies that express a 
constitutively active form of calcineurin (CnAact) in the female germline (Takeo et al., 
2006).  They found that CnAact females are sterile (Takeo et al., 2006).  The Aigaki 
lab then performed a deficiency screen to identify regions of the genome that, when 
hemizygous, suppressed the sterility caused by CnAact.  They found 17 different 
deficiencies that restored fertility to CnAact females (T. Aigaki, personal  
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Table 4.1 Deficiencies that strongly suppressed the CnAact female sterility. 
Listed are the 17 deficiencies that the Aigaki lab found to suppress the sterility caused 
by expression of CnAact in the female germline, the hatchability for each deficiency, 
and the number of genes within each deficiency (T. Aigaki, personal communication). 
  
Name of deficiency 
 
Deletion interval 
Egg 
Hatchability(%) 
Number of genes 
within the interval 
Df(1)JC70 4C15-5A02 70.6 133 
Df(1)v-L15 9B01-10A02 ND 221 
Df(2L)BSC5 26B01-26D02 1.3 94 
Df(2L)BSC17 30C03-30F01 5.0 87 
Df(2L)BSC50 30F04-31B04 16.4 81 
Df(2R)ST1* 42B03-43E18 77.0 273 
Df(2R)cn9* 42E-44C ND 336 
Df(2R)BSC29 45D03-45F06 1.9 63 
Df(2R)stan1 46D07-47F16 29.2 205 
Df(2R)Exel7130 50D04-50E04 ND 37 
Df(2R)BSC45 54C08-54E07 13.5 102 
Df(2R)14H10Y-53 54D01-54E07 45.9 87 
Df(2R)Egfr5* 57D02-58D01 28.5 237 
Df(2R)X58-12 58D01-59A 19.4 143 
Df(2R)Px2 60C05-60D10 12.1 94 
 
Df(3L)AC1 
67A02-67D13 
or 67A05-67D13 
 
50.6 
 
219 or 214 
 
Df(3R)Antp17 
84B01-84D12 
or 84A01-84D14 
 
ND 
 
162 or 239 
 
ND: Not determined 
*These three deficiencies are being studied by the Aigaki lab.
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communication).  After selecting specific regions on which to focus their own studies, 
T. Aigaki sent our lab the CnAact stocks and the list of deficiencies that suppressed 
sterility.  These deficiencies contained anywhere from 37 to 200+ genes (Table 4.1; T. 
Aigaki, personal communication).  Our goal was to identify which gene(s) in each 
deficiency was responsible for suppressing the CnAact sterility.  We focused on the 
five deficiencies with the highest level of suppression of CnAact sterility (determined 
by the greatest percentage of progeny compared to number of eggs laid), and either 
identified the gene or narrowed down the region that interacts with calcineurin. 
 
4.2 Materials and Methods 
Flies:  To knock down genes by RNAi, we used transgenic flies produced by the 
Transgenic RNAi Project (TRiP) at Harvard.  Lines were either requested directly 
from the TRiP or were ordered from the Bloomington Stock Center.  Specific stock 
numbers for each gene are included in the tables in the Results section.  To achieve 
knockdown specifically in the female germline, lines containing the RNAi constructs 
were crossed to either nanos-GAL4 (Bloomington stock #4937) or the Maternal Triple 
Driver (MTD)-GAL4 (Bloomington stock #31777).  P-element insertion lines and 
deficiency lines for the CnAact screen, or to test proteomics candidates, were ordered 
from the Bloomington Stock Center; the specific stock numbers are in the tables in the 
Results section.  Other stocks used were: Vap-33-1Δ20/FM7;; UAS-Vap, Vap-33-
1Δ448/FM7;; UAS-Vap, D42-GAL4, and C164-GAL4 (kind gifts of H. Bellen; Pennetta 
et al., 2002) and elav-GAL4 (Bloomington stock #8760) to test for a role of Vap-33-1 
in the female germline, y1 w67c23; P{EPgy2}mriEY01340 (Bloomington stock # 15834) 
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and w1118; ry Dr P{Δ2-3}99B/TM6C Sb (Bloomington stock #5908) to make mrityu 
mutants through imprecise P-element excision mutagenesis, and w1118;; nanos-GAL4, 
UASp-Pp2B-14Dact/TM3 Sb Ser for expression of constitutively active calcineurin in 
the female germline (kind gift of T. Aigaki; Takeo et al., 2006).   
Crosses:  TRiP lines were crossed to nanos-GAL4 or MTD-GAL4 to knockdown 
genes of interest specifically in the female germline.  Control females were nanos-
GAL4/balancer or MTD-GAL4/balancer siblings from crosses in which the TRiP lines 
were balanced.   
To test for the role of Vap-33-1 in the female germline Vap-33-1Δ20/FM7;; UAS-Vap 
or Vap-33-1Δ448/FM7;; UAS-Vap females were crossed to three different driver lines 
(D42-GAL4, C164-GAL4, and elav-GAL4) to express Vap-33 in the nervous system.  
Male progeny that did not contain the FM7 balancer chromosome were then crossed 
back to Vap-33-1Δ20/FM7;; UAS-Vap or Vap-33-1Δ448/FM7;; UAS-Vap females.  Non-
balanced female progeny from this cross are Vap-33-1 nulls expressing Vap-33 “only” 
in the nervous system (however, two of these drivers appear to produce expression in 
the germline, see Results).   
For the CnAact suppression screen, virgin females from deficiency or P-element 
insertion lines were crossed to nos>CnAact males.  Female progeny carrying both 
CnAact and the deficiency/mutation of interest were collected by selecting against all 
balancer chromosomes. 
Fertility assay:  Virgin females, aged 3-5 days, were individually mated with wild-
type (ORP2) males.  Following copulation, males were removed and females were 
allowed to lay eggs for 24 hours.  Every 24 hours, for 3-5 days, females were 
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transferred to a fresh vial and the number of eggs laid in the previous vial was 
counted.  In this way, the total number of eggs laid by each female was determined.  
The total number of pupae or adult progeny in each vial was also counted to determine 
the fertility of each female.  Hatchability was determined by dividing the total number 
of adult progeny by the total number of eggs laid.  The average hatchability is 
presented for each genotype.  For the CnAact screen, the number of eggs laid was not 
always counted and results may instead be presented as the average number of 
pupae/adult progeny over 3 days.  N values are presented in Results. 
Immunostaining and microscopy:  Embryos or ovaries were fixed in methanol/heptane 
and stained as described in Horner et al. (2006).  Guinea pig anti-Vap-33-1 antibody 
was used at 1:200 (kind gift of H. Bellen; Pennetta et al., 2002).  Mouse anti-tubulin 
antibody was used at 1:400 (Sigma, St. Louis, MO, catalog#T5168) and Alexa 
secondary antibodies were used at 1:200 (Invitrogen, Grand Island, NY).  RNaseA 
(Roche, Indianapolis, IN) was added at a final concentration of 5 μg/ml and propidium 
iodide (Molecular Probes, Eugene, OR) was used at a final concentration of 10 μg/ml.  
Images were collected using a Leica TCS SP2 confocal microscope as described in 
(Horner et al., 2006). 
 
4.3 Results and Discussion  
Candidates from phospho-proteomics: 
Insertion lines 
 The ability to knock down genes in the female germline using RNAi is a 
relatively recent advancement in Drosophila RNAi techniques (Ni et al., 2011).  Prior 
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to the availability of these lines, I searched for transposable-element insertions in the 
genes encoding each of the 311 proteins that we identified in the phospho-proteomics 
experiments (Chapter Two) to test if the insertions impaired female fertility.  I ordered 
19 lines from the Bloomington stock center for which the fertility and/or lethality was 
not described on Flybase, and one female-sterile allele with an unknown arrest point 
(flybase.org).  Of these 20 lines, 9 were balanced and there were no homozygotes 
within the stock, suggesting that they contain mutations that affect essential genes.  I 
also failed to obtain homozygotes from the one stock that was listed as a female-sterile 
allele (FBal0008607).  To determine if the genes affected by these mutations act 
during egg activation will require germline clonal analysis.  Another six lines were 
homozygous viable and fertile.  Since the mutations in these lines may only partially 
knockout gene function, or not affect it at all, testing of additional alleles and/or RNAi 
lines will be important to determine if the genes mutated in these six lines are 
important for egg activation.   
Of the remaining four lines, one (FBal0216980, Smg6) laid fewer eggs than 
controls and the other three (CG14749DG30308, FBal0219308; ssp3KG05595, 
FBal0148274; CG5245A366, FBal0222431) had lower hatchability than controls.  
These results are summarized in Table 4.2.  I further investigated one of the lines with 
low hatchability.  This line has an insertion predicted to affect the gene CG5245, so I 
crossed the stock to a deficiency in the same region.  Flies that were hemizygous for 
the CG5245A366 allele had wild-type hatchability (98% hatch for CG5245A366/Df 
compared to 22% hatch for CG5245A366/CG5245A366).  I confirmed these results by 
testing a second allele of CG5245 (CG5245C316, FBal0216993) which is also fully 
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Table 4.2 P-element insertion lines for candidates from phospho-proteomics. 
For CG14749, n = 10 (sibling control n = 4); short spindle 3, n = 8 (sibling control     
n = 10); and CG5245, n = 7 (control n = 7). 
Gene Stock # Phenotype 
CG14749  21314 
low hatchability 
(86.8%, p=0.005) 
short spindle 3 14597 
low hatchability 
(89%, p=0.026) 
CG5245  16099 
low hatchability 
(39%, p=0.006) 
Smg6  16301 low egg count 
hook-like (female sterile) 6102 no homozygotes 
CG10588  21529 lethal 
CG11188  18112 lethal 
CG6509 13692 lethal 
D1 chromosomal protein 17340 lethal 
splicing factor Srp54 20545 lethal 
CG11414  24087 lethal 
CG12945  17145 lethal 
CG31368 17825 lethal 
CG5602 18387 lethal 
CG10103  27211 fertile 
CG1910 21055 fertile 
RhoGAP92B  15776 fertile 
CG2091  21567 fertile 
CG11844 23270 fertile 
CG16952 19698 fertile 
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fertile.  Therefore, it appears that there is an additional mutation segregating with the 
CG5245A366 allele that affects female fertility independent of CG5245 gene function. 
RNAi knockdown 
 Once RNAi became an available tool for knocking down genes in the female 
germline (Ni et al., 2011), I began using this method to test candidates from the 
proteomics experiments for roles in egg activation and early embryogenesis.  I  
knocked down candidate genes specifically in the female germline by driving RNAi 
with a nanos-GAL4 or MTD-GAL4 driver and testing the fertility of these females.  
Fertility was examined by counting the number of eggs laid and the number of 
progeny produced from those eggs (either pupae or adult flies) to determine the 
percent that hatched.  Maternal effect genes that play a role in egg activation or 
embryogenesis should have low hatchability values.  I did not test genes with a known 
role in female fertility, that have already been tested by germline clonal analysis, or 
have fertile null alleles reported (flybase.org).  All other candidates were tested for 
which an RNAi line was available from the TRiP as of February 2012.   
Seventy-nine lines have been tested, corresponding to 71 different genes 
(Table 4.3; this includes the 18 genes reported in Chapter Two).  The egg counts and 
progeny counts for some of these lines were performed by an undergraduate, Lina 
Abdul Karim, who worked with me in the summer of 2011.  Of the 71 genes tested, 16 
produced zero, or very few, mature oocytes, suggesting that these genes are necessary 
for oogenesis.  With the tools that are currently available, the early action of these 
genes prevents us from testing any role in egg activation since knockdown during 
oogenesis prevents the formation of mature oocytes.  Another five genes (Pk92B,  
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 Table 4.3 Summary of RNAi results. Fertile means that hatchability was 90% or greater. *Reduced hatchability is due to results from a single day, while the other two days 
showed wild-type hatchabilty.  These genes should be retested. 
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Gene Stock # Driver Phenotype 
Rtf1 HMS00168 nanos-GAL4 no oocytes 
CG9609 HMS01000 nanos-GAL4 no oocytes 
CG5602 HMS01036 nanos-GAL4 no oocytes 
CG7597 HMS00155 nanos-GAL4 no oocytes 
CG7597 GL00031 nanos-GAL4 fertile 
NAT1 BL32357 nanos-GAL4 no oocytes 
mcm3 BL34686 MTD-GAL4 no oocytes 
putzig GL00373 MTD-GAL4 no oocytes 
Tango7 BL32879 MTD-GAL4 no oocytes 
lolal GLV21087 MTD-GAL4 no oocytes 
Tcp-1eta BL34931 MTD-GAL4 no oocytes 
Uba1 GL00491 nanos-GAL4 no oocytes 
CG2774 GL01089 nanos-GAL4 no oocytes 
Spc105R BL35466 MTD-GAL4 no oocytes 
Spindly BL34933 both no/few oocytes 
Uba2 BL35806 MTD-GAL4 no/few oocytes 
cdc37 BL34991 MTD-GAL4 few oocytes 
Pk92B GL00238 MTD-GAL4 30% 
Pk92B BL32464 MTD-GAL4 80% 
BRWD3 BL33421 nanos-GAL4 28% 
modulo GLV21029 MTD-GAL4 29% 
EDTP HMS01577 MTD-GAL4 50% 
FKBP59 BL35612 MTD-GAL4 60% 
mrityu GL00033 both 0% 
PyK GL00099 nanos-GAL4 0% 
alpha-adaptin BL32866 both 0-3% 
myopic BL32916 MTD-GAL4 0% 
myopic HMS00836 nanos-GAL4 fertile 
Bre1 GL00368 MTD-GAL4 0% 
Nipped-B GL00574 MTD-GAL4 >1% 
Nipped-B BL32406 MTD-GAL4 14% 
14-3-3 epsilon BL34884 MTD-GAL4 0% 
14-3-3 epsilon BL35441 MTD-GAL4 0% 
mod(mdg4) BL32995 MTD-GAL4 0% 
mod(mdg4) BL33907 MTD-GAL4 3% 
Apc HMS 00188 nanos-GAL4 fertile 
RPA2 HMS01061 nanos-GAL4 fertile 
Sodh-1 HMS01028 nanos-GAL4 fertile 
5-HT1A HMS00823 nanos-GAL4 fertile 
RhoGAP92B HMS00268 nanos-GAL4 fertile 
eif-4A HMS00927 nanos-GAL4 fertile 
Rasputin HMS00269 nanos-GAL4 fertile 
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Gene Stock # Driver Phenotype 
Hsc/Hsp70-interacting 
protein related HMS00988 
 
nanos-GAL4 fertile 
Hsc/Hsp70-interacting 
protein related BL32900 
 
MTD-GAL4 fertile 
Jarid2 BL32891 nanos-GAL4 fertile 
CG14446 BL32487 nanos-GAL4 fertile 
26-29kD-proteinase BL32887 nanos-GAL4 fertile 
SET domain binding factor BL32419 
 
nanos-GAL4 fertile 
SF2 BL32367 nanos-GAL4 fertile 
CG3689 BL32883 both fertile 
XNP BL32894 nanos-GAL4 fertile 
CG13350 BL32968 nanos-GAL4 fertile 
Eps-15 HMS00947 nanos-GAL4 fertile 
Eps-15 HMS00893 nanos-GAL4 fertile 
D1 HMS00061 nanos-GAL4 fertile 
Ptp61F BL32426 nanos-GAL4 fertile 
CG18259 BL34081 MTD-GAL4 fertile 
Hsp27 BL33007 MTD-GAL4 fertile 
CG42669 BL34016 MTD-GAL4 fertile 
Hsp26 GL00329 MTD-GAL4 fertile 
Cysteine proteinase-1 BL32932 MTD-GAL4 fertile 
Hsc70Cb BL33742 MTD-GAL4 fertile 
CG5527 BL34531 MTD-GAL4 fertile 
CG9705 GLV21074 MTD-GAL4 fertile 
CG8223 GLV21084 MTD-GAL4 fertile 
Df31 GLV21083 MTD-GAL4 fertile 
ACXD GL00425 MTD-GAL4 fertile 
Aut1 BL34359 MTD-GAL4 fertile 
Gadd45 BL35023 MTD-GAL4 fertile 
CG10103 BL34979 MTD-GAL4 fertile 
RhoGAP68 GL00580 MTD-GAL4 fertile 
CG30101 GL00602 MTD-GAL4 fertile 
RhoGAP1A BL33390 MTD-GAL4 fertile 
dikar BL32397 MTD-GAL4 fertile 
Med1 BL34662 MTD-GAL4 fertile 
CG4968 BL35615 MTD-GAL4 fertile 
Gp93 BL34346 MTD-GAL4 fertile 
l(3)82Fd GL00605 MTD-GAL4 65%* 
stathmin GL01099 MTD-GAL4 72%* 
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BRWD3, modulo, EDTP, and FKBP59) caused reduced hatchability (ranging from 
30%-60% hatchability) when knocked down.  Since these genes are only knocked 
down, it is possible that complete sterility may be observed if gene function is 
removed entirely.  Therefore, these five genes are good candidates for further study 
with null mutations and possibly germline clone analysis.  Finally, knocking down 
eight different genes produced complete (or nearly complete) sterility.  One of these 
genes, mrityu, is discussed in Chapter Two and below.  The other seven genes are 
PyK, alpha-adaptin, myopic, Bre1, Nipped-B, 14-3-3 epsilon, and mod(mdg4).   
I examined the embryos laid by females knocked down for each of these seven genes 
to determine the period of development that is affected when expression of these genes 
is reduced.  I stained 1-3 hour old embryos with propidium iodide and anti-tubulin 
antibody, to visualize DNA and microtubules, respectively.  When PyK, alpha-
adaptin, myopic, and Nipped-B are knocked down, embryos are able to undergo 
multiple rounds of mitosis as seen by the numerous mitotic nuclei present in these 
eggs (Figure 4.1 and results not shown).  This suggests that these genes either function 
after the early stages of embryogenesis, or that knockdown is not complete enough for 
us to observe their earlier roles.  When Bre1, a gene involved in histone modification 
and Notch signaling (Bray et al., 2005), is knocked down 11/16 embryos appeared to 
arrest at an early point in embryogenesis while the remaining five embryos had gone 
through many rounds of mitosis.  This could again be due to variability in the level of 
knockdown achieved by RNAi.  Since null alleles of Bre1 are lethal, further 
experiments to determine the role of Bre1 in the mature oocyte and activated egg will 
likely require germline clone analysis.  Knockdown of mod(mdg4) in the female  
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Figure 4.1  Embryos arrest after the early syncytial divisions when Pyk, alpha-
adaptin, or myopic are knocked down in the female germline. 
1-3 hour embryos laid by (A) control females or females knocked down for (B) PyK, 
(C) alpha-adaptin, or (D) myopic.  Females are sterile when any of these three genes 
are knocked down in the germline.  Embryos were stained with anti-tubulin antibody 
and propidium iodide to visualize microtubules and DNA, respectively.  None of these 
embryos show an early arrest phenotype.  Instead they all have gone through many 
rounds of embryonic mitosis and look similar to control embryos.
A B
C D
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 germline also leads to an early arrest, this time in all embryos observed (n=15).  
Additional experiments are required to determine the exact arrest point of these 
embryos.  Mod(mdg4) is involved in chromosome segregation during male meiosis 
and may play a similar role in female meiosis (flybase.org).  Finally, knockdown of 
14-3-3 epsilon, another gene that plays a role in cell cycle regulation (flybase.org), 
produced embryos with what appeared to be large DNA aggregates.  Examining 
earlier stage embryos, or possibly mature oocytes, may allow us to determine when 
14-3-3 epsilon first acts and how it causes this aggregation later in embryogenesis. 
Vap-33-1 
 Vap-33-1 is one of the proteins that I identified in Chapter Two as changing in 
phosphorylation state between mature oocytes and activated eggs.  In Chapter Three I 
also showed that this phosphorylation change is dependent on the egg activation genes 
sarah and cortex.  Next, I was interested in determining what role Vap-33-1 may play 
during egg activation.  Null mutations of Vap-33-1 are lethal and at present there is no 
RNAi line to knock down Vap-33-1 in the female germline (Pennetta et al., 2002).  
Therefore, to test the role of Vap-33-1 in the female germline, I took advantage of the 
fact that expression of Vap-33-1 in the nervous system is sufficient to rescue the lethal 
phenotype of a Vap-33-1 null mutation (Pennetta et al., 2002).   
In theory, expression of Vap-33-1 solely in neurons, in a Vap-33-1 null 
background, should mean that there is no Vap-33-1 expression in the germline.  To 
express Vap-33-1 in neurons I used three different nervous system drivers: elav-
GAL4, D42-GAL4, and C164-GAL4.  When driving Vap-33-1 expression with either 
elav-GAL4 or D42-GAL4 in a Vap-33-1 null background, I found that females were 
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completely fertile.  However, Western blots revealed that mature oocytes from these 
females expressed Vap-33-1 protein at levels comparable to balancer control siblings 
carrying an endogenous copy of Vap-33-1 (results not shown).  In contrast, when Vap-
33-1 expression was driven by C164-GAL4 in a Vap-33-1 null background, females 
did not lay any eggs over the course of seven days.  Dissection of these females 
revealed that they did not produce any mature oocytes.  This indicates that Vap-33-1 
expression is required for oogenesis and prevents us from determining its role at egg 
activation at this time. 
 In addition to the role and regulation of Vap-33-1, I also briefly examined the 
localization of Vap-33-1 in the developing oocyte and early embryo.  I found that 
Vap-33-1 is enriched in the developing oocyte and localized to the cytoplasm (Figure 
4.2A).  In embryos, Vap-33-1 appears to associate with the spindle envelope during 
mitosis (Figure 4.2B) and may remain peri-nuclear during interphase (Figure 4.2C).  
In the future, it will be useful to look at Vap-33-1 localization in mature oocytes.  
Since Vap-33-1 phosphorylation is regulated by sra and cortex, it will also be of 
interest to observe Vap-33-1 localization in embryos laid by these mutants. 
Mrityu 
 In Chapter Two I presented results showing that embryos laid by females with 
reduced levels of mrityu in the germline (mri RNAi embryos) arrest early in 
embryogenesis.  The majority of these embryos arrested during the first or second 
embryonic mitosis, and always during metaphase (Chapter Two).  Since this arrest is 
right after egg activation, I examined whether Mrityu function is necessary for the 
phospho-regulation of other proteins that occurs during egg activation.  I was  
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Figure 4.2  Localization of Vap-33-1 in developing oocytes and early embryos. 
Ovaries and embryos were stained to visualize Vap-33-1 (green) and DNA (red).  
Vap-33-1 is enriched in the developing oocyte (A).  In the early embryo, Vap-33-1 
appears to associate with the spindle envelope during mitosis (B) and remain peri-
nuclear during interphase (C). 
  
A B C
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especially interested in whether YA was properly dephosphorylated in mri RNAi 
embryos, since YA is required for the first embryonic mitosis (Lin et al., 1991; Yu and 
Wolfner, 2002; Sackton et al., 2009).  I found that mri is not required for the phospho-
regulation of YA, GNU, Spindly, or Vap-33-1 (Figure 4.3).  
Mrityu was identified by mass spectrometry as a protein that is phosphorylated 
upon egg activation (Chapter Two).  Since loss of maternal mrityu results in an early 
embryonic arrest, one of the next experiments should be to test whether the 
phosphorylation of Mrityu is important for its function.  This will involve mutating the 
phosphorylated residues identified by mass spec. and creating transgenic flies that 
express the mutated protein.  If the phosphorylation is required for Mrityu to function 
at egg activation, then mutating these residues to alanine should result in a loss of 
function phenotype.  Additionally, mutating these residues to phospho-mimetic amino 
acids could result in premature activation in oocytes.  In order to observe the effects of 
the mutated transgene, we will need to express it in a mri null background to remove 
the effects of the endogenous protein.  A null mutant should also allow us to determine 
a more exact arrest point, as the variability that we see with RNAi knockdown is likely 
due to the small amount of mri expression that still occurs in these oocytes/embryos. 
At present, there is no null allele of mri reported.  Therefore, I tried to create a 
null allele through imprecise P-element excision mutagenesis.  The Bloomington stock 
center has one line with a P-element insertion in the 5’ UTR of mri.  I crossed this line 
to a line carrying the ∆2-3 transposase, and then carried out single-pair matings of 
mriEY01340/Dr ∆2-3 males crossed to w1118;; +/TM3 Sb virgin females.  Excision events 
were identified by a w- phenotype, due to the loss of the mini-white gene in the 
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Figure 4.3  Protein phosphorylation changes take place normally in mri RNAi 
embryos.  No differences are seen in the phosphorylation states of YA, GNU, Spindly 
or Vap-33-1 for control and mri RNAi mature oocytes (mo; compare lanes 1 and 3) or 
for control and mri RNAi 0-1 hour embryos (emb; compare lanes 2 and 4).
Vap-33-1
GNUYA
Spindly
mo  emb  mo   emb
mo emb  mo embmo  emb  mo   emb
1       2     3      4
1       2        3      4
1      2     3      4
mo emb  mo emb
1     2     3      4
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P-element.  I collected approximately 60 w;; Dr+/TM3 Sb progeny.  These were then 
individually mated to w;; mriEY01340/TM3 Sb.  The white-eyed, Stubble progeny were 
collected and siblings were mated to establish mri mutant lines.   
The majority of the excision lines were homozygous viable and fertile.  Since RNAi 
knockdown of mri results in a female sterile phenotype, I concluded that these lines 
were either precise excisions, did not excise the entire P-element, or did not disrupt 
enough of the surrounding sequence to affect the coding sequence of mri.  But nine 
lines were homozygous lethal; progeny always possess the balancer chromosome.  
This suggested that mri may be an essential gene.  However, the gene immediately 
upstream of mri is rhinoceros, which is known to be essential (Voas and Rebay, 
2003).  Therefore, it is also possible that the homozygous lethal P-element excision 
lines are lethal due to disruption of rhinoceros rather than mri.  In support of this idea, 
I also established a single line (mri*40) that produces some homozygotes and affects 
female fertility.  Only 2% of the eggs laid by mri*40/ mri*40 females hatch (Figure 
4.4A).  These females also laid a reduced number of eggs on the second and third day 
after mating, compared to heterozygous control females (Figure 4.4B).  In the future 
the excision lines will need to be sequenced to determine the nature of the mri*40 and 
other alleles.  Complementation test with rhinoceros mutants will help to establish 
whether lethality of the other lines is in fact due to disruption of rhinoceros.  
Suppressors of the sterility caused by expressing constitutively active calcineurin 
in the female germline: 
We examined five different deficiencies that were previously found to suppress 
the sterility caused by expressing CnAact in the female germline.  These deficiencies  
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A 
  
B 
  
Figure 4.4  Hatchability and number of eggs laid for mri*40 homozygotes and 
heterozygous controls. 
Mri*40 homozygotes are almost completely sterile for the first three days after mating 
(A).  In addition, mri*40 homozygous females lay the same number of eggs as controls 
on day 1 but lay reduced numbers of eggs on days 2 and 3 (B).  Bars show the average 
hatchability/ number of eggs laid (n = 13 for mri*40  homozygotes, n = 14 for controls).  
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are Df(1)JC70, Df(2R)14H10Y-53, Df(2R)X58-12, Df(2R)stan1, and Df(3L)AC1.  
We picked these deficiencies because they produced some of the greatest levels of 
suppression, as determined by the percentage of laid eggs that hatched. 
 The majority of this project was carried out by a talented undergraduate 
student, Rebecca Zuckerman, whom I mentored for two and a half years.  Her results 
are written up in her senior honors thesis (R. Zuckerman, 2011) and are summarized 
here in Table 4.4.  Rebecca identified one P-element insertion within the region of the 
genome deleted by Df(1)JC70 that restored fertility to wild-type levels.  When females 
carried one copy of P{GT1}BG01861 and the CnAact transgene, 92.4% of the laid 
eggs hatched.  P{GT1}BG01861 is located just downstream of CG6927 and just 
upstream of another gene, CG32772.  Since another P-element insertion directly in the 
coding region of CG32772 does not restore fertility to CnAact females, we concluded 
that CG6927 is the gene responsible for the observed suppression by 
P{GT1}BG01861.  The function of CG6927 is unknown, though it is predicted to 
function in ion transport based on domain structure (flybase.org).   
One experiment that we tried, but did not complete, was to test if this same P-
element insertion can also suppress sra mutations.  But unlike the CnAact females, sra 
is only sterile when homozygous or hemizygous and required a more extensive 
crossing scheme to get females deficient in sra and carrying the P-element insertion.  
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Table 4.4 Summary of results of CnAact suppressor screen from the thesis of R. 
Zuckerman (2011). 
Deficiency Gene/Deficiency n Hatchability P-value 
Df(1)JC70 CG3009 9 0.108 0.086 
 rap 9 0.005 0.006* 
 Pp2C1 7 0.067 0.182 
 ctp 10 0.001 0.002* 
 CG7010 7 0.124 0.135 
 CG7024 10 0.001 0.018* 
 CG6986 8 0.000 0.002* 
 CG2861 10 0.000 0.001* 
 CG6927 23 0.924 <0.0001** 
 CG32772 10 0.048 0.612 
 CG42594 10 0.005 0.219 
 CG6903 8 0.044 0.627 
 CG4068 12 0.118 0.883 
 Ptp4E 6 0.013 0.128 
 CG32767 8 0.018 0.193 
 ovo 9 0.038 0.257 
 rg 7 0.000 0.004* 
 cdk7 3 0.005 0.130 
 CanB 8 0.079 0.154 
 sans fille 17 0.104 0.366 
 CG4198 10 0.032 0.336 
 XRCC1 8 0.016 0.230 
 CG15930 10 0.003 0.003* 
 sk 10 0.000 0.002* 
 NAAT1 9 0.000 0.001* 
 yu 6 0.059 0.581 
 CG15784 10 0.053 0.709 
 CG4165 10 0.001 0.037* 
 CG12730 15 0.093 0.695 
 Vsx2 7 0.000 0.007* 
Df(2R)14H10Y-53 Df(2R)Exel7149 8 0.644 0.0002** 
 Df(2R)BSC347 9 0.524 0.0012** 
 Df(2R)BSC348 10 0.024 0.4474 
 CG10936 8 0.079 0.678 
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Deficiency Gene/Deficiency n Hatchability P-value 
Df(2R)14H10Y-53 rhi 7 0.025 0.283 
 CG18186 8 0.000 0.003* 
 CG30106 9 0.037 0.351 
 eIF3-S8 10 0.187 0.007** 
 CG30108 8 0.042 1.000 
 CG30109 8 0.081 0.116 
 CG6459 6 0.049 0.707 
 sema-1B 10 0.005 0.098 
 HPS4 10 0.061 0.367 
 swi2 10 0.093 0.345 
Df(2R)X58-12 Df(2R)BSC597 9 0.024 0.1046 
 Df(2R)Exel7171 10 0.036 0.8237 
 Df(2R)Exel7173 10 0.145 0.009** 
 Df(2R)BSC598 10 0.182 0.0104** 
 CG3927 12 0.022 0.086 
 CG34445 10 0.091 0.384 
 RpS24 3 0.630 <0.0001** 
 Ugt58Fa 9 0.021 0.134 
 CG2852 9 0.119 0.490 
 CG13510 9 0.013 0.044* 
 CG42565 11 0.630 <0.0001** 
 CG42566 10 0.005 0.006* 
 CG3746 11 0.006 0.008* 
Df(3L)AC1 Df(3L)BSC390 10 0.002 0.0127* 
 Df(3L)BSC393 8 0.002 0.0148* 
 Df(3L)BSC576 10 0.002 0.0076* 
 Df(3L)BSC283 9 0.094 0.4474 
Df(2R)stan1 Df(2R)BSC281 10 0.074 0.5281 
 Df(2R)ED2098 6 0 0.0223* 
 Df(2R)BSC336 9 0.028 0.5694 
 Df(2R)BSC231 10 0.14 0.0196** 
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Since sra regulates calcineurin (Takeo et al., 2010), there is a strong possibility that 
genes that interact genetically with calcineurin may also interact with sra.  In the 
future it would be useful to test whether any of the genes identified through this screen 
can also suppress the sra phenotype.  
Another gene that is within the Df(1)JC70 deficiency that Rebecca tested is 
CanB, which encodes a subunit of calcineurin.  Rebecca found that CanB did not 
suppress the sterility caused by CnAact.  This result is consistent with the report that 
CanB2 is the regulatory subunit present in oocytes, and that CanB is not expressed in 
ovaries (Takeo et al., 2010). 
For the other four deficiencies that we looked at, Rebecca first narrowed down 
the possible suppressor genes by testing smaller deletions within each of the four 
regions.  For Df(2R)14H10Y-53, she then found one gene, eIF3-S8, that significantly 
restored fertility to CnAact females (18.7% hatchability compared to 45.9% for the 
deficiency).  For Df(2R)X58-12, Rebecca found that the gene, CG42565, restored 
fertility to CnAact females (63% hatchability).  She found a second gene, RpS24, which 
may also be a suppressor, but needs to be retested to confirm the result due to a low 
number of females (n=3) tested in the first experiment.  EIF3-S8 is a predicted 
translation initiation factor and RpS24 encodes a ribosomal protein (flybase.org).  
Since new protein translation is an event triggered by egg activation, these two genes 
could play a role in regulating this process.  There is currently nothing known or 
predicted about the function of CG42565 (flybase.org).   
For the final two deficiencies, Df(2R)stan1 and Df(3L)AC1, Rebecca was able 
to narrow down the region containing the gene(s) that suppressed the CnAact sterility 
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by showing that seven smaller deficiencies did not contain any suppressors.  I then 
tested 25 genes that were within these smaller areas under the deficiency; 11 within 
Df(2R)stan1 and 14 within Df(3L)AC1.  I also tested two P-element excision lines that 
Rebecca created to try to knock out CG6927 (CG69275 and CG69277).  These results 
are summarized in Table 4.5.  I only counted the number of pupae or progeny 
produced and did not determine hatchability for these 25 genes.  However it allowed 
me to rule out certain genes and highlights which genes should be retested with both 
egg counts and progeny counts.  In addition there are seven  more stocks that still need 
to be tested: Bloomington stock numbers 6402, 19321, 12683, 16329, 28422, 22448, 
and 14968, corresponding to genes tou, CG9003, Hsp67Bb, Hsp67Ba, CG3689, 
CG43325, and RYBP respectively.  There are also nine other deficiencies for which we 
have not yet begun to identify the genes that are responsible for the suppression of 
CnAact sterility.  Once we know the identities of these genes we can start to form 
hypotheses about how they interact with calcineurin and the role they may be playing 
during meiosis and egg activation. 
 
4.4 Summary 
This chapter contains the results from two different screens that have identified 
new candidates to study for roles in egg activation.  Genes such as mod(mdg4) and 
CG6927 are prime candidates for future studies.  I also described experiments directed 
at understanding the role of Mrityu, and the importance of phosphorylation for its 
function.  In addition, neither screen is completed, suggesting that there are a number 
of new egg activation/early embryogenesis genes that remain to be discovered by 
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Table 4.5  Progeny counts from additional genes under Df(2R)stan1 and 
Df(3L)AC1, testing for suppression of CnAact sterility.  In cases where a gene is 
listed twice, each line represents an independent experiment. 
 
Deficiency Gene Stock # 
Avg # 
Progeny n 
 CG69275 NA 7 10 
 CG69277 NA 7 10 
 CnAact NA 5 10 
 CnAact NA 2 6 
Df(2R)stan1 CG7759 18535 7 9 
 CG7759 18535 23 4 
 Drip 17740 27 5 
 CG7777 14750 8 10 
 qvr 16588 12 5 
 E(Pc) 9396 12 8 
 E(Pc) 9396 18 3 
 inv 26891 10 5 
 en 5343 8 4 
 Egm 11133 22 8 
 Egm 11133 55 4 
 CG9005 12768 4 5 
 Roc2 17251 0 5 
 Tret1-1 21925 4 4 
Df(3L)AC1 Hsp22 20055 1 10 
 Hsp22 20055 11 5 
 Hsp26 20186 6 5 
 Hsp23 12545 29 10 
 Hsp23 12542 107 4 
 Hsp27 20107 3 4 
 CG4080 15068 12 5 
 eIF-4E 2470 32 8 
 eIF-4E 2470 69 5 
 Cpr67B 17771 17 10 
 Cpr67B 17771 24 5 
 CG4022 22477 12 5 
 CG3967 17568 11 10 
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 Table 4.5 (continued) 
 
Deficiency Gene Stock # 
Avg # 
Progeny N 
Df(3L)AC1 CG3967 17568 38 5 
 aay 28577 1 4 
 shc 14051 9 5 
 RpS17 6177 7 8 
 MTF-1 9241 9 10 
 Nf-YA 14501 8 5 
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these methods.  Knockdown has not been confirmed for any of the genes tested by 
germline-specific RNAi, so it is possible that some of the genes did not give a 
phenotype due to insufficient knockdown.  In these cases, the genes will need to be 
tested with additional RNAi lines or by alternative genetic methods.  Once we know 
the players, the next step will be to understand how they work together and how they 
are regulated to coordinate the various events of egg activation. 
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CHAPTER FIVE 
 
DISCUSSION 
 
Egg activation is required for a mature oocyte to become developmentally 
competent.  Prior to egg activation, mature oocytes are held in a poised, but arrested 
state: paused in a species-specific stage of the cell cycle and stocked full of inactive 
mRNAs and proteins.  Upon an appropriate trigger, such as fertilization, an initiating 
signal sets off the various events of egg activation.  In most species studied to date, 
this initiating signal appears to be a rise in cytosolic Ca2+ levels.  Two molecules that 
transduce the Ca2+ signal to regulate egg activation are the kinase CaMKII and the 
phosphatase calcineurin (reviewed in Chapter One).  However, the pathways that 
connect Ca2+ and these upstream effectors to the individual events of egg activation 
remain largely unknown.  
Since CaMKII and calcineurin are both regulators of protein phosphorylation, 
it is reasonable to predict that one way in which the Ca2+ signal is connected to each of 
the events of egg activation is through changes in protein phosphorylation state.  
Phosphorylation can rapidly alter a large number of proteins and can have a variety of 
regulatory effects.  I hypothesize that global phosphorylation changes are a key 
contributor to the complete change in cellular state that a mature oocyte undergoes at 
egg activation.  Drosophila makes an excellent model to study this hypothesis due to 
the abundance of genetic and molecular tools available in this system.  Drosophila also 
has the advantage that, as in other insects, its egg activation is triggered independent 
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of fertilization (unlike many other organisms, such as vertebrates and most marine 
invertebrates).  This allows me to specifically study changes and mechanisms 
associated with egg activation, without the confounding events of fertilization and 
embryogenesis.   
 The studies presented in Chapter Two of this dissertation show that large-scale 
phosphorylation changes take place during egg activation in Drosophila.  The 
proteomic experiments that I performed identified 311 proteins that differ in 
phosphorylation state between mature oocytes and activated eggs.  These experiments 
inform us about egg activation in multiple ways.  First, they show that phospho-
regulation does affect a large number of proteins in the mature oocyte.  This is 
consistent with our hypothesis that global phosphorylation changes are a critical aspect 
of the oocyte-to-embryo transition.  As our results are parallel to observations made in 
sea urchins (Roux et al., 2006; 2008), it is likely that dynamic phosphorylation 
changes are a conserved feature of egg activation.  
Second, the identification of hundreds of proteins that are phospho-regulated 
during egg activation inform us of the biological classes that are important during or 
immediately after this transition.  For instance, I identified proteins involved in protein 
translation, components of the sumoylation pathway, and zinc-binding proteins.  In 
addition, we can now test each of these proteins individually for roles in egg activation 
and embryogenesis.  So far my mentees and I have tested 71 genes that encode 
proteins identified by the proteomics experiments (Chapters Two and Four).  Thusfar I 
identified one new gene, mrityu, that acts immediately after egg activation during the 
first few embryonic mitoses.  Other promising candidates include Bre1, mod(mdg4), 
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CG6927, and several others, which require further studies to determine their time of 
action.   
Finally, using the phosphorylation states of specific proteins as molecular 
markers has informed us about how some of these phosphorylation changes are 
regulated, and the relationship between the egg activation genes sarah, cortex, and 
prage.  In Chapter Three, I showed that sarah, cortex, and prage are all upstream of 
Spindly dephosphorylation, while only sarah and cortex are upstream of Vap-33-1 
phosphorylation.  My data have led to our current model in which sarah acts upstream 
of cortex in a single pathway and prage acts downstream of, or in parallel to, this 
pathway.   
My studies indicate the importance of understanding the role of 
phosphorylation in the regulation of egg activation.  I have contributed to the 
identification of new candidates genes that may act at this time and have helped to 
place some of the previously known genes/proteins, and a couple of new ones, into a 
pathway.  However, a number of important questions still remain.  I believe that 
finding the direct targets of calcineurin (and/or CaMKII in other organisms) will be 
critical to our understanding of how these proteins direct egg activation.  Are these 
proteins directly responsible for the majority of the phosphorylation changes that take 
place during egg activation?  Or do they only have a small number of direct targets, 
after which additional phosphorylation changes are regulated by other downstream 
kinases and phosphatases?   
One way to begin asking these questions could be additional proteomic 
experiments comparing the phosphoproteomes of eggs laid by sarah and cortex 
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mutants to the phosphoproteome of wild-type unfertilized eggs.  So far we have not 
seen a difference in the phospho-regulation phenotypes of sarah or cortex, except in 
the severity of their effects.  Proteomic experiments would allow us to determine to 
what extent their targets overlap.  In addition, proteins that are phosphorylated in 
sarah embryos, but are dephosphorylated in cortex and wild-type embryos are good 
candidates for direct targets of calcineurin.  
Another important area of study is to understand the functional importance of 
these phosphorylation changes.  How do the different phosphorylation states of these 
proteins affect their activity, localization, etc.?  One advantage of using IMAC to 
identify phospho-modulated proteins is that this method identifies specific residues 
that are phosphorylated.  Therefore, if a protein has an interesting loss-of-function 
phenotype we already have a specific site (or specific sites) for mutational studies.  It 
seems clear that phosphorylation is important.  However, a complete understanding of 
its regulatory role will only be possible when we know not only the global 
phosphorylation changes, but also how phospho-modification affects individual 
proteins.   
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APPENDIX A 
 
INVESTIGATING A ROLE FOR NPLP3 IN THE FEMALE POST-MATING 
RESPONSE 
 
A.1  Introduction 
 Mating induces a number of behavioral and physiological changes in the 
female of Drosophila melanogaster.  These changes include increased ovulation and 
egg laying, changes in feeding behavior, and decreased receptivity to remating 
(reviewed in Avila et al., 2011).  Seminal fluid proteins, transferred from the male to 
the female during mating, are largely responsible for inducing these changes in the 
female (reviewed in Avila et al., 2011).  Studies of individual seminal fluid proteins 
have provided insight into how these proteins function (for examples see LaFlamme et 
al., 2012; Avila and Wolfner, 2009).  However, the female molecules that interact 
with seminal fluid proteins and are required for the post-mating response remain 
largely unknown.   
 To identify female genes that may be involved in responding to seminal fluid 
proteins McGraw et al. (2004; 2008) performed microarray studies to investigate gene 
expression in mated female Drosophila.  These studies identified over 1500 genes 
whose expression changed as a result of mating; 160 of these changes resulted 
specifically from the receipt of accessory gland proteins (Acps; a subset of seminal 
fluid proteins) (McGraw et al., 2004).  To further dissect the influences of specific 
Acps, additional microarrays were performed with females mated to males lacking one 
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of four individual Acps (ovulin, Acp36DE, Acp29AB, and Acp62F) (McGraw et al., 
2008).  A large number of gene expression changes were identified by this study, but 
most of these changes were very small; only 19 genes had a 2-fold or greater change 
in expression level (McGraw et al., 2008).  One of the genes that exhibited the largest 
fold change in expression level was neuropeptide-like precursor 3 (nplp3),.  Nplp3 
was expressed at higher levels when females received either Acp29AB (5-fold higher) 
or Acp62F (2.5-fold higher), as compared to females that did not receive one of these 
Acps (McGraw et al., 2008).  These data, along with the prediction that nplp3 may be 
involved in neuropeptide hormone activity and signaling (flybase.org; Baggerman et 
al., 2002), led us to focus on this gene for a role in the female post-mating response.  
Therefore, for my rotation project I used RNAi and a P-element insertion line to 
examine if expression of nplp3 affects female fecundity. 
 
A.2  Materials and Methods 
 
Flies: Drosophila melanogaster stocks were raised on yeast-glucose-agar medium at 
23 ± 2oC in a 12-h L:12-h D photoperiod.  To make nplp3 “knockouts”, a P-element 
insertion line (Bloomington stock #17988) was crossed to the deficiency line 
Df(3L)st-f13, Ki rnroe-1 p/TM6B, Tb (Bloomington Stock #2993).  To knock down 
nplp3 by RNAi in the whole female, virgin females carrying an RNAi construct for 
nplp3 [from the Vienna Drosophila RNAi Center (VDRC); transformant ID 12972] 
were crossed to tubulin-GAL4 males.  Females knocked down for nplp3 were selected 
as Sb+.  Balancer siblings were used as controls.   
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Fecundity assay:  Virgin RNAi (or P-element insertion) females and control females, 
aged 3-5 days, were individually mated with wild-type (Canton-S) males.  Following 
copulation, males were removed and females were allowed to lay eggs for 24 hours.  
Every 24 hours, females were transferred to a fresh vial and the number of eggs laid in 
the previous vial was counted.  In this way, the total number of eggs laid by each 
female over 10 days was determined.  After 15 days, the total number of adult progeny 
in each vial was also counted to determine the fertility of each female.  Hatchability 
was determined by dividing the total number of adult progeny by the total number of 
eggs laid and is presented as the average (± standard deviation) for each genotype.  N 
values are presented in the Results. 
RT-PCR: RNA was extracted from whole nplp3 RNAi or control females.  750 ng of 
RNA was treated with 1 μl RQ1 DNase (Promega) for 37oC for 30 min.  The reaction 
was stopped with 1 μl RQ1 DNase Stop Solution and a 10 min incubation at 65oC.  
cDNA was synthesized using Superscript II Reverse Transcriptase (Invitrogen) and 
according to manufacturer’s protocol.  cDNA from nplp3 RNAi and control females 
was used as the template in a PCR with primers to nplp3 or the control gene RpL32 
(which is expect to be present in equal abundance in both samples).  The reaction was 
run for 30 cycles.  Products were run along with a 1 Kb Plus DNA ladder (Invitrogen) 
on a 1% agarose gel containing 0.5 μg/ml ethidium bromide. 
 
A.3  Results 
 
 I tested whether nplp3 expression was knocked down when the VDRC nplp3 
RNAi construct (ID# 4873) was driven by tubulin-GAL4.  RT-PCR comparing nplp3 
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RNAi females to control females shows that nplp3 in the RNAi females is expressed 
at less than 10% of the levels observed in controls (Figure A.1).  As a preliminary test 
to determine if nplp3 is required for the female post-mating response, I counted the 
number of eggs laid by RNAi and control females for 10 days.  I showed that, in three 
independent trials, females knocked down for nplp3 laid significantly less eggs than 
controls over a 10 day period (Figure A.2).  Only one of these trials (trial 2) showed a 
significant effect on day 1.  In trial 2 nplp3 RNAi females laid significantly more eggs 
on day 1 than control females (p = 0.0136).   
I also tested a P-element insertion line as an independent method to remove 
nplp3 function.  I crossed this line to a deficiency to obtain nplp3 hemizygous females 
that carried the P-element.  In contrast to knocking down nplp3 by RNAi, I found no 
significant difference in the number of eggs laid over 10 days by females hemizygous 
for the P-element insertion and heterozygous controls (females carrying one copy of 
the P-element insertion and one wild-type copy of nplp3) (Figure A.3).  I did see a 
significant difference in the number of eggs laid on day 1.  However, this also 
contrasted with the RNAi results because the P-element insertion females laid fewer 
eggs on day 1 than controls (p = 0.0182).   
 
A.4  Discussion 
 
 The finding that females knocked down for nplp3 lay fewer eggs after mating 
than controls provides promising preliminary evidence that nplp3 expression in the 
female may contribute to the regulation of the post-mating response.  However, many 
experiments remain to conclusively define a role for nplp3.  While the VDRC line that  
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  Figure A.1  nplp3 is knocked down by RNAi.  (A) PCR products amplified using 
nplp3 primers.  Lanes: 1) 100% control cDNA 2) 50% control cDNA 3) 25% control 
cDNA 4) 10% control cDNA 5) 2.5% control cDNA 6) 1% control cDNA 7) 100% 
RNAi cDNA 8) 50% RNAi cDNA. (B) PCR products amplified using RpL32 primers. 
Lanes: 1) 100% control cDNA 2) 100% RNAi cDNA. 
A B
1       2      3       4     5      6       7       8 1     2
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Figure A.2  Females lay significantly fewer eggs when nplp3 is knocked down by 
RNAi.  Total number of eggs laid in 10 days (A, C, and E) and number of eggs laid 
each day over 10 days (B, D, and F) for 3 independent trials.  
n = 7                          n = 11
n = 19                          n = 19
n = 15                          n = 15
p < 0.015
p < 0.0001
p < 0.0001
A
C
E
B
D
F
p = 0.0068
p < 0.0001
p < 0.0001
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Figure A.3  There are no significant differences in number of eggs laid between 
hemizygous females with a P-element insertion in nplp3 and heterozygous 
controls.  Total number of eggs laid in 10 days (A) and number of eggs laid each day 
for 10 days (B).
A B
n = 10                         n = 17
p < 0.4
p = 0.27
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I tested successfully knocks down nplp3, it unfortunately also has 30 predicted off-
targets (stockcenter.vdrc.at).  Therefore it is possible that the egg laying phenotype 
observed for the RNAi females is due to knockdown of one (or more) of these off-
targets rather than the knockdown of nplp3.  An undergraduate in the lab has recently 
tried to repeat the egg laying results using an independent RNAi line (Bloomington 
stock #28760).  Unfortunately, she found that this line fails to knock down nplp3 and 
therefore cannot provide us with the confirmation that we had hoped for (S. Mattei and 
J. Sitnik, personal communication).  There is also a second nplp3 RNAi line that has 
become available at the VDRC since I originally performed these experiments 
(transformant ID #105584).  This line has no predicted off-targets and can be tested in 
the future to confirm that nplp3 is the gene responsible for the phenotype that I 
observed. 
 The fact that the P-element insertion line did not recapitulate the phenotype 
observed for the RNAi line, could suggest that the phenotype is in fact due to off-
target effects.  However, the P-element insertion is located in the intron of nplp3 
(flybase.org).  Therefore, the P-element may not affect gene function or expression 
and the level of nplp3 transcript expression should be determined in these females.  If 
the P-element does not affect gene expression, one possibility for future studies is to 
use imprecise P-element excision to try to knockout nplp3. 
 Provided we can confirm that nplp3 affects the number of eggs laid after 
mating, additional post-mating behaviors should also be tested.  In the microarray 
experiments, nplp3 expression was affected by Acp29AB and Acp62F (McGraw et 
al., 2008).  Acp29AB plays a role in sperm storage in the female (Wong et al., 2008) 
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and is associated with a male’s success at sperm competition (Clark et al., 1995; 
Fiumera et al., 2005).  The localization of Acp62F to the sperm storage organs, 
suggests that it too may play a role in sperm storage (Lung et al., 2002).  Gene 
association studies also show that neuronal genes are enriched among female genes 
predicted to play a role in sperm competition (Chow et al., unpublished data).  Taken 
together, these data suggest that nplp3 should be tested for a role in sperm competition 
and/or sperm storage.  Further investigations of nplp3 may help us to understand how 
the female post-mating response is regulated though female genes that work with 
transferred seminal fluid proteins. 
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